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Abstract 
The usefulness of the nematode Caenorhabditis elegans as a model of bacterial infection 
has been assessed. Initially a plate-based mortality assay was established using 
Pseudomonas aeruginosa. A novel method for assessing bacterial virulence towards C. 
elegans in liquid media was also developed. These assays were used to investigate the 
virulence of strains from the Burkholderia cepacia complex, Burkholderia pseudomallei 
and Burkholderia thailandensis. The results from the plate-based mortality assay mirrored 
the virulence of B. pseudomallei and B. thailandensis in mammals. However the results 
also showed that this method was not suitable for the investigation of the B. cepacia 
complex. Assays carried out in liquid media were not a robust measure of bacterial 
virulence for any of the Burkholderia strains tested. 
The C. elegans model was also used to investigate virulence mechanisms of B. 
pseudomallei. B. pseudomallei can adhere to and invade a variety of mammalian cell types. 
Transmission electron microscopy was used to investigate the interactions of B. 
pseudomallei with the cells of the C. elegans gut. No evidence of adherent bacterial cells 
or invasion of the tissues surrounding the gut was seen. A panel of B. pseudomallei 
transposon mutants was screened in C. elegans. A single transposon mutant was identified 
that was attenuated in nematodes and was subsequently also shown to be attenuated in 
BALB/c mice. The interrupted gene encoded a putative aldehyde dehydrogenase. This 
protein has not been previously shown to play a role in the virulence of B. pseudomallei. 
The nematode model was also used to screen a B. pseudomallei genomic cosmid library in 
E. coli for clones with increased virulence. However the data indicated that this method 
could not be utilised for the identification of B. pseudomallei virulence genes without 
further development. 
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Chapter 1: Introduction 
Chapter 1: Introduction 
Chapter 1: Introduction 
1.1. Bacterial pathogenicity and infectious disease of the mammalian host. 
Only a small proportion of the bacterial species associated with humans give rise to the 
biological changes that are interpreted as disease by clinicians. When these bacteria are 
actively growing within the host, the host is said to be experiencing an infection (Prescott 
1996). Infectious disease may then result when part or all of the host body becomes 
incapable of carrying out normal functions due to the presence of an organism or its 
products. Any bacterium that causes disease is referred to as a pathogen and its ability to 
cause disease is termed pathogenicity (Prescott 1996). 
To cause disease a pathogen must be capable of carrying out five obligatory steps. That is 
to enter the host, attach to host cells or surfaces with invasion of these cells in some cases, 
multiply within the host, avoid host defence mechanisms and finally cause damage to the 
host (Prescott 1996). Many of these steps are mediated by virulence factors (Casadevall. A 
and Pirofski. L 1999). A range of virulence factors are used by bacterial pathogens to cause 
an infectious disease. As it is not possible to provide an exhaustive description of every 
virulence factor used in each stage of infection by every bacterial pathogen of man, only 
examples of the best characterised of these and their role in each stage of infection are 
discussed below. 
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1.1.1. Entry. 
The first feature in the initiation of infectious disease is the transmission and entry of the 
pathogen into the host. The mammalian body is covered by relatively impermeable skin 
and this along with resident skin flora present a considerable barrier to infection. However 
the skin does not cover all body surfaces and is replaced by mucous membranes at the 
conjunctiva of the eye, in the alimentary tract, in the urogenital tract and in the respiratory 
tract. These offer routes of infection to pathogenic organisms as the penetration of these 
surfaces is more easily accomplished than of intact skin (Mims 1997). 
Pathogens may enter host tissues after direct contact with other infected individuals, as is 
the case with many sexually transmitted bacterial diseases such as gonorrhea caused by 
Neisseria gonorrhoeae (Prescott, Harley et al. 1996). Infectious organisms may also be 
shed into the environment during infection. This allows possible contamination of soil, 
food and water sources. Some environmental bacteria have the potential to cause disease in 
man. Thus pathogenic organisms can be ingested or inhaled from the environment or from 
other infected individuals, to cause infection of either the respiratory or alimentary tract. 
Additionally pathogens may also enter the body in an opportunistic fashion through breaks 
in the skin from wounding events or from pre-existing conditions that result in the 
disruption of the normal barriers to infection such as immunodefficiency (Mims 1997). 
Some pathogenic organisms are also transmitted via vectors such as biting insects (Mims 
1997). This allows pathogens that are not normally capable of penetrating unbroken skin to 
enter a host. This is particularly exemplified by the transmission of Yersinia pestis, the 
etiological agent of bubonic plague. Y. pestis persists in certain rodent populations in some 
3 
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parts of the world and is transmitted primarily by the rat flea Xenopsylla cheopis 
(Hinnebusch 1996). After being ingested in a blood meal from an infected host, the 
bacteria multiply in the flea gut and form a mass that can occlude the proventriculus, a 
spined chamber located between the flea oesophagus and midgut, which prevents the flea 
from feeding. During persistent attempts to feed on a new host the flea regurgitates 
infected blood containing Y. pestis into the bite site, transmitting the organism to the 
mammalian host (Hinnebusch 1996). 
Thus it is evident that some bacterial species have mechanisms that allow them to be 
transmitted from host to host, through dissemination into the environment or through 
infection of a vector that in turn allows infection of the definitive host. This however is 
only the first stage in the initiation of any infection and an outcome that results in disease 
is also dependent on the subsequent stages described below. 
4 
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1.1.2. Attachment and invasion. 
The adherence of a pathogen to host mucosal or cell surfaces is often pivotal in the 
establishment of infection. Two common mechanisms are employed by bacterial pathogens 
to attach themselves to host cells. This is through the use of fimbrae or pili and afimbrial 
adhesins. These allow a colonising organism to resist the physical removal by host 
clearance mechanisms such as peristalsis in the gut and hydrodynamic forces in the urinary 
tract. The abolishment of the ability of a bacterial pathogen to attach and colonise a 
specific host tissue, through adhesin-mediated processes, is often sufficient to cause the 
attenuation of the organism indicating the importance of these structures in virulence 
(Hultgren 1993; Klemm 2000). Bacterial adhesins can also be responsible for the tropism 
for particular tissues seen in bacterial diseases such as that caused by W. gonorrhoeae in 
the urinary tract or diarrhoea-causing Escherichia coli in the gastro-intestinal tract of 
humans (Nassif 1999). 
The best understood mechanism of adherence to host cells is through attachment mediated 
by fimbral adhesins also termed pili (Salyers 1994). Most bacterial adhesins are organised 
as organelles on the bacterial cell surface with lengths of approximately 1 µm. Some are 
thin fibres with diameters of about 2 run. Others are more rigid structures with diameters of 
5-10 nm (Klemm 2000). The bulk of the organelle generally consists of a complex of a 
single protein subunit called pilin, which is arranged, in a helical array to form a long 
cylindrical structure. This allows the formation of a long flexible structure that emanates 
outward from the bacterial surface. The role of these structures is to establish initial contact 
between the bacterial surface and the outer surface of the host cell. The tip of the fimbriae 
mostly consists of a specialised structure, containing proteins distinct from the structural 
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pilin subunits. Often it is these tip structures that mediate binding to host cell surface 
ligands such as carbohydrate residues and glycolipids (Salyers 1994). In some cases the 
structural protein itself can also act as the specific adhesin as is the case with the CFA-1 
fimbriae of entero-pathogenic E. coli (EPEC). 
The biosynthesis and assembly of fimbriae is a complex process. The secretion of pilin and 
other proteins involved in fimbriae biogenesis is usually mediated through the normal 
protein secretion mechanisms of the organism. However in some instances a fimbriae- 
specific system secretion system is used. There are two fundamentally different 
mechanisms used for the secretion of pili to their final site on the bacterial surface. This is 
represented by the autotransporter pathway and the other more complex chaperone-assisted 
surface display mechanism. The AIDA-1 adhesin of certain EPEC strains is responsible for 
the diffuse adherence to the intestinal mucosa (Klemm 2000). It belongs the 
autotransporter protein family that encompasses many other virulence factors and is 
characteristic in that the protein itself contains the required information to reach the 
bacterial cell surface and lacks a cleavable signal peptide as in some other secretion 
mechanisms. 
However, in most Gram-negative species many adhesins are displayed on the bacterial 
surface by chaperone-assisted transport, an illustrative example being type-1 fimbriae of E. 
coli (Klemm 2000). In general, chaperones aid in the transport of proteins to the outer 
membrane. The adhesive tip structure is assembled and the shaft of the fimbriae created. 
This occurs through the sequential addition of structural subunits to the proximal part of 
the structure, in doing so pushing the assembled portions outward from the bacterial 
membrane. Finally a periplasmic protein halts the extrusion process (Salyers 1994). 
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A prime example of the function of fimbrial adhesins as virulence factors is shown by the 
PapG adhesin of P fimbriae present on strains of uropathogenic E. coll. This is an essential 
virulence factor in the establishment of pyelonephritis by allowing specific binding to 
receptors found in the globoseries of the human kidney (Klemm 2000). Similarly the FimH 
adhesin of type-1 fimbriae has also been shown to contribute to the virulence of 
uropathogenic E. coli strains in the urinary tract (Bahrani-Mougeot 2002). Deletion of 
these pathogenicity determinants causes a corresponding decrease in virulence. 
Afimbral or non-pilus adhesins are proteins that although important for the adherence of 
bacteria to host surfaces do not assemble themselves into fimbriae-like structures. These 
cell surface proteins often mediate the tighter binding of bacteria to the host cell following 
the initial binding via fimbriae (Salyers 1994). 
An example of the importance of afimbrial adhesins in pathogenicity is shown by non- 
capsulated strains of Hemophillus influenzae. To cause disease H. influenzae must first 
colonise the respiratory tract. As with other Gram-negative bacteria this organism 
expresses adhesive fimbriae that are involved in colonisation. However, organisms that 
lack these fimbriae also remain capable of binding to eukaryotic cells suggesting the 
presence of afimbrial adhesins. It was subsequently found that H. influenzae expresses two 
such proteins designated HMW1 and HMW2. Both of these proteins show homology with 
filamentous hemagglutanin, an afimbrial surface protein of Bordetella pertusis . They also 
appear to play a critical role in adhesion in vivo to human epithelial cells (Hultgren 1993). 
After initial attachment some pathogens may invade host cells. This occurs through normal 
phagocytic processes or the induction of actin rearrangements at the cell surface that 
mediate engulfment in normally non-phagocytic cells. This is induced by a class of 
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bacterial surface proteins collectively called invasins (Salyers 1994). After ingestion by 
host phagocytic cells some pathogens can also escape into the cytoplasm of the cell 
through disruption of the phagosome. Once in the cytoplasm some bacterial pathogens 
continue to exploit actin to allow motility. Here condensation of actin at one end of the 
organism propels the bacterium through the host cells cytoplasm and into adjacent cells. 
This phenomenon is particularly seen in Listeria and Shigella species which have become 
the paradigm of intracellular invasion and motility (Salyers 1994). 
The adherence to and possible invasion of host cells represents the first stage in the 
establishment of a bacterial infection, where host-pathogen interactions that occur on a 
cellular level, determine the out come of that infection. If successful in colonising host 
tissues a pathogen must then multiply to allow sufficient numbers of organisms to 
overwhelm any immune response mounted by the host. 
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1.1.3. Multiplication within the host. 
To grow and multiply within a host a pathogen must first find or produce an environment 
that meets its particular requirement for nutrients, pH, temperature and redox potential 
(Prescott 1996). Some pathogens invade and grow within host cells such as the Listeria 
species already mentioned. This includes professionally phagocytic cells such as 
macrophages. Invasion allows access to an abundance of nutrients and provides protection 
from host defence mechanisms and some antibiotics (Salyers 1994). Listeria species have 
mechanisms that allow them to survive and replicate intracellularly. This includes the 
production of Listeriolysin 0, a hemolysin used to rupture the phagocytic vacuole and 
facilitate the escape of the organism into the cytoplasm. Additionally Listeria species 
produce the enzymes catalase and superoxide dismutase. These aid in protection from the 
bactericidal oxidative burst within the phagolysosome of machrophages by scavenging 
oxidative free radicals (Salyers 1994). 
Other intracellular pathogens utilise other survival strategies that allow persistance within 
host phagocytic cells. This includes the interference of phagosome and lysosome fusion, as 
seen in Mycobacterium tuberculosis infection of human macrophages and monocytes. This 
interruption inhibits the release of the bactericidal contents of the lyosome into the 
phagosome allowing survival of the organism (Malik 2000). Some pathogens also actively 
resist the change in internal environment within the phagolysosome. This is shown by 
Salmonella enterica serovar Enterica, which is able to survive the highly acidic conditions 
within the phagolysosome after lysosomal fusion. This occurs through a process called the 
acid tolerance response and allows survival of the organism and replication within 
macrophages (Clements 2001). 
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Extracellular bacterial pathogens often produce virulence factors that also aid in the spread 
of the organism from the site of initial infection. Staphylococcus aureus is the causative 
agent of a variety of both community-acquired and nosocomial infections. These range 
from superficial skin infections to life threatening conditions such as pneumonia (Sifri 
2003). The ability of S. aureus to cause a wide spectrum of disease is attributed to its 
ability to produce a broad array of virulence factors. These include hyaluronidase, which 
allows the hydolysis of hyaluronic acid in the basement membranes of eukaryotic cells 
rendering intracellular spaces amenable to passage by the pathogen (Prescott 1996). S. 
aureus may also produce fibrinolysin. This mediates the digestion of fibrin clots at 
infection sites allowing the pathogen to move from clotted areas within wounds into 
underlying tissues (Prescott 1996) thus contributing to the spread of the organism. 
Perhaps the most important attribute of a successful bacterial pathogen that facilitates 
multiplication with in the host is the ability to acquire iron from the environment. Iron is 
essential for the multiplication of all bacterial pathogens as it is a component of many 
enzymes which are required for the biosynthesis of macromolecules such as DNA and 
energy-generating electron transport systems (Rabsch 1999). However, it has been 
estimated that in vivo the concentration bioavailable Fe3+ is 10"18 M (Poole 1996). This is 
several orders of magnitude less than the 10'7 M required for bacterial growth (Braun 
2002). Bacterial pathogens employ a variety of mechanisms to acquire iron from the 
environment. However the most common method involves the production of high affinity 
iron chelators called siderophores (Poole 1996). These bind iron ouside of the cell and 
transport it through the bacterial outer membrane via specific receptors (Meyer, Neely et 
al. 1996). 
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Transcription of siderophore biosynthetic genes is tightly regulated by intracellular iron 
concentration and ferric uptake regulation (Fur) proteins (Ratledge 2000). When the 
intracellular concentration of iron is sufficient the synthesis of the siderophore and 
corresponding transport proteins is shut off. This occurs through binding of ferric ions to 
the proteins Fur and DtxR, which when bound to iron act as transcriptional repressors 
through binding to promoters containing a Fur binding sequence (Fur box). Positive 
regulation of siderophore synthesis and iron uptake may also occur in some systems 
through extracytoplasmic sigma factors (Braun 2002; Crosa 2002). These regulatory 
mechanisms allow bacteria to activate and repress sets of genes that encode proteins for the 
assembly and export of siderophores and the specific uptake of the iron-siderophore 
complexes (Crosa 2002). 
After liberation into the external milieu and binding of iron, the uptake of siderophore-iron 
complexes requires special mechanisms of ferric ion transport. In Gram-negative bacteria, 
this is achieved through the binding of the iron -carrying compounds to specific outer 
membrane proteins that function as transporters. After binding the iron complexes are 
released and transported across the outer membrane into the periplasm where they bind to 
transporter proteins. These deliver the iron to the ATP binding cassette (ABC) transporters 
of the cytoplasmic membrane which coveys it to the cytoplasm (Braun 2002). The 
siderophore component may then be recycled to be used again to acquire further supplies 
of iron. 
The release of siderophore- iron complexes from the binding site and subsequent transport 
across the outer membrane is an energy consuming process. The bacterial outer membrane 
contains no energy source due to the lack of any membrane potential. To ameliorate this 
problem Gram-negative bacteria have developed a system for energising the outer 
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membrane through the proton motive force of the cytoplasmic membrane (Braun 2002). 
This is achieved in E. coli through the Ton system, which consists of three proteins TonB, 
ExbB and ExbD. TonB spans the periplasmic space and shuttles between cytoplasmic and 
outer membrane during energy transduction with ExbB and ExbD responsible for its 
localisation in the cytoplasmic membrane (Higgs 2002). The proteins further interact with 
each other and form a complex that responds to proton motive force by binding a proton. 
This causes a structural change in TonB that converts it to an energised form. This further 
interacts with the outer membrane transporters causing ferric complexes to disassociate 
from their binding sites and diffuse through the channel that is simultaneously opened to 
the cytoplasm (Braun 2002). 
Many siderophores are capable of removing iron from host iron binding proteins such as 
lactoferrin and transferrin in vitro and thus may contribute to the ability of many organisms 
to survive and grow in the host (Meyer, Neely et al. 1996). Siderophores are then 
considered as important virulence factors in many bacterial pathogens, which allow the 
invading pathogen to grow and multiply in spite of the iron depleted conditions 
encountered in vivo. 
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1.1.4. Avoidance of host defence mechanisms 
A pathogen once within the host body is faced with a variety of non-specific and specific 
defence mechanisms that it must overcome to be able to effectively produce disease. Thus 
bacterial pathogens have evolved a number of mechanisms that allow them to circumvent 
the host immune response and promote persistence within infected tissues, a selection of 
which are described below. 
The disabling of the cells that mediate host antibacterial responses is one method used by 
pathogens to allow active avoidance of host defences. In many cases this is achieved 
through the use of type III secretion (TTS) mechanisms. This allows the contact-dependant 
delivery of effector molecules directly into a target cell's cytoplasm with a variety of 
effects on the host (Feltman, Schulert et al. 2001). Similar secretory pathways have been 
identified in a variety of animal pathogens including S. flexneri, S. enterica, EPEC and 
enterohemorrhagic E. coli (EHEC). However, one of the most completely described TTS 
systems is the Ysc-Yop virulence apparatus of pathogenic Yersinae which include Yersinia 
enterolitica, Y. pestis and Yersinia peudoturberculosis. 
The Ysc-Yop TTS of Yersinia species consists of a TTS apparatus termed the Ysc 
injectosome and set of proteins secreted by the system called Yops, which have a variety of 
detrimental effects on eukaryotic cells and in particular those of the immune system 
(Cornelis 2002). These are encoded on a 70 kb plasmid that is essential for virulence in 
animal models of infection (Haller 2000). Four of these Yop proteins exert a negative 
effect on the cytoskeletal dynamics of host cells. YopH is a phosphotyrosine phosphatase 
(Haller 2000) that disrupts the adhesion of macrophages and reduces invasin-mediated 
13 
Chapter 1: Introduction 
engulfment of cells. T and B cells exposed to YopH are impaired in their ability to be 
activated through their antigen receptors. Thus YopH contributes not only to the evasion of 
the innate immune response but may also incapacitate the host adaptive immune response. 
Furthermore YopE, YopT and YopO all exert their effects on the actin cytoskeleton. This 
leads to morphological changes in host cells, which have been shown to be essential in 
resistance to macrophage mediated killing (Cornelis 2002). Other identified Yop proteins 
do not affect the structural components of host cells but serve to modulate the immune 
response. YopP/YopJ once injected, is able to counteract the normal pro-inflamatory 
response in a variety of cell types and induces apoptosis specifically in macrophages. As 
well as the reduction of the release of TNF-a and IL-8 by macrophages it also reduces the 
presentation of adhesion molecules such as intracellular adhesion molecule-1 (ICAM-1) 
and E-selectin, reducing the recruitment of neutrophils to the site of infection. This occurs 
as a result of the inhibition of the activation of NF-KB, a transcription factor central to the 
onset of inflammatory reactions (Cornelis 2002). Finally the protein YopM also 
contributes to virulence. It belongs to a family of type III effector molecules that have 
representatives in Shigella and Salmonella spp. YopM is delivered into the cytoplasm of 
target cells where it traffics to the nucleus through the use of a vesicle-associated pathway. 
However, so far its action in the nucleus has not been elucidated (Cornelis 2002). 
Thus TTS systems can be important virulence factors that allow pathogenic organisms to 
effectively defend against phagocytic cells of the immune system. These systems may also 
modulate the signalling cascades responsible for induction of immune responses, 
abrogating their antimicrobial function and allowing survival within the host. 
The possession of a TTS system is only one example of a bacterial virulence factor that 
allows active protection of pathogenic species within a host through the attack of immune 
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cells. However other mechanisms exist that provide a more passive form of protection 
through resistance to host defence strategies. Many pathogens synthesise 
exopolysaccharides (EPS) which in most cases are polymers consisting of repeating units 
of simple sugars. These may remain attached to the cell through a lipid moiety as in Gram- 
negative species or appear covalently linked to the outer membrane as seen in Gram- 
positive organisms. These are referred to as capsular polysaccharides or capsules. 
However, EPS is also found in an unattached form surrounding the bacterial cell. In these 
cases the term slime layer or S-layer is used to describe the often loosely fitting structure 
(L1ull 2001). 
EPS production is usually associated with an increase in virulence in many pathogens as it 
may help the organism to avoid host defence mechanisms. The possession of a capsule 
inhibits activation of the complement cascade and subsequent opsonisation and killing by 
bactericidal complement components of normal serum. It is also an important determinant 
in the resistance against phagocytic-mediated killing (L1ull 2001). Although often weakly 
immunogenic capsular polysaccharides may modulate immune functions through 
influencing the production of cytokines such as the pro-inflammatory TNF, IL-8 and IL-10 
(Steinmetz, Nimtz et al. 2000). Furthermore EPS can be produced under conditions of 
environmental stress and play a key role in the formation of biofilms that can confer an 
increase in antibiotic resistance to the colonising organism. This is of particular concern in 
the hospital environment where colonisation of medical equipment such as indwelling 
catheters by pathogenic organisms is a continuous problem (Llull 2001). 
Many resistance mechanisms employed by pathogenic bacteria focus on the avoidance of 
host defence mechanisms through the interference with these processes, as described in the 
sections above. However some bacterial pathogens may also camouflage their products 
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from host defence mechanisms through mimicry of host processes or host antigens. In 
some cases mimicry is achieved through virulence factors that are direct homologues of 
host proteins. In others, evolution has produced molecules that although not similar at the 
amino acid level display mimicry at the structural level (Stebbins 2001). This is 
particularly exemplified by the hyaluronic acid capsule of some Streptococcus species. The 
structure of this extracellular component is identical to components of mammalian 
connective tissue (Mims 1997). Furthermore the cytoplasmic membrane of Streptococcus 
pyogenes contains antigens similar to those of human cardiac, skeletal, and smooth muscle, 
heart valve, fibroblasts, and neuronal tissues, resulting in molecular mimicry and a tolerant 
or suppressed immune response by the host 
(http: //www. bact. wisc. edu/Bact330/lecturespyo). 
A similar mechanism for avoidance of host immune responses is through antigenic 
variation. This allows a rapid change in the antigenic structure of bacterial surface proteins 
that ensures that any specific immune response raised against these proteins is rendered 
ineffective. This mechanism is seen in the structural components of pili and other outer 
membrane proteins from N. gonorreae. The pilin subunits off. gonorreae consist of 
constant, variable and hypervariable regions analogous to immunoglobulin molecules 
(Mims 1997). Thus spontaneous genetic rearrangements and recombinations occurring 
within genes encoding pilin proteins ensures that a different antigenic target is constantly 
presented to the host immune system. This reduces the effectiveness of the immune 
response induced and allows persistence of the organism within affected tissues. 
Avoidance of host immune responses does not always require the possession of specialised 
cellular structures. Several pathogens exploit areas that are inaccessible to host defence 
mechanisms. This includes survival within host cells and also cells of the immune response 
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itself such as macrophages. For example Shigella invade mucosal cells of the colonic 
mucosa through the M-cells of the payer's patches. The organism then ruptures the 
phagocytic vacuole in which it is internalised and divides rapidly. Lateral movement 
through the polymerisation of actin allows the infection of other adjacent cells. Hence the 
bacterium is effectively protected from the host immune response, as exposure to host 
microbicidal processes is limited (Salyers 1994). 
The small selection of virulence factors and mechanisms thus far described allow a 
pathogen to colonise, grow and persist within an infected host. However to produce disease 
a pathogen must also be able to cause damage to the host. This involves the use of a variety 
of both cell-associated and extracellular virulence factors, some of which are described in 
the section below. 
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1.1.5. Virulence factors that cause damage to the host. 
The host-pathogen interaction is reducible to two outcomes. That is, those that result in 
damage to the host causing disease and those that result in no damage to the host and 
therefore no disease. Thus disease occurs when sufficient damage is sustained to perturb 
the normal functioning of the host. In this context the word "damage" is then an inclusive 
term that encompasses damage to cells such as necrosis, apoptosis and malignant 
transformation and also organ and tissue damage represented by granulomatous 
inflammation, fibrosis and tumour (Casadevall. A and Pirofski. L 1999). 
Damage to the host can be mediated by either the pathogen or the host itself. Often the 
nature and extent of this damage is modulated by the immune status of the host. Damage in 
a host that has an insufficient immune response is primarily pathogen mediated where as 
damage in a host that mounts an abnormally strong immune response is often host- 
mediated (Casadevall. A and Pirofski. L 1999). However in interactions between pathogens 
and hosts with a normal immune status, a continuum exists that results in disease only 
when damage impairs the normal function of the host. Hence disease is one possible 
outcome of a complex host-pathogen interaction that can arise due to pathogen-mediated 
damage. 
Damage to a host can result partly from the growth of the pathogen that can often produce 
tissue alterations. However in many cases damage results from the secretion of bacterial 
exoproducts such as toxins. Most bacterial exotoxins can be classified as either membrane- 
damaging or those that have an intracellular activity. Membrane-damaging toxins may 
damage membranes through proteolytic action and in some cases through degradation of 
components of the lipid bi-layer itself. Other toxins may also be pore-forming or detergent 
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like causing cell lysis through solubilisation and rupture of the cell membrane (Mims 
1997). 
Extracellular enzymes called phospholipases are produced by many different pathogenic 
species. These remove the charged head group from the lipid portion of phospholipids, 
comprising the eukaryotic cell surface membrane. The charged head group is responsible 
for the stabilisation of the phospholipid bilayer. Hence the removal of this group results in 
membrane instability and eventual lysis of the host cell (Salyers 1994). 
The most completely studied example of a phospholipase is the a toxin produced by the 
anaerobic Gram-positive bacterium Clostridium perfringens, the organism most commonly 
associated with gas gangrene. This has been shown to be a phospholipase C, a metallo- 
enzyme that cleaves the phosporyl choline head group from phosphatidyl choline and 
spingomyelin (Mims 1997; Titball 1999). 
It is the products of the phospholipid hydrolysis and the production of diacylglycerol or 
ceramide by the enzyme rather than the overt cell membrane damage, which are 
responsible for the damage to the host. Diacylglycerol acts as an important secondary 
messenger within cells through activation of PKC and triggering PKC mediated responses. 
This includes the activation of platelet-activating factor by endothelial and epithelial cells, 
which may contribute to local inflammatory responses. PKC also activates eukaryotic 
membrane-bound phospholipases which hydrolyse membrane bound phospholipids further 
contributing to cell damage (Titball 1999). 
Unlike phospholipases pore-forming toxins insert themselves into the host cell membrane 
and form channels. The difference in osmotic potential between the extra and intracellular 
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environment allows the out flux of the cytoplasmic contents of the cell with a concomitant 
influx of water. Thus the formation of pores causes the cell to swell and eventually lyse 
due to increased osmotic pressure (Salyers 1994). Pore-forming toxins include the 
adenylate cyclase hemolysin produced by B. pertussis and the staphylococcal S, a and 'y- 
toxins (Mims 1997). 
Many toxins that act intracellularly share a similar mode of action in that they bind to 
specific receptor on the cell surface membrane are internalised and interact with an 
intracellular target (Middlebrook and Dorland 1984). Most of these toxins also share 
common structural features in that they are comprised of two basic subunits. The B subunit 
mediates binding of the toxin to the cell surface membrane and often facilitates entry of the 
toxin to the cell cytoplasm. The A subunit is the active component of the toxin, and it is in 
this that the biological activity resides that confers toxicity (Mims 1997). 
Many A-B toxins may be synthesised as a single polypeptide chain. Post-translational 
modification through proteolysis releases the A portion which can then exert its toxic 
effect on the cell. Alternatively the toxin may be produced as a more complex form that 
utilises multiple B subunits which oligomerise on the cell surface membrane and allow 
entry of the toxin to the cell. It is this B portion of the toxin which binds to specific 
receptors on the host cell and hence confers the host cell specificity and tissue tropism seen 
in many toxins (Salyers 1994). 
After the binding of the B subunit the toxic A subunit must be internalised to exert toxic 
activity. This can occur through endocytosis of the bound toxin prior to internalisation of 
the A portion. Acidification of the endocytic vacuole may further facilitate internalisation 
by causing structural changes in the A and B portions (Salyers 1994). In other cases 
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endocytotic processes do not appear to be involved. The A portion in these instances is 
seen to directly translocate through the host cell's cytoplasmic membrane to its site of 
action in the cytoplasm. 
Once internalised the activity of many bacterial toxins is enzymatic. A common 
mechanism that these enzymes employ to disrupt cellular pathways is through ADP- 
ribosylation of endogenous nicotinamide adenosine diphosphoribose (NAD) and 
attachment of the adenosine diphosphoribose moiety to a cellular substrate such as a host 
protein (Mims 1997). This in some cases inactivates components of the cellular 
biosynthetic machinery. It may also cause a marked increase in cellular metabolism which 
although not deleterious to the cell, has severe over all consequences in animals 
(Middlebrook and Dorland 1984). A number of bacterial toxins that act through ADP- 
ribosylation of host proteins have been investigated in detail, some of which are described 
below. 
Corynebacterium diptheriae is the causative agent of the disease diphtheria. The clinical 
symptoms observed are almost exclusively caused by the production of diphtheria toxin by 
the organism following colonisation of the epithelial surface of the naso-pharynx (Mims 
1997). The toxin is encoded by a ß-lysogenic bacteriophage but its expression is 
controlled by the bacterium in response to iron starvation. Diphtheria toxin is lethal to 
many animal species and to a wide range of cultured cell-lines. The toxin is disseminated 
from the site of infection and has deleterious effects on both the heart and nervous system 
(Middlebrook and Dorland 1984; Mims 1997). 
Diphtheria toxin conforms to the A-B paradigm already described with the B-subunit 
mediating binding to host cells and the A-subunit having an enzymatic activity. 
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Internalisation of the toxin occurs through receptor mediated endocytosis through clathryn- 
coated pits. This gives rise to acidified endosomes in which the low pH facilitates escape 
of the A-subunit into the cytosol. A conformational change of the B-subunit in the acidic 
conditions allows interaction with the endosomal membrane, which results in the 
formation of cation channels through which diphtheria toxin A-subunit can escape (Mims 
1997). Once in the cytosol diphtheria toxin ADP-ribosylates the cytoplasmic elongation 
factor EF-2 through binding to a modified histadine residue on the molecule called 
dipthamide. As EF-2 plays an essential role in protein production the toxin eventually kills 
host cells through inhibition of protein synthesis (Salyers 1994). 
Vibrio cholerae toxin is responsible for the severe diarrhoea seen in patients with clinical 
cholera. In contrast to diphtheria toxin, the toxin produced consists of five B-subunits and 
two A-subunits Al and A2. The Al-subunit posses the enzymatic activity used to ADP- 
ribosylate the target host protein (Middlebrook and Dorland 1984). Entry of Al occurs not 
through receptor-mediated endocytosis as with diphtheria toxin but is mediated through the 
five B-subunits and the A2-subunit after binding to the cell surface gangliside GMl (Mims 
1997). 
Once internalised the target for cholera toxin is the multi-subunit adenylate cyclase 
localised on the cytoplasmic side of the plasma membrane, which is responsible for the 
production of cyclic AMP (cAMP). This is an important second messenger molecule and is 
responsible for the amplification of cellular responses to external stimuli including 
hormones. The production of cAMP is controlled by a heterodimeric regulatory complex 
collectively called G-protein (Mims 1997) ADP-ribosylation of the G-protein by cholera 
toxin interferes with the proper functioning of the adenylate cyclase causing the over 
production of cAMP. This causes a number of metabolic defects, among which is the loss 
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of control of iron flow within the cell. This subsequently results in the loss of water from 
host tissues, which is seen as the watery diarrhoea characteristic of the disease (Salyers 
1994). 
Not all bacterial virulence factors cause direct damage to host systems. Some may also 
cause damage indirectly through the induction of immune responses. This includes the 
production of inflamatory mediators such as cytokines, thromboxanes and prostaglandins 
(Salyers 1994). This method of damage is particularly exemplified by the role of 
lipopolysaccharide (LPS) in Gram-negative bacterial sepsis. 
LPS is found predominantly in Gram-negative bacteria and is an integral component of the 
bacterial outer membrane (Salyers 1994). This molecule is also referred to as endotoxin as 
the administration of LPS to animal models has a variety of toxic biological effects. 
Diseases in which endotoxin mediated responses may play an important role include 
typhoid fever, bubonic plague and brucellosis. It is also considered important in a variety 
of nosocomial infections caused by Gram-negative opportunistic pathogens particularly 
after surgery such as E. coli, Enterobacter species and Serratia marcessens (Mims 1997). 
It is the lipid A portion of LPS that is the toxic moiety. The polysaccharide component 
although not directly toxic is also important for conferring stability on micellar aggregates 
of LPS. These may form as membrane derived blebs during growth of some species or 
after cell lysis (Mims 1997; Beveridge 1999). These interact with the host to produce a 
wide array of biological activities with often very complicated modes of action. 
LPS released into the bloodstream is first bound by special plasma proteins called LPS- 
binding proteins. These LPS-LPS binding protein complexes then interact with CD14 
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receptors on monocytes, macrophages and with other receptors on endothelial cells. This 
causes the release of vasoactive substances and activates the alternative complement 
cascade. It may also activate factor XII that is the first step in the coagulation cascade, 
which then may result in disseminated intravascular coagulation in the terminal stages of 
the disease. Many of these reactions are due to the release of cytokines from macrophages 
and other cells in response to endotoxin. These include IL-1 (IL-la and IL-1) IL-6, IL-8, 
TNF-a and PAF that in turn stimulate the release of protaglandins and leukotriens (Salyers 
1994). 
Only small quantities of LPS are required to stimulate cytokine release. Production of the 
endogenous pyrogens IL-la, IL-1 P and TNF-a act on the hypothalamus and give an 
elevation of body temperature within one hour (Salyers 1994). There is an effect on 
circulation, leading ultimately to vascular collapse. Different vascular regions are effected 
depending on species but in man the most noticeable changes are seen to occur in the lungs 
(Mims 1997). If large amounts of LPS enter the bloodstream vascular pooling may occur 
along with a drastic fall in blood pressure. Thus as endotoxin enters the blood stream 
during Gram-negative bacterial sepsis, the vasomotor action of LPS becomes important 
and the effect is seen systemically as septic shock. This may then subsequently lead to 
multiple organ failure and death (Mims 1997). 
Thus a successful bacterial pathogen has a multitude of capabilities represented by its 
complement of virulence factors. These are intrinsic to its status as a pathogen and allow 
virulence. Without the special abilities conferred by these virulence factors a bacterium 
could not produce disease. 
Several brief examples of how some bacterial virulence factors can contribute to disease in 
the mammalian host have already been given. However the role of these has not been 
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discussed in relation to particular species that are seen as successful pathogens of humans. 
To this end, examples of two pathogenic species are given and the interaction of the 
virulence factors that they use to cause disease are discussed in detail in the following 
sections. 
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1.2. Pseudomonas aeruginosa: The bacterium and mechanism of virulence 
Pseudomonas aeruginosa is a Gram-negative, non-fermentative rod that is ubiquitous in 
the environment. It is found in soil and wetland habitats as well as associated with plant 
and animal tissues. Though normally free living, it can cause opportunistic infections 
particularly in the hospital environment where it has become the pathogen most frequently 
isolated from individuals who have been hospitalised for more than a week. It is capable of 
multiplying in eye drops, disinfectants and even in the small pools of water that collect on 
sinks (Vindenes and Bjerknes 1995). Increasingly P. aeruginosa is also becoming an 
important pathogen in immunocompromised individuals where it can cause a systemic 
infection, with mortality rate approaching 100%. A common feature of infections 
involving P. aeruginosa is the interruption of the natural barriers that protect from 
infection, allowing entry of the organism to the body. Unfortunately, P. aeruginosa is 
naturally resistant to many antibiotics often making effective treatment impossible 
(Prescott, Harley et al. 1996). 
Cysitic fibrosis (CF) is the most common autosomal recessive trait found in approximately 
tin 2000 caucasian individuals. The mutated gene responsible for this disorder has been 
identified as a transmembrane protein called the CF transmembrane regulator (CFTR). 
CFTR functions as a chloride ion transporter with mutations giving defects in chloride ion 
transport. The imbalance of ions leads to the aggregation of very viscous and dehydrated 
bronchopulmonary and gastrointestinal secretions which block the male sex ducts, the 
ducts to the pancreas and the airways to the lungs (Nelson, Butler et al. 1994). Mucous 
producing glands continuously secrete, causing them to swell and cysts to form. In the 
lungs this "sticky" layer impairs the function of the muco-cilliary system, which results in 
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the inefficient clearance of microorgansims. Also the high sodium concentration in the 
mucous of CF patients has been found to inhibit the activity of bacteriocidal peptides 
secreated by respiratory epithelial cells (Saini, Galsworthy et al. 1999). The increased 
susceptibility to bacterial infection often results in a persistent colonisation, which in turn 
initiates chronic inflammatory responses. This chronic microbial colonisation of the airway 
by a number of different bacterial species and in particular P. aeruginosa, is the major 
cause of mortality in CF patients, accounting for up to 90% of deaths. 
The genome of P. aeruginosa has been sequenced and found to be larger than most of the 
other bacterial genomes so far sequenced. At 6.3 Mb and 5,570 open reading frames 
(ORFs) the genetic complexity of this opportunistic pathogen approaches that of a simple 
eukaryote (Hancock 1998; Stover, Pham et al. 2000). Of all the sequenced bacterial 
genomes to date P. aeruginosa has the highest proportion of regulatory genes. This 
includes a large number of genes in the LasR, AraC, and ECF-a groups and two- 
component regulator families (Hancock 1998). These systems permit organisms to respond 
to environmental changes rapidly and are often associated with the regulation of virulence. 
Hence the increased environmental versatility and pathogenic potential observed in P. 
aeruginosa is the product of a high degree of genetic complexity. 
1.2.1. Virulence factors produced by P. aeruginosa and their role in disease. 
P. aeruginosa produces a range of cell-associated and extracellular products, some of 
which have been identified as key virulence determinants. These include pili, exoenzymes, 
siderphores, Pseudomonas exotoxin A, TTS systems and EPS (Vindenes and Bjerknes 
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1995). These may work synergistically or along with the hosts own immune response to 
cause damage to infected tissues. 
Adherence of P. aeruginosa to cell surfaces is mediated through the use of a class of 
protein adhesins called type IV pili. These are also involved in twitching motility and have 
been implicated in a form of social movement called swarming. Type IV pili have also 
been shown to be essential in the formation of biofilms on both biotic and abiotic surfaces 
(Bellido, Martin et al. 1992) and so may mediate initial colonisation of the lung, as biofilm 
formation is essential for persistent colonisation of respiratory tissues. Additionally a 
decrease in virulence is observed when the genes involved in pili bisynthesis are 
inactivated through mutation, indicating their importance in the virulence of this organism. 
In its late logarithmic to stationary phase P. aeruginosa is capable of secreting high levels 
of the degradative enzyme elastase. This elastolytic activity of P. aeruginosa has been 
shown to be important in disease, particularly in lung infections, as up to 30% of the total 
protein in the lung is comprised of elastin that allows the lung to expand. The elastolytic 
properties stem from the co-ordinated activity of two enzymes, LasA and LasB. LasA, a 
serine protease, nicks the protein probably causing it to denature, allowing LasB, a zinc 
metalloprotease to degrade it. The elastolytic activity is likely to be the major cause of the 
direct damage and the haemorrhaging observed in P. aeruginosa infections of the lung. 
The proteins may also aid in the establishment of infection and aid in the avoidance of 
non-specific immune responses due to their ability to degrade components of the 
complement cascade (Prescott, Harley et al. 1996). 
The acquisition of iron by P. aeruginosa involves the secretion of two chemically 
unrelated siderophore molecules, pyoverdin and pyochelin. The receptors for ferri- 
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pyoverdin and ferri-pyochelin have also been well studied. In addition to the characteristic 
negative regulation by iron concentration mediated indirectly through the Fur repressor, 
expression of the receptors is also positively regulated by the production of corresponding 
siderophore (Meyer, Neely et al. 1996; Poole 1996). 
Pyoverdins (also called pseudoactins) have been shown to be the most important 
siderophore produced by P. aeruginosa (Meyer, Neely et al. 1996). They are characterised 
by a conserved hydroxyquinolone moiety called the chromophore and an amino acid tail of 
variable length. The differences in this side chain are used to differentiate the various 
pyoverdins produced by the pseudomonads and are likely to be responsible for the 
observed specificity of pyoverdin utilisation by individual strains of P. aeruginosa (Poole 
1996). The siderophore is capable of removing transferrin-bound iron in vitro which may 
contribute to the organism's ability to grow in human serum (Meyer, Neely et al. 1996). 
Pyoverdin as also been shown to be required for the colonisation of the lung in a rat model 
of infection (Choi 2002). Pyoverdin is then important for iron acquisition and growth in 
the lung environment and thus likely contributes to the chronic pulmonary P. aeruginosa 
infections seen in those patients with CF (Poole 1996). 
Unlike pyoverdin, pyochelin only exhibits low affinity for iron in vitro. However the 
siderphore has been shown to promote bacterial growth and lethality when injected into the 
peritoneal cavity of mice along with avirulent mutant strains of P. aeruginosa (Choi 2002). 
It may also contribute to virulence through the production of free radicals and damage of 
endothelial cells. Thus its role in the virulence may not be related to the acquisition of iron 
in vivo. 
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Pseudomonas exotoxin A has the same cellular activity as diphtheria toxin in that it 
inhibits protein synthesis by cleavage of NAD+ and ADP- ribosylation of elongation factor 
(EF) 2 (Mims, Dimmock et al. 1997). However the two proteins differ antigenically and 
cross reactivity of neutralising antibodies has not been reported. Different receptors on the 
cell surface are also used by the toxin subunits to facilitate entry to the cell through 
receptor mediated endocytosis. Originally LPS was thought to be the most toxic 
component associated with P. aeruginosa but Pseudomonas exotoxin A has since been 
reported to be 20,000 times more toxic than LPS in animal studies. Mutants deficient in 
Pseudomonas exotoxin A production show reduced pathogenicity, indicating a direct role 
in virulence (Bodey, Bolivar et al. 1983; Whitt and Salyers 1994). Furthermore the toxin 
has also been shown to contribute to disease process through tissue damage and reduction 
of the bactericidal activity of macrophages and other phagocytic cells (Whitt and Salyers 
1994). 
An important virulence determinant of P. aeruginosa is the TTS mechanism. This has been 
shown to be present in almost all clinical and environmental isolates of P. aeruginosa 
(Feltman, Schulert et al. 2001). Currently four effector proteins, secreted through the P. 
aeruginosa TTS system have been identified. These include ExoS, ExoT, ExoU and ExoY 
(Fink-Barbancon 2001). ExoS belongs to the family of ADP-ribosylating toxins that 
include cholera toxin and pertussis toxin, which are capable of ADP-ribosylation of a 
number of host proteins such as Ras and Rab. This effects vesicular traffic within the cell 
resulting in eventual cell death. For full enzymatic activity ExoS must first be activated by 
a eukaryotic 14-3-3 protein (Barbieri 2001). After activation, the enzyme is cytotoxic to 
eukaryotic cells and has been reported to play a role in disease caused by this organism 
(Barbieri 2001). 
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The amino-terminus of ExoS contains a GTPase-activating domain for Rho GTPases. This 
induces cell rounding through actin rearrangements within target cells (Feltman, Schulert 
et al. 2001). Thus ExoS may also play a role in disease through the modulation of bacterial 
internalisation into cells (Feltman, Schulert et al. 2001). Studies suggest that it may disrupt 
epithelial cell signal transduction pathways, resulting in breakdown of the epithelial 
barrier, hastening the onset of disease (Goranson, Hovey et al. 1997). It can also impair 
phagocytosis by affecting both the cytoskeleton-engulfment process and phagosome 
maturation (Barbieri 2001). 
The other effector molecules of the P. aeruginosa TTS system have so far been poorly 
characterised. ExoT also like ExoS has an ADP-ribosyltranferase activity. It is also a 
GTPase activating protein that is capable of inhibiting bacterial internalisation by 
eukaryotic cells (Feltman, Schulert et al. 2001). The role of ExoY in the pathogenesis of P. 
aeruginosa has not yet been fully determined but it has been shown to be an adenylate 
cyclase that is capable of elevating intracellular cAMP levels. Likewise the mechanism of 
action of ExoU has not been defined. The enzyme mediates the killing of a wide range of 
mammalian cell types in as little as 3-4 hours of the initial infection. These include 
macrophages, epithelial cells and fibroblasts. In animal models of lung infection the 
delivery of ExoU by P. aeruginosa causes acute cytotoxicity and appears to play a major 
role in the septic shock caused by the organism. It may also aid in evasion of the host 
responses by decreasing macrophage viability and phagocytic function (Fink-Barbancon 
2001). 
An interesting and extensively studied virulence factor of P. aeruginosa is the production 
of an exopolymer comprised of mannuronic and guluronic acid called alginate. Conversion 
to the alginate producing phenotype is often associated with a chronic persistent 
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colonisation of the lung in CF and signifies a poor prognosis for the patient, as infection is 
seldom eradicated even with aggressive antibiotic therapy (Govan and Deretic 1996). 
Alginate surrounding the bacterium or as a free substance may contribute to the 
pathogenesis of the organism in several ways. Alginate surrounding the cell may serve as 
a direct barrier against phagocytic cells and effective opsonisation by antibodies. It is also 
capable of quenching reactive oxygen species and scavenging the hypochlorite molecules, 
important in the bactericidal ability of macrophages (Govan and Deretic 1996). 
Alginate also plays a role in the adhesion of P. aeruginosa to biotic surfaces such as the 
respiratory epithelia. Alginate may act as a non-pilus adhesin aiding in the formation of the 
characteristic microcolony containing biofilm found in the lungs of CF patients. 
Furthermore, in these and other affected individuals alginate may have imunomodulatory 
effects through suppression of lymphocyte function and stimulation of the production of 
the proinflamatory cytokines IL-1 and TNF-a. Alginate also stimulates the release of IL-8 
from epithelial cells, which possibly contributes to the recruitment of neutrophils, which 
dominate the inflammation of the airways in CF (Govan and Deretic 1996). 
Although alginate only plays a limited role in the primary adhesion of the organism it does 
directly contribute to the persistence of the organism in the lung. It is likely that alginate 
interferes with the action of antibiotics through mechanical restriction of antibiotic 
penetration to the cell. Thus contributing to the inability of mucoid P. aeruginosa strains to 
be eradicated from the lung even with very aggressive antibiotic therapy (Govan and 
Deretic 1996). 
P. aeruginosa is an important pathogen that is responsible for a variety of life-threatening 
conditions largely in immunocompromised populations. However other related genera also 
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have the capacity to cause disease in humans. This is particularly exemplified by some 
members of the Burkholderia genus. These are capable of causing severe disease in the 
immunocompromised but importantly also in apparently healthy individuals. 
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1.3. Burkholderiapseudomallei: The bacterium and mechanisms of virulence. 
Burkholderia pseudomallei, formerly Pseudomonas pseudomallei is an environmental 
saprophyte that is capable of causing a wide spectrum of disease in a variety of hosts 
including humans, dolphins, sheep and pigs which is collectively known as melioidosis 
(Ellis 1999). Although very similar to Burkholderia cepacia in both biochemical and 
chemical characteristics (Kanai 1994) B. pseudomallei is considered the more dangerous 
pathogen as it causes a more severe disease in humans. It has also recently been described 
as an emerging pathogen that could represent a potential global problem as its prevalence 
increases (Dance 2000). 
Melioidosis was first described by Whitmore in 1913 after observation of a previously 
undescribed disease affecting the population of the Indian city of Rangoon (Whitmore 
1912). It was not until the late 1950's when investigators began to understand that both 
man and animals were likely to be exposed to the organism through contaminated soil and 
water (Dance 2000). Later, attention was focused on the organism as a consequence of the 
military operation of American soldiers in the Vietnam War. A disproportionate number of 
helicopter crewmen were reported to develop pulmonary melioidosis. This was thought to 
be caused by inhalation of contaminated dusts raised by helicopter rotor blades. This 
prompted further research into the ecology and distribution of B. pseudomallei and the 
prevalence of melioidosis in endemic areas (Kauai 1994). 
In the environment B. pseudomallei is a free-living soil saprophyte, which is found in 
tropical areas from 20 °N to 20°S of the equator. It is isolated most frequently in China 
(Yang 2000), Africa, the Indian subcontinent, Iran, sub-Saharan Africa, Northern 
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Australia, Papua New Guinea (Currie, Fisher et al. 2000) and Central and South America 
(Dance 2000). These consist of two main serotypes classified on the basis of thermostable 
and thermolabile antigens. Serotype 1 possesses both types of antigen and is found 
predominately in Asia. However serotype 2 has only themostable antigens and is found in 
Australia and Africa (Yang 2000). The increase in world travel to areas of endemicy has 
also increased the isolation rate of B. pseudomallei and cases of melioidosis have now been 
recorded in Europe (Kanai 1994). 
Sites most likely to contain B. pseudomallel are cleared cultivated or irrigated agricultural 
sites such as sports fields, animal paddocks and rice paddies. In endemic areas such as 
Northeast Thailand where melioidosis is common, the number of B. pseudomallei per gram 
of soil is up to 20 fold higher than in other non-endemic areas (Dance 2000). In these 
areas, those in contact with rice paddies may be at particular risk of B. pseudomallei 
infection as many of the conditions found in wet rice paddies favour the growth of the 
organism. The optimum temperature for growth of B pseudomallei is 37- 42 °C and at a pH 
between 5.0 and 8.0. These conditions are found in rice fields of Northeastern Thailand 
which is covered in mostly acidic soils (Kanai 1994). Within the rice paddy the action of 
nitrifying and denitrifying bacteria allows anaerobic conditions to form. As B. 
pseudomallei is a facultative anaerobic organism which can obtain energy through nitrate 
reduction in anaerobic environments the conditions encountered seem ideal for the 
pathogen's growth (Kanai 1994). The application of nitrate fertilisers to rice fields may 
also contribute to the organisms proliferation in agricultural land as the addition of 
supplementary nutrients to the environment may promote its growth (Dance 2000). 
There is a strong correlation between rainfall and the incidence of B. pseudomallei 
infection, as 75% of cases are reported during the rainy season (Dance 2000). The isolation 
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rate of B. pseudomallei is highest from clay soils. Bacteria and water are thought to be 
attracted to clay particles through electrostatic interactions. This retains moisture that 
would normally be lost in the dry season, possibly contributing to the organism's 
persistence in endemic areas. The rise in the water table in the rainy season would then 
carry bacteria to surface waters increasing the chance of exposure (Ellis 1999). However 
this seasonality of infection may also reflect the increased exposure to the organism during 
rice harvesting and planting which occur at the wettest times of the year. 
It has been reported that approximately 80% of the population in Northeastern Thailand are 
sero-positive for antibodies to B. pseudomallei by the age of 4 years old (Ellis 1999). Also 
in these areas B. pseudomallei is responsible for 20% of the community-acquired 
septicaemia observed in the indigenous population (Chaowagul, Suputtamongkol et al. 
1993; Brett and Woods 2000). Thus B. pseudomallei infection represents a major health 
concern to both rural and urban communities in endemic areas. 
Infection is thought to occur through one of several possible routes. These include the 
inoculation of organisms through penetrating wounds or through existing skin lesions 
(Brett and Woods 2000). The aspiration of contaminated water during near drowning 
episodes, iatrogenic inoculation and laboratory acquired infection which result in 
melioidosis have also been shown to occur. There are no reports of animal-to-human 
spread but person-to-person spread of B. pseudomallei has been documented twice (Dance 
2000). Arthropod-borne infection has also been reported to occur although this has only 
been demonstrated under laboratory conditions (Ellis 1999). There are no well documented 
cases of infection through ingestion although experimental animals can be infected through 
this route (Dance 2000). 
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Disease, after a usual incubation period of 2-3 days, may lead to one of four of different 
clinical outcomes which include acute fulminant septicaemia, sub-acute illness, chronic 
infection and sub-clinical disease (Ellis 1999). The disease may be disseminated 
throughout the body or localised to a particular organ. However pathology most commonly 
occurs in the liver, spleen and lung (Brown, Boddy et al. 2002). 
The acute septicaemic form of melioidosis is characterised by meningitis with cutaneous 
and sub-cutaneous lesions and may be rapidly fatal. This form of the melioidosis is 
usually associated with an additional underlying disease or condition (Haase, Janzen et al. 
1997). The most common predisposing factors are diabetes mellitus, chronic renal disease, 
alcoholism, malignancy, connective tissue diseases, HIV and steroid therapy (Dance 2000) 
(Ellis 1999; Brett and Woods 2000; Ulett, Currie et al. 2001). These conditions lead to 
immune deficits including phagocytic defects, diminished humoral responses and 
diminished cytokine production which possibly contribute to the increase in susceptibility 
observed (Dance 2000). 
A second form of the acute disease is pulmonary melioidosis. This has been reported to be 
the second most frequent form of disease presentation and is often mistaken for 
tuberculosis (Kanai 1994). The disease is characterised by a high fever, respiratory distress 
and the appearance of visceral abscesses. As with the septicaemic form, if left untreated 
death often occurs within days and in severe cases in as few as 48 hours (Haase, Janzen et 
al. 1997). Both forms of acute disease have a very high mortality rate of approximately 50- 
75% (Ellis 1999) and death may occur even if prompt and aggressive antimicrobial 
chemotherapy is carried out. 
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The sub-acute form of the disease is characterised by a prolonged fever with multiple 
abscesses on the viscera. In the latter stages of the disease bacteria can be isolated from 
blood, pus, urine and other bodily secretions. This may then represent a possible 
mechanism for environmental dissemination of the organisms to non-endemic areas. 
Death from the sub-acute disease may occur in a few days or after months if the condition 
is left untreated (Leelarasamee and Bovornkitti 1989). This is unlike the sub-clinical form 
where death only occurs on activation of the disease by a traumatic event. It may be even 
left undiagnosed only to be detected upon post-mortem examination of tissues (Brett and 
Woods 2000). 
Melioidosis with neurological involvement without meningitis only occurs in a small 
percentage of cases. The disease affects the brainstem and spinal cord and can cause facial 
palsy and motor weakness similar to that seen in Guillian-Barre syndrome, a progressive 
demylination of the motor neurones (Currie, Fisher et al. 2000). A number of patients with 
neurological melioidosis have been reported to also have perforated eardrums. Thus entry 
through the damaged timpanic membrane in these individuals may be a further source of 
inoculation, through exposure to contaminated water (Currie, Fisher et al. 2000). 
Although B. pseudomallei can cause severe and often rapidly fatal illness it may also form 
latent infections in infected individuals. These can then recrudesce to give disease 
anything up to 26 years following the initial exposure to the organism (Mays and Ricketts 
1975; Brett and Woods 2000). The relapse of latent infections has previously been 
associated with recovery from acute B. pseudomallei infection. Analysis of 16s ribosomal 
DNA (ribotyping) of organisms isolated from patients with reoccurring disease has shown 
that almost all cases of reinfection are actually relapses caused by the original infecting 
strain (Chaowagul, Suputtamongkol et al. 1993; Ellis 1999; Jenney 2001). 
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In one study the reported median time to relapse was approximately 21 weeks with the 
chance of relapse falling with a longer disease free interval (Chaowagul, Suputtamongkol 
et al. 1993). It has also been shown that a number of factors may influence the likelihood 
of relapse. These include the severity of the original disease presentation and the level of 
dissemination of the organism throughout the patient. Other factors thought to contribute to 
the relapse of latent infections include the invasion and survival of B. pseudomallei within 
privileged sites such as phagocytic cells and the persistence of the organism within non- 
phagocytic cells (Brown, Boddy et al. 2002). Large numbers of organisms are also found 
in the sealed off abscesses that are characteristic in the pathology of melioidosis. This may 
represent another potential source of reinfection and relapse of disease in previously 
infected individuals (Chaowagul, Suputtamongkol et al. 1993). Relapse is reported to be 
much more likely in those who have had systemic disease. The choice of initial 
antimicrobial treatment may also be an additional risk factor, as appropriate treatment can 
reduce the risk of relapse by half (Chaowagul, Suputtamongkol et al. 1993). Additionally, 
although as already described acute melioidosis is more prevalent in those with pre- 
existing medical conditions such as diabetes, no such link with underlying disease and the 
chance of relapse has been described. 
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1.3.1. Virulence factors produced by B. pseudomallei and their role in disease. 
B. pseudomallei produces a wide variety of extracellular and cell-associated virulence 
factors. These include proteases, lecthinases, lipases, siderophores and putative toxins that 
have a cytolethal or cell elongating activity. Suggested cell associated virulence factors 
include pili, LPS, flagella and an EPS capsule (Ellis 1999; Corbett 2003). These 
presumably allow the organism to colonise a potential host and persist intracellularly 
within the body while also allowing avoidance of the host immune response as in other 
pathogenic species. The precise role of these virulence determinants in the pathogenesis of 
melioidosis is not fully understood and many remain poorly characterised (Ellis 1999). 
However the release of the completed B. pseudomallei K96243 genome from the Welcome 
Trust's Sanger Center (http: //www. sanger. ac. uk/Projects/B_pseudomallei/) will underpin 
new studies concerning the pathogenesis of B. pseudomallei and provide valuable missing 
information regarding the molecular basis of the pathogenicity of this organism in the 
mammalian host. 
A number of biochemical, immunological and molecular approaches might be taken for the 
identification of B. pseudomallei virulence factors that are important in disease. A selection 
of these techniques are described in the following sections. 
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1.4. Approaches to the identification of bacterial virulence factors. 
Before the advent of accepted scientific methodology and modem techniques the 
investigation of bacterial virulence was limited to the determination of an organism's 
ability to cause disease. This was achieved through the use of a set of postulates 
formulated by Koch in the 1800s. These stated that a causal link could be drawn between a 
particular organism and a disease if; (1) the bacterium was consistently found in those with 
the disease or its products found in parts of the body affected by the disease. (2) The 
bacterium could be isolated from lesions and maintained in culture. (3) Re-administration 
of the organism to a susceptible host should produce symptoms of disease. (4) Finally the 
same bacterium should be re-isolated from the infected host. However due to the inability 
to culture some pathogenic organisms and subsequent advances in technology coupled 
with a deeper understanding of bacterial pathogenicity Koch's postulates became too 
restrictive (Salyers 1994). Thus a new view of the investigation of bacterial pathogenesis 
was taken based on investigation of host-pathogen interactions using more powerful 
techniques. 
1.2.1. Classical methodologies. 
Before the advent of molecular biological methods and genome sequencing, technologies 
for the identification of bacterial virulence factors were limited to biochemical and 
immunological methods. Biochemical methods relied principally on the purification of a 
molecule suspected of mediating a particular host-pathogen interaction and studying its 
action in both in vitro and in vivo systems (Salyers 1994). This type of approach allows 
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detailed information to be obtained about the physical properties of a molecule, which 
would not be available any other way. However, this method has two important 
limitations. Firstly, the molecule being studied must have an measurable activity. The 
biochemical approach is then most useful when the identity of a bacterial virulence factor 
is known or suspected. A second limitation of the biochemical approach is that 
measurements on a purified molecule in vitro may not reflect its activity in vivo. To prove 
function in vivo, an immunological approach must be taken (Salyers 1994). 
The immunological approach to the identification of a bacterial virulence factor was to 
determine whether antibodies to a bacterial product were protective in animals infected 
with the bacterium from which the product originated. If protection was seen, the bacterial 
product can be assumed to contribute to virulence. However antibodies to bacterial surface 
components may allow protection from infection through opsinisation of bacterial cells or 
through the enhancement of complement mediated killing. Thus a link between the 
production of antibodies to a particular virulence factor and the pathogenicity of a given 
organism cannot be made, without information given through the use of the biochemical 
techniques already described. 
The use of specific antibodies to bacterial virulence factors has also allowed the 
development of other technologies that have been useful in the isolation and confirmation 
of suspected virulence factors. This includes immunoelectron microscopy. This method 
allows the direct observation and localisation of bacterial products in infected host tissues, 
through binding of specific antibodies carrying a marker detectable through the use of 
electron microscopy. Also techniques such as enzyme-linked immunosorbent assay 
(ELISA) have been developed. This method relies on specific antibodies to a known or 
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suspected virulence factor and can be used to monitor levels of particular bacterial 
products through out the course of an infection (Quinn 1997). 
The use of these classical techniques has provided a wealth of information about a variety 
of bacterial virulence factors and their role in disease. However the process of 
identification was slow, and often limited to products that had an obvious role in disease 
such as toxins or specific adhesins. This limitation was addressed through the advent of 
modem genetic methods. These have allowed the development of new approaches to the 
identification of bacterial virulence factors. This has lead to a re-definition of Koch's 
postulates of disease. This new set of criteria is called the molecular Koch's postulates and 
gives three conditions that must ideally be met to allow identification of genes involved in 
virulence. These are: (1) specific mutants deficient in the phenotype of interest must be 
isolated, (2) the wildtype virulence gene must be cloned and (3) the wildtype phenotype 
must be restored through re-introduction of the wildtype gene into the mutant (Quinn 1997; 
McDaniel 2000). 
The wide availability of molecular biological methods and the relative ease with which 
these can be used to address the molecular postulates of disease has lead to the 
development of newer technologies that rely on three basic approaches. This includes 
mutagenesis, complementation analysis in avirulent strains and analysis of differential 
expression of genes in response to the host environment. However, although a wide variety 
of molecular biological methods now exist based on these themes, to acquire accurate 
information regarding the virulence mechanisms used by human pathogens through these 
methods, a model system utilising animals or parts of animals inevitably must be used 
(Quinn 1997). 
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1.4.2. Animal models of bacterial infection. 
Due to ethical constraints, humans can rarely be used as a model system to study bacterial 
pathogenesis. Therefore in order to identify virulence determinants experimental models 
that mimic the specific environment of the natural host are required (Quinn 1997). A 
variety of model systems have gained acceptance as appropriate for the study of human 
disease. Although not an exhaustive this list includes non-human primates, guinea pigs, 
mice and genetic variant mice. It also includes other less commonly used animal species 
such as hamsters, rabbits, dogs and the nine-banded armadillo. 
The mouse model has become the most commonly used small animal model for 
microbiological research (Houpikian 2002). A wide variety of different wildtype mouse 
strains have been created through selective breeding of desirable characteristics with 
subsequent inbreeding to maintain the phenotype in the population. Large numbers of 
spontaneous and radiation induced mutations are also available. This allows for differential 
responses to particular pathogens to be induced and has given insights into many disease 
processes. Isogenic knock-out strains of mouse are also available. In these mice, defined 
mutations in targeted genes of the germ line give rise to selectable phenotypes (Rossant 
1998). These may resemble inherited genetic disorders such as CF (Davidson, Dorin et al. 
1995) and may also give rise to other phenotypes useful in the investigation of bacterial 
pathogenicity. This includes the lack of an immune system or a down regulation of a part 
of the immune system, such as the lack of a particular cytokine or cell-surface receptor 
(Kuhn 1991). 
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Non-human model systems may have considerable disadvantages with regard to the 
logistical burdens experienced during animal husbandry. Also, safety concerns when 
working with animals infected with dangerous pathogens such as B. pseudomallei must be 
addressed. However, without the use of these animal model systems many modern 
techniques for the identification of bacterial virulence factors described in the following 
sections would not be possible. 
1.4.3. Mutagenesis. 
One of the earliest and most widely used techniques for the investigation of bacterial 
virulence involved the creation of mutants in the pathogen of interest. In the past this has 
been achieved through the use of changes in culture conditions or DNA damaging agents 
such as chemicals and irradiation (Quinn 1997; McDaniel 2000). When used in 
conjunction with enrichment strategies (McDaniel 2000) for particular mutations this 
approach has proved particularly powerful. However the limiting factor in this approach is 
that the gene in which the mutation occurs cannot be easily identified. This limitation was 
addressed with the discovery of transposons, which have revolutionised the investigation 
of bacterial pathogenicity. 
Transposons were identified some 60 years ago and are defined as mobile genetic elements 
that can move within the bacterial genome and integrate randomly (Salyers 1994; Lehoux 
2001). Transposons commonly carry a selectable marker such as resistance to a particular 
antibiotic. This makes the selection of mutants simple. The position of the transposon can 
be determined and this facilitates cloning of the genes of interest (Salyers 1994). Thus 
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transposon mutagenesis has become one of the most commonly used and inexpensive tools 
for the molecular-genetic study of bacterial virulence. 
Although very effective with considerable advantages over the other methods described, 
transposon mutagenesis has disadvantages. Potentially, libraries of thousands of mutants 
are created each with a transposon insertion in a single gene. To identify mutations that 
affect virulence, each mutant must be screened in a suitable host. However to screen the 
entire genome of a pathogen a prohibitively large number of animals would be required. 
This problem was first addressed by Hensel et al (Hensel, Shea et al. 1995) who described 
a modification of transposon mutagenesis method called signature-tagged-mutagenesis 
(STM). This allows multiple transposon mutants to be screened in the same animal 
simultaneously for their inability to survive in vivo. This is achieved through the tagging 
of each transposon with an 80 base pair (bp) tag, which has a variable central portion and 
constant flanking regions. The unique tag then allows the detection of a given mutant 
through DNA-DNA hybridisation (Fuller, Kennedy et al. 2000). Briefly a pool of mutants 
is used to infect an animal. At an appropriate time post infection the bacteria are recovered. 
The tags in the recovered pool are then amplified using the polymerase chain reaction 
(PCR) and used to probe an array consisting of all the tags present in the innoculum. 
Mutants displaying an attenuated phenotype are seen as those that are absent from the 
output pool as shown by a lack of binding on the array (Foulongne, Bourge et al. 2000). 
Although originally developed for the study of Salmonella enterica serovar Typhimurium 
pathogenesis, STM has also subsequently been used to identify virulence factors in other 
bacterial species including V. cholerae (Chiang and Mekalanos 1998), Brucella Buis 
(Foulongne, Bourge et al. 2000), Yersinia enterocolitica (Darwin and Miller 1999), B. 
pseudomallei (Atkins 2002), P. aeruginosa and Mycobacterium tuberculosis (Fuller, 
Martin et al. 2000). 
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1.4.4. Complementation analysis. 
Mutation of bacterial pathogens and screening the resulting mutant library for mutations in 
virulence related genes, represents only one approach for the identification of bacterial 
virulence factors. Another method for identifying virulence determinants is through 
complementation analysis. 
Complementation analysis requires the identification of congenic pairs of virulent and 
avirulent strains and tools that allow transfer of genes from the virulent strain to its 
avirulent counterpart. Putative virulence genes can be isolated from virulent strains and 
transferred to the avirulent strain. If transfer confers virulence, a role in pathogenicity can 
be shown for the selected gene (Quinn 1997). However this approach requires that the 
cloned gene has a known or suspected function. Furthermore standard cloning procedures 
using plasmid vectors are limited in that they isolate only small portions of the bacterial 
genome less than 30 kb (Salyers 1994). Therefore, this method is most successful if only 
single or a few linked genes are sufficient to induce a virulent phenotype. 
This limitation is addressed through the use of different cloning vectors such as cosmids. A 
cosmid vector is formed from components of plasmids and bacteriophage X In addition to 
the antibiotic selection markers and origin of replication (ori) commonly used in plasmid 
vectors, cosmids also contain one or more cohesive-end sites (cos) (Ehrich 1987). This 
allows recognition of the vector and its insert by the packaging system of the X 
bacteriophage. Using this method relatively large segments of DNA, up to 42 kb can be 
packaged into phage heads. These can then be used to transfer cosmids, through 
transfection , into a suitably competent E. coli host (Collins and Hohn 1978). 
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By repeating this process with fragments of DNA from a pathogen, ordered libraries 
representing the genome of the organism, housed in thousands of individual cosmid clones, 
can be created. These clones can then be propagated and used for investigation of the 
function of the genes contained with in the cosmid insert. If the inserted sequence confers 
an increase in virulence to the otherwise non-pathogenic host, the genes contained within 
the cosmid insert may then be considered as potential virulence factors. 
This approach has proven valuable for the investigation of virulence in a variety of 
pathogens including Salmonella enteritidis (Park 1997), B. pseudomallei, Burkholderia 
mallei (Abaev 1997), V. cholerae (Connell 1995) and P. aeruginosa (Franklin 1993). It 
continues to be an important adjunct to other commonly used techniques, allowing an 
insight into the genetic basis of virulence. 
1.4.5. Differential expression analysis. 
The methods discussed so far have focussed on the search for virulence associated genes 
through an approach involving the creation of mutations or the expression of cloned genes 
in heterologus host species. These methods although very powerful are not specific for 
genes only expressed in vivo. Other methods have been subsequently developed that allow 
the enrichment of genes specifically active during infection. 
Bacteria generally express genes when this benefits survival. Accordingly the expression 
of a subset of genes in vivo is necessary for a pathogen to colonise, survive, replicate and 
cause disease (McDaniel 2000). This principle has been exploited in several strategies for 
the identification of candidate virulence genes, based on their preferential expression 
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within animals or under laboratory conditions that mimic the environment within the host. 
Some of these methods entail the isolation of mRNA, others involve the identification of 
promoters with host-specific activity. Once mRNAs or promoters are identified, the gene 
itself can then be identified by using a short segment of the corresponding amino acid or 
nucleotide sequence and DNA sequencing. This can be compared to genomic DNA 
sequence databases or used as a probe to clone the gene from an unsequenced genome, 
facilitating investigation of the genes of interest (McDaniel 2000). 
An example of a technique that utilises host-mediated selection of genes expressed during 
infection is in vivo expression technology (NET). IVET was first described for the 
identification of virulence-related genes in the Gram-negative organism S. enterica serovar 
Typhimurium (Lowe 1998). In the IVET system, a promoter fusion library is constructed 
in which cloned promoters direct the expression of a gene that complements a defect in an 
auxotrophic mutant of the host strain, along with a selectable marker. When introduced 
into a suitable model, only promotors which are active in vivo are identified (Quinn 1997). 
Bacteria which also show complementation in vitro are discarded. Using this method 
several S. enterica serovar Typhimurium in vivo induced (ivi) genes have been isolated that 
are expressed exclusively during murine infection (Quinn 1997). 
Although now adapted for use in many other Gram-negative and Gram-positive organisms, 
including Yersinia and staphylococcal species, many of the genes that have so far been 
isolated using IVET have been so called "house-keeping" genes that are involved in 
general biosynthetic processes or transcriptional regulation (Valdivia 1997). However 
these genes may also be of interest as potential virulence factors active during the disease 
process. Hence IVET is considered to be an important strategy for the identification of 
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bacterial virulence determinants and continues to be applied to the investigation of a 
variety of pathogenic species. 
Other methods of differential expression analysis have also been developed. Differential 
fluorescence induction (DFI) is a semi-automated method that allows the isolation of 
conditionally active promoters through fusion to the green fluorescent protein (GFP) 
(Valdivia 1997). GFP originally isolated from the jellyfishAequorea victoria, when 
excited with blue light fluoresces green. This signal can then be detected by a fluorescence 
activated cell sorter (FACS). Thus promoters corresponding to many potential virulence 
related genes, can be rapidly isolated. When compared to NET, DFI has yielded a high 
proportion of virulence genes relative to housekeeping genes (McDaniel 2000). 
The majority of genome wide studies of in vivo gene expression has used techniques such 
as NET and DFI (Mangan 2002). Although these procedures have lead to the 
identification of putative virulence factors, they are time consuming, technically 
challenging and difficult to apply to many genetically intractable organisms. Moreover 
they only partially probe the genome of a given pathogen for virulence related genes. 
However, new technologies have emerged to monitor bacterial gene expression at a whole 
genome level during host-pathogen interactions. One such technology is microarray 
analysis (Mangan 2002). 
Using microarrays it is possible to identify genes that are preferentially expressed under 
the environments of interest or at particular time points throughout the infection process 
(McDaniel 2000). Genes that are up regulated under each given condition can then be 
assumed to be important for survival or persistence of the organism (Moxon 2002). 
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Much of the interest in bacterial whole genome microarrays lies in the identification of 
gene expression profiles associated with a particular environmental condition or stage of 
infection. In this way a correlation between expression and function may be derived for 
many of the genes of bacterial genomes with no known function, some of which may be 
involved in virulence (Mangan 2002). The potential of microarray technology is great and 
it will continue to provide information concerning the interplay of genes needed by 
pathogenic organisms to cause disease. However, the other more traditional techniques 
described here, will still be required to elucidate the contribution of individual genes to 
pathogenesis and disease. 
The techniques described in this section merely identify candidate virulence genes. These 
cannot be considered as true virulence related genes until they have met further criteria to 
satisfy the requirements of the molecular Koch's postulates. In many cases this can only be 
achieved through the use of a suitable model system such as animals. 
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1.5. Alternative animal models of bacterial infection. 
Animal models utilising higher order organisms remain the gold standard for the in vivo 
investigation of bacterial pathogenicity. However, in today's socio-political climate the use 
of animals has become undesirable and the minimisation or elimination of the use of 
animals in research is actively encouraged (Smith and Oyston 2002). Thus, the scientific 
community has adopted the ideals of the three R's approach to animal experimentation first 
proposed by Russel and Birch more than 40 years ago (Rowan 1980). The reduction, 
replacement and refinement of existing animal models has driven the development of 
alternative technologies for the substitution of animals in science. 
An alternative model of infection is defined as one that does not use higher order 
mammalian species such as mice, rabbits or non-human primates. Some alternative models 
use cell culture techniques. This allows experimental investigations of tissue tropism, 
colonisation and tissue destruction, particularly when relating to human pathogens which 
are often not possible to perform in whole animal models. Thus, when identifying bacterial 
genes required to establish human disease, in vitro model systems containing human cells 
may be more appropriate (Quinn 1997). However, cell culture systems generally utilise 
monolayers of cells attached to an artificial substrate and so have significant limitations in 
the study of bacterial pathogenesis. The most obvious of these being that they are artificial 
systems and do not represent the complex interactions that occurs in a whole animal. 
This limitation is addressed through the use of alternative animal models of bacterial 
infection. These may use insect, vertebrate or non-vertebrate hosts in place of mammals. 
This partly ameliorates the various ethical and legislatory problems involved with the use 
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of experimental animals. It also allows large assays to be carried out and the host-pathogen 
interactions occurring at each stage of the infection can be studied at the molecular level. 
This can be achieved through the creation of mutants in host and pathogen, which are both 
generally amenable to genetic analysis. All this can be done without consideration for the 
numbers of individual animals being used and at a fraction of the cost of that of classical 
animal models. Importantly some of those virulence genes found to be important in the 
pathogenesis towards alternative models of infection have also been found to be essential 
in disease of classical mammalian models, thus showing their value for the investigation of 
bacterial pathogenicity (Tan 2002). 
1.5.1. Fish 
Currently the only alternative vertebrate host that has been used for the investigation of 
bacterial pathogenicity is the Zebra fish, Danio rerio. Most alternative model organisms 
currently in use lack defence systems important in mammalian host-pathogen interactions 
including leukocytes, innate cellular immunity and adaptive immune responses. In contrast 
the zebra fish has a well-developed immune system that is similar to that of mammals. 
This includes the ability to produce immunoglobulin, antigen processing cells, T cells and 
B cells as well as the possession of leukocytes capable of producing reactive nitrogen and 
oxygen species (Neely 2002). 
Due to the availability of standard genetic techniques for manipulation of zebra fish genes, 
its small size and rapid generation time the zebra fish has become an important model for 
the investigation of vertebrate development. Ongoing genomic sequencing has also 
identified numerous orthologues of human genes. This suggests that the zebra fish can be 
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used in the functional analysis of these genes as models of human disease (Neely 2002). 
Although originally considered as a model of vertebrate development the zebra fish has 
now been used as an alternative model for the study of strains of streptococci pathogenic to 
both fish and humans. 
Streptococcus iniae is a pathogen of both fish and mammals, originally identified from 
subcutaneous abscesses on Amazon fresh water dolphins (Neely 2002). In fish the most 
common presentation of S. iniae infection is meningoencephalitis. Systemic invasive 
infection is also common which resembles some streptococcal infections of humans, 
including that caused by S. pneumoniae. In humans, S. iniae infection commonly causes 
soft tissue diseases such as cellulitis of the hand. This resembles soft tissue diseases 
including pharyngitis, necrotising faciitis and myositis caused by S. pyogenes. Thus the 
infection of zebra fish with S. iniae reproduces many features of many important 
streptococcal infections in humans, several of which can cause life-threatening systemic 
disease (Neely 2002). 
S. pyogenes can also infect and cause disease in zebra fish. The pathogenesis of the 
infection is distinctly different from that of S. iniae and very similar to that reported for 
experimental, fatal intramuscular infection in primates. Use of the S. pyogenes-zebra fish 
model has identified S. pyogenes genes that contribute to pathogenicity in both fish and 
mammalian models. These include genes involved in toxin expression, peptidoglycan 
resistance to lysosyme and putative ABC transporter proteins (Neely 2002). This model 
has allowed the identification of genes important in the production of disease. This 
suggests that it will be of use for the investigation of other pathogenic species that are also 
capable of infecting fish. 
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1.5.2. Insects 
The fruit fly Drosophila melanogaster spends a part of its life cycle in decaying organic 
matter, such as dead and rotting fruit. In this environment it often acts as a vector for 
microbial infection. The adult flies transmit yeast and bacteria from one plant to another 
while the larvae deliver them deeper into the fruit as they burrow (Tzou 2002). As a result 
Drosophila has evolved efficient mechanisms to prevent microbial infection. 
In addition to the impermeable chitinous cuticle of the gut Drosophila also possesses a 
complex innate immune system that protects it from pathogenic attack. Initially disruption 
of the cuticle induces rapid proteolytic cascades that lead to blood clotting and 
melanisation. This allows the production of cytotoxic reactive oxygen species. Secondly a 
cellular immune response is initiated. This is mediated by different types of blood cells or 
haemocytes that participate in pathogen clearance by phagocytosis (Dushay and Eldon 
1998). Finally, a set of inducible effector molecules are produced during systemic 
infection. These include antimicrobial peptides (AMPs), stress response proteins, factors 
involved in the opsonisation of invading organisms and iron sequestering molecules. 
Production of these factors occurs in an organ called the fat body which has been likened 
to the mammalian liver (Tzou 2002). 
The signal transduction cascade that underlies this process has been the subject of intense 
investigations. They have revealed that there are numerous similarities to the mammalian 
innate immune response. In both insects and mammals, Toll family receptors signal 
through Rel family transactivators, mediating responses that are specific to different 
classes of pathogens (D'Argenio, Gallagher et al. 2001). Thus the genetic tractability of D. 
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melanogaster makes it an ideal model for the study of the mammalian innate immune 
response to bacterial pathogens. 
D. melanogaster is susceptible to a wide range of human bacterial pathogens, including P. 
aeruginosa. When injected with P. aeruginosa strain PAO1, bacteria grow exponentially 
within the fly, which eventually dies. This observation suggests that D. melanogaster could 
be used as an alternative model of infection that could be used screen mutants of P. 
aeruginosa for attenuated phenotypes. 
Through the use of this model D'Argenio et al (D'Argenio, Gallagher et al. 2001) screened 
approximately 1500 transposon-insertion mutants of P. aeruginosa strain PA01 for those 
that were impaired in fly killing. The screen subsequently identified 33 mutants that 
displayed an attenuated phenotype when compared to the parent wildtype strain. All of 
those mutants that were strongly impaired in fly killing also had defects in twitching 
motility. However, twitching motility was not required for full virulence in D. 
melanogaster. This suggested that the genes required for twitching motility and fly killing 
control the expression of yet unknown virulence factors important in pathogenicity in fruit 
flies (Tan 2002). The pil /chp transduction system consisting of thepilGH JKL 
chpABCDE gene cluster in which all of the mutations occurred may be important for 
virulence in both flies and mammals (D'Argenio, Gallagher et al. 2001). Other insect 
species have also been used for the study of bacterial virulence such as the larvae of the 
greater wax moth Galleria mellonella and the larvae of the silk moth Bombyx mori. These 
are susceptible to a range of opportunistic human bacterial pathogens similar to D. 
mellanogaster. This includes Proteus vulgaris, Serratia marcecsens and P. aeruginosa but 
importantly also V. cholerae and S. aureus (Jander, Rahme et al. 2000; Kaito 2002). 
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B. mori the silk worm although susceptible to infection by P. aeruginosa strain PA14 is 
also colonised and killed by strains of S. aureus, V. cholerae and EHEC 0157. Again 
mutants with reduced virulence in the silk moth also exhibit reduced virulence in 
mammalian models of infection. Additionally it has also been shown that these infections 
can be eradicated through the use of clinically relevant antibiotics. This suggests that 
supplementary to the investigation of the molecular events of the host-pathogen 
interaction, B. mori may also be useful for the preliminary evaluation of antibiotics prior to 
their investigation in mammalian models (Kaito 2002). 
Other attributes of B. mori that make it particularly attractive as an alternative animal 
model of bacterial infection is its relatively large mass of 150-250 mg. This enables the 
injection of defined doses of bacteria that allows the examination of the pathology of the 
infection and the calculation of the precise dose at which 50 % of animals die (LD50) 
something not easily attainable with other alternative models (Jander, Rahme et al. 2000). 
1.5.3. Amoeba 
Dictyostelium discoideum is a bactivorous, unicellular amoeba that lives in soil. Usually 
the cells exist in the amoebal form and are highly motile, ingesting bacterial cells through 
phagocytosis. However, during starvation, the organism undergoes a complex 
developmental cycle in which the normally free-living cells aggregate to form a 
multicellular organism. This takes the form of a motile, phototactic slug that further 
develops into a fruiting body containing D. discoideum spores. These are then released to 
colonise other areas where nutrients are available after germination again to the amoebal 
form (Solomon, Rupper et al. 2000). 
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The endosomal and phagosomal processes involved in D. discoideum phagocytosis have 
been well characterised and found to be very similar to that of mammalian macrophages 
(Solomon, Rupper et al. 2000). This has lead to the use of D. discoideum as a model for 
the study of the host-pathogen interactions between mammalian macrophages and 
intracellular bacterial pathogens. 
Usually, the study of macrophage-pathogen interactions is hampered by the fact that these 
cells are not amenable to genetic analysis. However the availability of suitable genetic 
tools makes D. discoideum a genetically tractable host. The organism is haploid and has a 
relatively small genome of 34 Mb. It is possible to transform cells through electroporation 
and inactivate genes by homologus recombination and marker replacement. There are also 
plasmids that replicate in the amoeba that can be used for complementation or ectopic 
expression of artificially introduced genes. This along with the availability of a complete 
genome sequence makes D. discoideum a particularly powerful model for the study of 
pathogen interactions with macrophages (Solomon, Rupper et al. 2000; Pukatzki 2002; 
Tan 2002). 
The D. discoideum model has been used to study the interactions between L. pneumophila 
and human macrophages. The pathogenesis of the bacterium within mammalian hosts and 
its ability to grow in D. discoideum has been shown to be closely linked. There is also 
strong genetic evidence that the molecular basis for L. pneumophila invasion of amoeba 
and entry into human macrophages are similar (Tan 2002). 
Through the use of this model it was found that growth of L. pneumophila in D. 
discoideum is dependant on functions provided by so called dot/icm genes that are 
responsible for contact-dependant cytotoxicity. These may form a transport system 
responsible for transferring an as yet unidentified effector protein or proteins in to the host 
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cell, causing lysis and death (Solomon, Rupper et al. 2000). The relevance of this model to 
mammalian pathogenesis is further supported by the finding that mutants in each of the 
dotH/icmK, dotl/icmL and dotO/icmB genes that had severe intracellular growth defects in 
mouse bone marrow-derived macrophages also failed to grow intracellularly in D. 
discoideum. 
The alternative animal models of bacterial infection already described have all been shown 
to be effective for the investigation of bacterial pathogenicity. They allow the investigation 
of the various factors that contribute to pathogenesis in the mammalian host at the 
molecular level, while only utilising a minimum of higher order organisms to confirm 
these observations. However, although these models show some utility the most widely 
used and best-characterised pathogenesis model, currently in use in many laboratories is 
the nematode worm Caenorhabditis elegans. 
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1.5.4. The nematode Caenorhabditis elegans. 
C. elegans is a free-living nematode round-worm belonging to the family Rhabditidae in 
the phylum Nematoda. Members of this phylum are many and diverse and have become 
well adapted to a free-living existence in nearly all terrestrial and marine habitats. Some 
have also adopted a parasitic mode of life in a wide variety of plant and animal hosts 
(Wixton, Blaxter et al. 2000). 
C. elegans is found in many parts of the world mainly among decaying vegetation where it 
lives by grazing on microbes (Wixton, Blaxter et al. 2000). The female is a self-fertilising 
protandrous hermaphrodite, which first produces sperm and then oocytes forming a brood 
of about 300 eggs. The male although a similar size, at approximately 1mm, is 
morphologically distinct and only occurs at a very low frequency in the population. The 
male worm may fertilise the hermaphrodite, but hermaphrodites are not able to fertilise 
each other (Wood 1988). 
C. elegans is able to propel itself forward or backward through co-ordinated undulatory 
movements of the body wall muscles. It may respond to a variety of stimuli such as touch, 
temperature and many different volatile chemical compounds. When placed on a 
temperature gradient they tend to move towards the temperature to which they were 
previously exposed through a process called nociception (Wittenburg 1999). 
Juvenile worms hatch from the egg and develop through four larval stages, punctuated by a 
moulting of the cuticle, to allow further maturation to the next larval stage. If conditions 
become unfavourable during larval development an alternative to the usual third larval 
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stage may be produced, called the dauer larvae, which is resistant to a variety of 
environmental stresses. When conditions improve the dauer moults and continues its 
development. The emerging adult is fertile for a period of approximately 4 days during 
which time egg laying occurs along with mating if male worms are present. The adult then 
lives for further 10-15 days after which it dies (Wood 1988). 
C. elegans can be easily maintained in the laboratory where it can be grown on agar plates 
seeded with E. coll. It may also be cultured in a liquid media either with E. coli or 
axenically to a high population density. Throughout its life cycle the body is transparent 
allowing observation of cellular differentiation at each developmental stage through the 
use of differential interference contrast (DIC) Normarski imaging techniques (Schnabel 
1999). In this way the entire developmental history of every cell in the nematode, from the 
founder cells of the early events of embryogenesis within the egg to adulthood has been 
described in detail. The application of electron microscopy to serial sections of the 
nematode has also allowed the construction of a list of the identified epithelial, muscle, 
neuronal and other cell types that comprise the entire anatomy of the adult nematode 
(Hodgkin, Palsterk et al. 1995). 
C. elegans is not only simple biologically but also relatively simple at the genetic level. 
The haploid set of chromosomes includes five autosomes and a sex chromosome which are 
all approximately equal in size, giving a total of approximately 8x 107 bp, which 
apparently approaches the limit for a differentiated metazoan animal (Hodgkin, Palsterk et 
al. 1995). Sex is determined chromosomally, depending on the ratio of autosomes to sex 
chromosomes. Hermaphrodites are diploid for all six chromosomes (XX), whereas males 
are diploid for the autosomes only and have one X chromosome (XO). Males arise 
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spontaneously in populations by X-chromosome non-disjunction at meiosis, with a 
frequency of approximately 1 in 500 individuals (Wood 1988). 
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Figure: I. I. Scanning electron micrograph of the nematode C. elegans. The size of the 
specimen indicates that it is in the second larval stage. Specimens were prepared using the 
method described in section: 2.2.2.2. 
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1.5.4.1. The C. elegans life history. 
The nematode life history starts with the fertilisation of mature oocytes by the 
hermaphrodites own sperm or sperm obtained from a male at a previous mating. This is 
stored within a specialised storage organ called the spermatheca until required for 
fertilisation. During the first 30 minutes after fertilisation the chitinous eggshell develops, 
derived from components within the egg. This tough layer renders the egg impermeable to 
most solutes and allows survival outside the uterus (Wood 1988). The chitinous layer is 
often the thickest layer comprising the eggshell and gives structural strength to protect the 
developing embryo within (Wharton 1980). 
The eggs are retained for approximately 3 hours and are then deposited through the vulva 
to the outside environment. Embryogenesis follows where selected cells move, proliferate 
and die according to a precisely timed pattern that is identical from one growing embryo to 
another. This gives rise to a fixed number of cells with pre-determined fates. 
Approximately 7 hours after fertilisation cell proliferation ceases almost entirely and 
during the following 7 hours the developing body elongates, neuronal processes grow and 
the cuticle is secreted (Wood 1988). A photomicrograph of the C. elegans egg is shown in 
Figure 1.2. a. 
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Figure: 1.2. The developmental stages of the nematode C. elegans. Figure 1a: eggs, lb-1 e: 
hermaphrodites from L1 to L4 stage respectively. If. a young adult, I g: fully-grown adult 
hermaphrodite and Ih: adult male. Scale bar = 400 µm. 
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The first larval stage (L1) (Figure: lb. ) hatches from the egg 14 hours after fertilisation. It 
is approximately 250 µm long and consists of 558 cells in the hermaphrodite and 560 in 
the male. About 10% of the cells in the Ll are blast cells that divide during subsequent 
larval development and contribute to the hypodermis, nervous system, musculature and 
gonad. Also at this stage the cells in the gonad primordium begin to divide and this 
continues through adulthood. Over a period of 50 hours larval development proceeds 
through three additional stages, L2, L3 and L4 (Figure: 1.2. b-e). Like that of the embryo, 
the post embryonic cell divisions follow precise patterns of multiplication giving rise to a 
fixed number of cells with pre-determined fates. Each larval stage is punctuated by a moult 
where new cuticle is synthesised under the old. Pharyngeal pumping ceases during this 
period called lethagus while the old cuticle is shed (Wharton 1980; Wood 1988). The 
cuticle at each larval stage differs both structurally and molecularly. A diagrammatic 
representation of the C. elegans life cycle is shown in Figure 1.3. 
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Figure: 1.3. A diagrammatic representation of the life cycle of the nematode C. elegans. 
The duration of each larval stage is shown in parentheses. The black arrows represent 
moults. The 8 hours from the egg to Ll stage is the interval between egg laying and 
hatching. The entire life cycle takes approximately 3 days at 25°C. 
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1.5.4.2. The Dauer Larvae. 
The dauer larvae (German; enduring) (Figure: 1.4. ) is an alternative third larval stage that 
is formed under conditions of environmental stress. Environmental signals such as lack of 
food or adverse temperature promote the formation of the characteristic stage in C. 
elegans, which is adapted for long term survival and dispersal (Riddle 1988). The 
concentration of a specialised dauer pheromone, produced constitutively by the population, 
acts as a measure of population density and also prompts the transition to the dauer stage 
under conditions of over-crowding. The dauer is non-feeding and has morphological 
adaptations that allow it to become resistant to a range of stresses including dessiccation, 
chemical detergents and temperature. The larvae show behaviour that is not seen in any 
other larval stage. Feeding and pharyngeal pumping is completely stopped and they often 
lie motionless. However they show a rapid response to touch by moving away from the 
stimulus. Dauer larvae also have a tendency to climb up objects that protrude from the 
substrate. They have the unique ability to stand on their tails and wave their heads back 
and fourth. This may be an adaptation to aid in the dispersal of the organism through 
attachment to insects or larger animals (Cassada and Russel 1975). 
The dauer larvae are considered to be non-ageing because the duration of the dauer 
diapause does not affect the post-dauer life span (Riddle 1988). They may be maintained 
for up to 70 days (Klass and Hirsh 1976). If they are subsequently placed under more 
favourable conditions, developmental commitment to exit the dauer stage occurs within 1 
hour. After approximately 2-3 hours the larvae begins to feed and resumes its development 
by moulting to the L4 stage (Riddle 1988). 
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Figure: 1.4. The non-ageing dauer larval stage. Note the changes in morphology as 
compared to Figure: 1.2. d a normal L3 larvae. The dauer L3 larvae is longer and thinner 
than the normal L3 larvae with a dark colouration due to storage granules within the gut. 
Scale bar represents 200 µm. 
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1.5.4.3. The L4 Larvae 
At the fourth larval stage the formation of the gonad is complete. In the hermaphrodite, 
sperm production begins which is stored in the spermatheca. At the final moult to 
adulthood the sperm production stops and subsequent meiosis and differentiation generates 
only oocytes. A characteristic and diagnostic feature of the fourth larval stage is the vulval 
plug. This consists of a single cell that blocks the opening of the vulva to the outside 
environment. At the final moult this is lost with the shed cuticle opening the vulva and 
allowing eggs to be laid. Figure: 1.5. shows the vulval plug as a white spot plugging the 
vulva. This allows easy differentiation of the L4 larvae from the other larval stages by 
microscopy (Wood 1988). 
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Figure: 1.5. A phase contrast photomicrograph of the vulva of an L4 larva. The arrow 
shows the vulval plug that is characteristic of the L4 larval stage. Scale bar represents 20 
µm. 
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1.5.4.4. The Adult Male 
Males are morphologically distinct from hermaphrodites as they are smaller and have 
specialised structures for mating. They also have a number other less obvious differences 
involving behaviour, musculature and the nervous system (Hodgkin 1988). The 
development of the male gonad follows a different lineage as it is geared primarily to the 
production of sperm only and not oocytes as in the hermaphrodite. Other physiological 
differences include the intestine, as in the hermaphrodite this is the site of yolk production. 
The region of the biggest physiological difference is the tail. The tail contains several 
complicated sex specific structures. These include the phasmids, sensory appendages that 
are involved in the positioning of the copulatory apparatus during mating. The tail is 
comprised of an acellular cuticular fan supported by rays. There are two copulatory 
spicules that lie in channels associated with the genital tract. These are extensively 
sclerotized giving them structural rigidity. During mating these are inserted into the vulva 
of the hermaphrodite by means of the protractor muscles, muscles in the tail region 
specialised for copulation. Sperm is introduced which is stored in the spermatheca and 
preferentially fertilises the oocytes (Hodgkin 1988). Males are capable of cross-fertilising 
hermaphrodites and yield equal numbers of males and hermaphrodites. However the 
higher growth rate of the hermaphrodite population means the frequency of males in the 
population remains low. Males have a longer reproductive life than that of the 
hermaphrodite and may produce up to 3000-4000 functional sperm during the 6 days of 
their fertility (Hodgkin 1988). 
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1.5.4.5. Innate immunity in C. elegans. 
The term innate immunity refers to a number of evolutionarily ancient mechanisms that are 
used by plants and animals to defend themselves against infection (Mallo 2002). Although 
a very simple organism, C. elegans has a complex innate immune system, which shows 
similarities to that of insects and mammalian species. This is comprised of a set of 
inducible lipases, lysosymes and lectin-binding proteins under the control of the 
transforming growth factor ß (TGF-ß)-related gene dbl-1. These are expressed in the 
intestinal tract of the nematode and act directly against invading microorganisms and may 
serve in self, non-self recognition of pathogens as in other organisms (Mallo 2002). 
The C. elegans innate immune system also contains a pathway with homologies to the 
mammalian p38 mitogen activated protein kinase (MAPK) pathway. The p38 homologues 
PMK-1 and PMK-2 signal through SEK-1 and NSY-1. These are orthologues of the 
mammalian MAPK kinase MKK3/MKK6 and MAPK kinase kinase ASK-1 respectively. 
This mechanism has been shown to mediate programmed cell death in the nematode germ 
line in response to S. enterica serovar Typhimurium infection. Mutations in the 
corresponding genes also give rise to an enhanced susceptibility to infection (Esp) 
phenotype indicating their importance in the C. elegans innate immune system (Kim 2002; 
Aballay 2003). 
Finally homologues of mammalain Toll-like receptors (TLR) have been found in C. 
elegans. These encode transmembrane proteins containing extracellular leucine-rich 
repeats (LRR) and an intracellular domain known as the TolUinterlukin receptor (TIR) 
domain. In mammals the LRR domains of TLR's are involved in the recognition of 
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conserved molecular patterns of pathogens, activating the innate immune response (Kopp 
1999; Tan 2002). However, unlike the Toll systems found in humans and fruit flies C. 
elegans only possesses one Toll-homologue, tol-1. This is only expressed in cells of 
developing larvae and in certain classes of neurones in the adult nematode. Studies have 
shown that instead of functioning to arm pathways of the innate immune system as in other 
organisms it is essential for correct larval development. It has also been shown to function 
in pathogen recognition but due to its neuronal localisation it modulates behaviour to avoid 
potential pathogens (Pujol, Link et al. 2001). 
1.5.4.6. C. elegans as an alternative model of bacterial infection. 
In 1965 Sidney Brenner first proposed the use of C. elegans as promising model organism 
for a concerted genetic, ultrastuctural and behavioural investigation of development and 
function of a simple nervous system (Wood 1988). As a result of this vision C. elegans 
became the first and so far only animal for which the complete cell lineage and neuronal 
wiring diagram is known. As a further consequence of Brenner's original work, in 1998, C. 
elegans provided the first complete genome sequence to be determined for any 
multicellular organism (Hodgkin 2002). Since this time C. elegans has been used as the 
typical model metazoan and has allowed the investigation of cell lineage and function in 
other free-living and parasitic nematode species. The availability of a complete C. elegans 
genome sequence has also allowed the deduction of the structure and function of genes in 
other nematode species due to the large amount of structural homology seen between genes 
of members of this phylum (Wood 1988). In addition to its role as a model organism for 
biological processes in eukaryotes, recent studies have shown that useful attributes of the 
nematode model may exist in the investigation of host-pathogen interactions. 
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A variety of both Gram-negative and Gram-positive bacterial pathogens have been shown 
to cause the death of C. elegans by three different mechanisms. These correspond to 
infection of the intestinal tract, intoxication from bacterial exoproducts and blockage of the 
alimentary tract. Known pathogens of C. elegans and their killing mechanism are 
summarised in Table: 1. This table includes opportunistic pathogens such as P. aeruginosa 
and S. marcsescens and human pathogens such as S. enterica serovar Typhimurium. For 
those pathogens, the C. elegans model has been used to investigate the host pathogen 
interactions that occur during infection. This has allowed the identification of novel genes 
essential for pathogenesis in nematodes. Further work has also shown that some of these 
genes also play a role in the pathogenesis of disease in mammals and has provided 
valuable information regarding the pathogenesis of these organisms. 
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Table: 1.1. Known bacterial pathogens of the nematode C. elegans and killing 
mechanisms, which they use to cause death of the nematode in culture. * Does not cause 
significant disease in humans. 
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Species Killing mechanism Reference 
Gram Negative 
P. aeruginosa Intoxication/ Infection (Darby, Cosma et al. 
1999; Miklos, Tan et 
al. 1999) 
P. fluorescens Intoxication/ Infection (Tan, Miklos et al. 
1999) 
B. cepacia Intoxication/ Infection (O' Quinn, Wiegand 
et al. 2001; Tan 
2002) 
B. pseudomallei Intoxication/ Infection (O' Quinn, Wiegand 
et al. 2001) 
Burkholderia thailandensis * Intoxication/ Infection (Gan 2002) 
Serratia marcescens Intoxication/ Infection (Aballay and Ausubel 
2002) 
S. enterica serovar Typhimurium Infection (Aballay, Yorgey et 
al. 2000; Labrousse, 
Chauvet et al. 2000) 
Y. pestis Blockage (Darby 2002) 
Yersinia pseudotuberculosis I Blockage I (Darby 2002) 
Aeromonas hydrophilia I Infection I (Ewbank 2002) 
Agrobacterium tumefaciens* I Infection I (Ewbank 2002) 
Erwina chritamthemi I Infection I (Ewbank 2002) 
E. carotovoa carotovora* I Infection I (Ewbank 2002) 
Shewanella massalia I Infection I (Ewbank 2002) 
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Shwanella putriefaciens Infection (Ewbank 2002) 
Gram -positive 
Bacillus megaterium* Intoxication (Andrew and 
Nicholas 1976) 
Bacillus thuringiensis* Intoxication (Leyns 1995; 
Couillault 2002) 
Enterococusfaecalis Infection (Garsin, Sifri et al. 
2001) 
Microbacterium nematophilum Infection (Hodgkin, Kuwabara 
et al. 2000) 
S. aureus Infection (Sifri 2003) 
S. pneumoniae Intoxication (Jansen 2002) 
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Despite the evolutionary distance between C. elegans and that of the higher order 
mammalian models, there exists a large degree of homology between the genomes of these 
organisms. For example 36% of the 19.000 predicted proteins of the C. elegans genome 
have matches in humans (Darby, Cosma et al. 1999). This allows it to be used in the 
correct context to identify new genes of related function and elucidate pathways within 
which such genes act. The C. elegans pathogenesis model then allows host-pathogen 
interactions at the molecular level to be dissected. The genetic tractability of both host and 
the infecting organism along with the availability of standard genetic techniques has 
greatly increased the ease with which the molecular basis of pathogenicity can be 
investigated. The use of non-mammalian hosts has also greatly facilitated our 
understanding of the molecular basis of the universal virulence mechanisms conserved 
throughout evolution. These underlie the host-pathogen interactions seen in many of the 
organisms investigated and allow them to infect a broad range of hosts from taxonomically 
distant phyla. As infection of C. elegans has been shown to be directly relevant to the 
pathogenesis of disease in mammalian hosts, it may also provide a valuable insight into the 
processes that lead to disease in higher-order mammalian species such as humans. 
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1.6. Aims. 
In this study, techniques for the investigation of bacterial pathogenicity using the nematode 
C. elegans were assessed. Novel applications for existing techniques using nematodes were 
explored and used to establish a C. elegans model of infection. The validity of the 
nematode as a model of B. pseudomallei infection was then assessed through investigation 
of a range of Burkholderia strains. The established C. elegans-Burkholderia model was 
then used to study the pathogenesis of B. pseudomallei at the cellular and molecular level 
through the use of TEM, the investigation of B. pseudomallei mutants and the study of 
genomic cosmid libraries. Finally the usefulness of C. elegans as an alternative model of B. 
pseudomallei infection was discussed. 
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2.1: Microbiological Methods. 
2.1.1: Preparation of media. 
2.1.1.1. Nematode growth media (NGM). 
Unless otherwise indicated growth of C. elegans and challenge experiments involving 
nematodes took place on this media. The constituents were as follows. 
Sodium chloride 3 g/1 
Noble agar 17 g/1 
Peptone 2.5 g/1 
Made up to 11 with distilled water. 
The mixture was sterilised by autoclaving at 121 °C for 15 minutes. 
After cooling to 55 .Ca number of supplementary additives were added to facilitate the 
growth of the bacterial strains used. 
Amounts are per litre of molten, sterile NGM agar. 
1M Potassium phosphate Buffer (pH 6) 25 mUl 
1M Calcium chloride solution 1 ml/l 
Uracil 2 mg/ml I mUl 
1M Magnesium sulphate solution 1 ml/l 
Cholesterol in ethanol 10 mg/ml 0.5 mUl 
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Due to its heat labile nature uracil was sterilised using a 0.22. m filter prior to use. 
2.1.1.2. Luria-Bertani (L B) Media. 
Unless otherwise stated all bacterial strains were initially cultured in LB media. 
Difco Bacto tryptone 10 g/1 
Difco bacto yeast extract 5 g/l 
Sodium chloride 5 g/l 
Difco bacto agar (plates only) 20 g/l 
The ingredients were dissolved in distilled water and made up to the appropriate volume 
before sterilising by autoclaving at 121 °C for 15 minutes. 
2.1.1.3. Freezing Solution. 
This buffered solution was used in the preparation of frozen nematode stocks. 
1M Sodium chloride 100 mUl 
1M Potassium phosphate buffer at pH 6.0 50 mIl 
Glycerol 300 mill 
The constituents were added to 11 of distilled water and sterilised by autoclaving at121 °C 
for 15 minutes. Prior to use 150.1/1 of sterile 1M MgSO4 was also added after 
autoclaving. 
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2.1.1.4. K -Medium. 
K- medium was used as a buffer for the removal of nematodes from plates and the re- 
suspension of bacteria when necessary. 
Sodium chloride 3.075 g/l 
Potassium chloride 2.42 g/1 
Added to 11 of distilled water and sterilised by autoclaving at 121 °C for 15 minutes. 
2.1.1.5.50C Broth. 
SOC broth was used as a recovery medium for transformed bacterial cells. 
Bactotryptone 2g 
Bacto yeast extract 0.5 g 
Sodium chloride 10 mm 
Potassium chloride 2.5 mM 
Magnesium sulphoxide lo mm 
Glucose 20 mM 
Dissolve in 100ml of dH2O and autoclave at 121 °C for 15 minutes. Store at -20 °C until 
needed. 
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2.1.2: Bacterial Strains. 
Bacterial strains used in this study are listed in Table: 2.1. E. coli OP50 was routinely 
cultured as described by Sambrook et al (Sambrook, Fritsch et al. 1989). E. cola OP50 has 
a genetic lesion that prevents the de novo synthesis of uracil, which must be added growth 
media to a final concentration of 0.2. g/ml. E. cola OP50 was cultured on NGM to provide 
a food source for the nematodes. P. aeruginosa strains, B. pseudomallei and B. cepacia 
complex strains were routinely cultured in LB broth overnight unless otherwise stated. 
All bacterial pathogens described were cultured under appropriate containment conditions, 
in sealed flasks shaking at 200 rpm. Bacteria were harvested by centrifugation at 3000 xg 
for 15 minutes and resuspended in K-medium before use in nematode feeding inhibition 
experiments. 
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Table: 2.1. Bacterial strains used in this study. Synonymous strain numbers are shown in 
parentheses. Genotypes where applicable are shown below the strain name. '. National 
collection of type cultures (NCTC) Central Public Health Laboratory, 61 Colindale 
Avenue, London. http: //www. hpa. org. uk/snnd/div_cdmssd_nctc/index. htM, 2. American 
Type Culture Collection (ATCC) http: //www. atcc. org, 3. National Collection of Industrial 
and Marine Bacteria Ltd (NICMB) http: //www. ncimb. co. uk, 4. Belgium Coordinated 
Collections of Microorganisms/ Laboratorium Microbiologie Ghent (BCCMILMG) 
http: //www. belspo. be/bccm, T. Type strain for that genomovar. 
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Species and Strain Source or Reference 
Caenorhabditis genetics centre, 
E. coli OP50 University of Minnesota, USA (Brenner 
1974) 
P. aeruginosa PA14 
P. aeruginosa PA01 
(Rahme, Stevens et al. 1995) 
(Holloway 1955) 
B. pseudomallei 
Dr. David Dance, Health Protection 
B. pseudomallei 576 
Agency, Plymouth 
B. pseudomallei K96243 
NCTC 
B. pseudomallei NCTC 4845 
(Mack 1996) 
B. pseudomallei 204 Dtsl Porton Down 
B. pseudomallei BRI Dstl Porton Down 
B. pseudomallei 
ATCC2 
ATCC 23344 
Dr. T. L. Pitt. Central Public Health 
B. pseudomallei 52 
Laboratory, London. 
Dr. T. L. Pitt. Central Public Health 
B. pseudomallei 2889 
Laboratory, London. 
Dr. T. L. Pitt. Central Public Health 
B. pseudomallei 42 
Laboratory, London. 
B. pseudomallei EpilA Dr. A. Hayes, Dstl. Porton Down. 
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This study 
Dr. T. Atkins. Dstl., Porton Down 
(Atkins 2002) 
B. thailandensis 
B. thailandensis E254 I DSTL Porton Down 
B. thailandensis E135 I DSTL Porton Down 
B. thailandensis E125 I DSTL Porton Down 
B. thailandensis E132 I DSTL Porton Down 
B. cepacia Complex 
(Mahenthiralingam, Coenye et al. 2000) 
Genomovar I 
B. cepacia ATCC 
ATCC 
25416T 
B. cepacia ATCC 
ATCC 
17759 
B. cepacia 
Dr. J. Govan, University of Edinburgh. 
J2540 
B. cepacia 
Dr. J. Govan, University of Edinburgh. 
C2970 
B. cepacia 
Dr. J. Govan, University of Edinburgh. 
C1963 
B. cepacia C1964 Dr. J. Govan, University of Edinburgh. 
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B. cepacia 
Dr. J. Govan, University of Edinburgh. 
C3159 
B. cepacia 
LMG 6860 NCIMB 3 
(NCRvIB 9091) 
Genomovar II 
B. multivorans 
BCCN"G 4 
LMG 13010T 
B. multivorans 
ATCC 
ATCC 17616 
Genomovar III 
B. cenocepacia sp. nov. 
LMG 16656 T BCCM/LMG 
(J2315) 
B. cenocepacia sp. nov. 
LMG 18863 BCCM/LMG 
(K56-2) 
B. cenocepacia sp. nov. 
BCCM/LMG 
LMG 16654 (J415) 
B. cenocepacia sp. nov. 
Dr. J. Govan, University of Edinburgh. 
C1394 
B. cenocepacia sp. nov. 
Dr. J. Govan, University of Edinburgh. 
J2956 
B. cenocepacia sp. nov. 
Dr. J. Govan, University of Edinburgh. 
C2836 
e 
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Genomovar IV 
B. stabilis 
BCCM/LMG 
LMG 14294 T 
B. stabilis 
BCCM(LMG 
LMG 14086 
Genomovar V 
B. vietnamienesis 
BCCM/LMG 
LMG 10929 T 
B. vietnamiensis 
BCCM/LMG 
LMG 18836 
Transformation competent bacterial strains 
XL1 Blue MR 
recAl endAl gyrA96 thi-1 
hsdR17 supE44 relAl lac 
[F prQAB lacPZAM1 S TWO 
(Tet')] 
XL10 Gold 
Teti A(mcrA)183 A(mcrCB- 
hsdSMR-mrr)173 endAl 
supE44 thi-1 recAl gyrA96 
relAllac Hte [F' proAB 
lac14ZAM15 Tn10 (Tet') Amy 
4 
Stratagene, Amsterdam 
The Netherlands 
Stratagene, Amsterdam 
The Netherlands 
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2.2. Nematological Methods. 
2.2.1. Culture of C. elegans wild type and mutant strains. 
2.2.1.1. Culture on Solid Media. 
C. elegans wild type N2 (var. Bristol) was obtained from the Caenorhabditis genetics 
centre (GCG, 250 Biological Sciences Centre, University of Minnesota, 1445 Gortner 
Avenue, St. Paul, MN, USA). Stocks were maintained by transferring 1 cm2 pieces of 
NGM agar on which nematodes had already been cultured to fresh plates of NGM which 
had been previously seeded with E. coli 0P50. Routine culture of C. elegans was at 16 °C 
for 4 days. C. elegans phm-2 (Avery 1993) and srf mutant strains were also obtained from 
the CGC. Culture conditions are as described above for C. elegans N2. 
2.2.1.2. Culture in Liquid Media. 
A bacterial food source was first created through inoculation of a 100 ml of LB-broth with 
E. coli OP50 and incubating overnight at 37 °C. The resulting bacterial suspension was 
then centrifuged at 3000 xg for 15 minutes. The supernatant was discarded and the 
bacterial pellet resuspended in 10 ml of K-medium. The suspension was stored at 4 °C until 
required. 
One 9 cm NGM plate of C. elegans was washed with 6 ml of K-medium and 5 ml 
containing the nematodes removed. The worm suspension was added to approximately 85 
ml of K-medium along with 1 ml of the previously prepared E. coli 0P50. The culture was 
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then placed at 16 °C on a rotating platform for 7 days. During this period the turbidity of 
the culture was monitored and if clearing occurred more bacterial suspension was added. 
2.2.1.3. Preparation of frozen nematode stocks. 
Nematode worms were washed from one 9 cm NGM plate with 3 ml of K-medium and 
centrifuged at 1000 xg for 5 minutes. After centrifugation 1.5 ml of the supernatant was 
removed and 1.5 ml of freezing solution added. 1 ml aliquots were placed in Nunc cryo- 
tubes (Nunc, UK). Prior to freezing the tubes were insulated with polystyrene packing to 
ensure a gradual freezing of the samples and placed at -70 °C. After 24 hours one of the 
tubes was thawed gradually. The bottom 250.1 containing the nematode worms was 
pipetted onto a NGM plate previously seeded with E. cola 0P50 and incubated at 16 °C 
overnight. The plate was then examined using light microscopy at x 40 magnification using 
an inverted microscope to assess the approximate viability of the thawed stock. The 
remaining two tubes were removed from the polystyrene packing to a place of permanent 
storage at -70 °C. 
2.2.1.4. Synchronisation of nematode populations. 
A synchronised population of nematode worms ensures that any variability in the 
susceptibilities of the individual larval stages to the pathogen, is controlled by giving a 
population that is at the same growth stage. This was achieved by washing a mixed 
population through a S. m mesh sieve (Wilson sieves, Nottingham. UK) with K-medium. 
The sieve allows all Ll stages to pass through but retains the larger larvae. The Ll stages 
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were recovered through centrifugation at 2000 xg for 15 minutes at 4 C. After 
centrifugation most of the supernatant was carefully removed and the remaining suspension 
containing the worms used to inoculate plates of NGM pre-seeded with E. coli OP50. After 
3 days at 16 .C (not 
including the day of plating) the population will have reached the IA 
larval stage, which was then used in the subsequent challenge experiments. 
Alternatively nematode populations can be synchronised using a hyper-chlorite treatment 
that disrupts gravid females to release viable eggs (Sulston and Hodgkin 1988). Briefly, a 
mixed population of nematodes was washed from a9 cm NGM plate and centrifuged at 
1000 xg for 5 minutes to recover the suspended nematodes. The supernatant was discarded 
to leave 3.5 ml containing the nematodes. The worms were then disrupted by the addition 
of 1 ml of a 5% (v/v) hyper-chlorite solution along with 0.5 ml of a 0.5 M NaOH solution. 
The suspension was then vortexed every 2 minutes for a total of 10 minutes. The 
suspension was again centrifuged and 4.5 ml of the supernatant discarded. A 4.5 ml aliquot 
of dH2O was then added, which helps to further disrupt the gravid females through the 
change in osmotic potential. The eggs were recovered through centrifugation at 1000 xg 
for 10 minutes. A4 ml aliquot of the supernatant was removed leaving 500. l containing 
the nematode eggs. This was then added to K-medium containing no bacterial food supply 
and incubated at 16 .C overnight on a rotary platform. Development of the nematodes 
becomes arrested at the Ll stage. When these arrested Ll larvae are recovered through 
centrifugation as described above and transferred to a plate pre-seeded with E. coli 0P50 
they continue with their development. After 3 days at 16 .C the population reached the IA 
stage 
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2.2.2. Preparation for and examination of nematode worms by electron 
microscopy. 
2.2.2.1. Examination of C. elegans by thin-section transmission electron microscopy. 
Nematodes were fixed for 24 hours with 5% (v/v) glutaraldehyde (Agar Scientific, UK) in 
0.1 M phosphate buffer (pH 6) (Taab Laboratories Equipment Ltd., UK. ). They were then 
pelleted by centrifugation at 1000 xg for 10 minutes and the supernatant removed before 
they were resuspended in 0.1 M phosphate buffer (pH 6). Nematodes were stored in buffer 
at 4-8 °C for approximately 21 days while sterility checks were undertaken prior to their 
visualisation by transmission electron microscopy (TEM). 
Samples containing nematodes were centrifuged at 1000 xg for 15 minutes and the 
supernatant removed. Nematodes were then resuspended in 1% (w/v) osmium tetroxide 
(Agar Scientific, UK. ) in O. 1M phosphate buffer (pH 6) (Taab Laboratories Equipment 
Ltd., Aldermaston, Berks. ) for 4 hours at room temperature, with intermittent agitation. 
Nematodes were again centrifuged at 1000 xg for 15 minutes and the secondary fixative 
supernatant removed. The nematode pellet was then gently mixed with molten agar (2 % 
w/v Oxoid no. 1). This was allowed to cool and when solid, cut into approximately lmm 
cubes using a razor blade. The agar cubes containing the nematodes were then dehydrated 
through a graded ethanol series at room temperature according to the following schedule: 
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30% ethanol - 10 minutes. 
50% ethanol - 10 minutes. 
70% ethanol - 20 minutes. 
90% ethanol - 30 minutes. 
100% ethanol -2x 30 minute changes. 
(all timings approximate) 
The agar cubes were then immersed in 100% propylene oxide (Taab Laboratories 
Equipment Ltd., Aldermaston, Berks. ) for 2x 10 minute changes. 
Araldite® resin mixture used for final embedding of samples was prepared as follows: for 
10 ml total volume, 5 ml dodecenyl succinic anhydride (DDSA) hardener was added to 5 
ml Araldite® CY212 with thorough mixing. 0.2 ml N-benzyldimethylamine (BDMA) 
accelerator (all resin components from Agar Scientific, UK. ) was then added, again with 
thorough mixing. The final resin mixture was allowed to stand for approximately 1 hour to 
allow the escape of air bubbles introduced by the mixing process. 
Agar cubes were immersed in 50: 50 propylene oxide: Araldite® resin mixture at room 
temperature in sealed tubes for approximately 18 hours. After incubation the cubes were 
then transferred to 100 % Araldite® resin mixture in open tubes and incubated for 
approximately 8 hours at room temperature. 
Each agar cube was placed in an embedding capsule (BEEM no. 0- Agar Scientific, UK. ) 
and covered with fresh resin mixture. A unique sample-identifying label was inserted into 
each capsule. Capsules were then allowed to stand for approximately 60 hours at room 
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temperature to ensure thorough infiltration of the nematodes by the resin. Embedding 
capsules were then held at 60 'C. 5 °C for approximately 72 hours to polymerise the resin. 
Polymerised resin blocks were removed from the embedding capsules. Using a hand held 
glass knife, clear resin was trimmed away from the tip of each block to expose the 
embedded nematodes. The roughly trimmed block face was then smoothed using an 
ultramicrotome (Reichert-Jung, model Ultracut E- Leica Microsystems UK Ltd. UK. ) 
fitted with a glass knife. The edges of the smoothed block face were then shaped into a 
truncated pyramid with sides of maximum length 1 mm. Blocks were returned to the 
ultramicrotome and thin-sections ( 70 nm. thickness) prepared using a diamond knife 
(Diatome, Switzerland) set at a clearance angle of 5 'Thin-sections were picked up on 3 
mm, 300 mesh copper EM specimen grids held in tweezers. 
The grids with adherent thin-sections were immersed in 2% (w/v) aqueous uranyl acetate 
solution (Agar Scientific, UK. ) for 2 hours followed by three 30 second washes in dH2O 
then 30 minutes in 0.1 % (w/v) lead citrate (Ultrastain 2- Leica Microsystems UK Ltd., 
UK. ). Grids were then washed in a further three times in distilled water, placed on filter 
paper (No. 1- Whatman International Ltd., Maidstone, Kent) and allowed to air dry. Grids 
with stained sections were then coated with. 10 nm. of carbon in a vacuum coating unit 
(model 208 - Cressington Scientific Instruments Ltd., UK. ). 
Grids were examined in a model CM100 transmission electron microscope 
(FEI / Philips, Eindhoven, The Netherlands) operated at appropriate magnifications at 80 
kV accelerating voltage and using a 15. m thin-film gold objective aperture. Micrographs 
were recorded on Ilford EM technical film (Ilford Ltd., UK. ) which was processed in 
Dektol developer (Kodak plc, Chalon-sur-Saone, France). Photographic prints were 
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prepared from micrographs on Ilford multigrade IV photographic paper using a Durst 
L1200 enlarger (Durst, Bolzano, Italy) and an Ilford 2150RC processor. These prints were 
scanned at 100 dpi resolution on a flat-bed scanner (SnapScan 1236 - AGFA UK Ltd., 
UK. ) to produce digital image files which were allocated a unique identifying filename and 
saved in tagged image file format (tiff). 
2.2.2.2. Examination of C. elegans by scanning electron microscopy. 
Nematodes were initially fixed through the procedure already described for TEM in 
section: 2.2.2.1. before final processing for visualisation through scanning electron 
microscopy (SEM). 
Poly-l-lysine hydrobromide (Sigma-aldridge. UK) coated 10 nun diameter glass cover slips 
(Agar Scientific, Bishops Stortford, Herts. ) were placed on moist filter paper (No. 1- 
Whatman International Ltd., UK) in an open glass petri dish. Approximately 0.1ml aliquots 
of nematode suspension were placed on the cover slips to form a shallow meniscus. The 
petri dish was then covered and incubated overnight at room temperature to allow 
nematodes to settle from suspension and attach to the surface of the coverslips. After 
incubation the cover slips were immersed in 1% (w/v) osmium tetroxide in 0.1 M 
phosphate buffer (pH 6) (Taab Laboratories Equipment Ltd., UK. ) for 2 hours at room 
temperature for secondary fixation. The cover slips were then dehydrated through a graded 
ethanol series at room temperature according to the following schedule: 
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25% ethanol -15 minutes. 
50% ethanol -15 minutes. 
75% ethanol - 15 minutes. 
100% ethanol -2x 30 minute changes. 
(all timings approximate) 
After dehydration the cover slips were immersed in hexamethyldisilazane (HMDS - Taab 
Laboratories Equipment Ltd., UK. ) for 2x 15 minute changes. Cover slips were then 
removed form the HMDS using tweezers and gently agitated in air to encourage rapid 
drying. Dried cover-slips were then mounted on Va inch aluminium SEM pin stubs (Agar 
Scientific, UK. ) using double-sided adhesive carbon discs (Agar Scientific, UK. ). The base 
of each stub was inscribed with a unique identifying specimen code. 
An approximate 10 nm thick coating of gold was applied to the surface of each stub with 
affixed cover slip using an ion beam vacuum coating system (Model 800 - Atom Tech 
Ltd., UK). The stubs were rotated and tilted during the coating process to ensure an even 
and continuous gold layer on the specimens. 
Specimen stubs were examined in a model XL30FEG scanning electron microscope (FEI / 
Philips, Eindhoven, The Netherlands) operated at appropriate magnifications at 4 kV 
accelerating voltage and using a 30. m platinum final lens aperture. Digital micrographs 
were recorded at 800 x 600 resolution, allocated a unique identifying filename and saved in 
tagged image file format (tiff). Analogue micrographs were recorded on Kodak T-max 100 
120 roll film (Kodak plc, Chalon-sur-Saone, France) which was processed in Kodak T-max 
developer. Photographic prints were produced on Ilford multigrade IV photographic paper 
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(Ilford Ltd., Mobberley, Cheshire) using a Durst L1200 enlarger (Durst, Bolzano, Italy) and 
an Ilford 2150RC processor. 
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2.3. Molecular biological methods. 
2.3.1. Isolation of bacterial genomic DNA. 
Bacterial genomic DNA was isolated from overnight bacterial cultures of B. pseudomallei 
through the use of a Gentra sytems (Minneapolis, MN, USA) genomic DNA isolation kit 
following the manufacturers instructions for isolation of DNA from Gram-negative 
bacteria. Briefly bacterial cells are recovered by centrifugation followed by resuspending in 
an anionic detergent containing a DNA stabiliser. The suspension was then incubated at 50 
.C overnight 
during which cell lysis occurs. After incubation contaminating RNA was 
removed by addition of RNAase. Extraneous protein was then removed through salt 
precipitation and genomic DNA recovered through precipitation in alcohol. DNA was then 
resuspended in distilled water and stored at -20 .C until required. 
2.3.2. Agarose gel electrophoresis. 
Agarose was disolved in 1x Tris Acetate EDTA (40 mM Tris, 20 mM acetic acid, 1 mM 
EDTA pH 8.0) (TAE) buffer to create a solid gel matrix in which to run DNA samples. 
Ethidium bromide was also added before pouring of the gel to a final concentration of 0.5 
. g/ml. 
A1% (w/v) agarose gel was used for DNA fragments smaller than 1 kb and 0.7 % 
(w/v) for fragments larger than 1 kb. To aid in loading of gels, to each sample 2.1 of 6x 
gel loading buffer was added (Sigma-aldridge, UK). Gels were run at 80-90 volts and 
visualised using ultraviolet light (310 nm) and a Multigenius Bio-imaging system 
(Syngene, Cambridge, UK). 
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2.3.3. Isolation of plasmid and cosmid DNA. 
Plasmid DNA was isolated using Qiagen tips according to the manufacturer's instructions 
for plasmid isolation. Cosmid DNA was also recovered from host bacterial cultures using 
Qiagen tips, following the manufacturer's instructions for isolation of low copy number 
plasmids and cosmids (Qiagen, UK). This method of extraction used alkaline lysis to 
disrupt the bacterial cell membrane. The cell debris was removed and the supernatant 
passed through silica columns that bind supercoiled DNA. Plasmid and cosmid DNA was 
then eluted from the column into a low salt buffer (Qiagen miniprep kit) or into high salt 
buffer (Qiagen maxiprep kit). Purified DNA was then quantified by spectrophotometry at 
260 nm and visualised by electrophoresis. Vector DNAs used in this study are detailed in 
Table: 2.2. 
101 
Chapter: 2. Materials and methods. 
Vector Genotype Comments Source 
Cloning vector 
containing MCS 
pUC 18 AmpT Stratagene, 
with a. - 
galactocidase gene 
7.9 kb cosmid vector 
that accepts 30-42 
kb inserts. Dual cos 
Supercos-1 Amer sites allow high- Stratagene 
efficiency cloning of 
non-size-selected 
DNA. 
Table: 2.2. Vector DNA used in this study. Physical maps of these vectors showing the 
restriction endonuclese cutting sites used for cloning in this study can be found in the 
appendix. 
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2.3.4. Restriction digestion of DNA. 
Restriction endonuclease digestion of DNA was performed using endonuclase restriction 
enzymes (Roche, UK. ) These enzymes cleave at specific nucleotide sequences within the 
DNA molecule facilitating controlled cleavage and cloning of DNA. A typical digestion 
contained 2-3. g of DNA and 20 U of enzyme (10 U. 1). The digests were performed in 
20.1 reactions at the temperature required by the endonuclease enzyme and the 
corresponding buffer solution. Digested DNA was visualised on an agarose gel as 
described above. 
2.3.5. Ligation of DNA fragments. 
Ligation of plasmid vector and endonuclease digested DNA fragments was performed 
using a rapid DNA ligation kit (Roche, UK. ) following the manufacture's standard 
protocol. Briefly, the chosen vector was dephoshorylated using alkaline phosphatase. This 
prevents recircularisation through removal of phosphate groups from cohesive termini. 
Samples of 50 ng of vector DNA and 150 ng of insert DNA were mixed in a 10 µl volume. 
The addition of a ligase enzyme facilitates the ligation of insert into the plasmid vector. 
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2.3.6. Transformation through heat-shock. 
Ligated DNA was transformed into XL10-Gold ultra-competent cells (Stratagene, UK) 
using heat-shock following the manufacturer's transformation protocol. Briefly, ß- 
mercaptoethanol was added to 100 µl aliquots of competent cells. This increases the 
transformation efficiency of the reaction. The cells were then incubated on ice for 10 
minutes. Following incubation 2 gl of a ligation mixture was added to the mixture and the 
tubes again incubated on ice for 30 minutes. The cells were then heat pulsed at 42 °C for 
30 seconds, which facilitates passage of plasmid DNA into the bacterial cell. Cells were 
recovered in SOC broth for 1 hour at 37 °C with constant shaking at 200 rpm before 
plating onto the appropriate selective media. 
2.3.7. Transformation through electroporation. 
Supercos-1 was electroporated into E. coli XL1-Blue MR electro-competent cells 
(Stratagene) using a Gene Pulser (Bio Rad Laboratories Ltd. ). Electroporation cuvettes (0.2 
cm gap), SOC medium, Polypropylene pots were chilled on ice. Between 50-500 ng of 
cosmid DNA was mixed with 40.1 of cells. The cuvette was dried and pulsed in the 
electroporation chamber at 2.5 kV, 200 ii using a 25. F capacitor. One ml of SOC 
medium was mixed with the cells immediately, placed in a polypropylene tube and 
incubated at 37 °C, 250 rpm shaking for 1 hour. The cells were then plated onto selective 
medium and incubated overnight. 
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2.3.8. Sodium dodecyl sulphate-Polyacrilamide gel electrophoresis (SDS-PAGE). 
Analysis of protein expression from cosmids within E. coli XL1 Blue MR containing B. 
pseudomallei 576 genomic DNA was achieved by SDS-PAGE. Both the upper stacking 
and lower separating gel were cast using the method described by Laemmli (Laemmli 
1970) using a casting cassette (BioRad. UK). This was then wrapped in laboratory sealing 
film and stored at 4 °C until needed. 
Overnight cultures of the cosmid clones were centrifuged at 6000 xg for 10 minutes. The 
supernatant was discarded and the resulting pellet resuspended in phosphate buffered saline 
(PBS) to obtain a viscous solution. A 100 µl aliquot of ß-mercaptoethanol and 7 µl of 
bromophenol blue were added to 2 ml of LPS solubilisation buffer (10 % v/v glycerol, 5 
v/v 2-. mercaptoethanol, 3% w/v sodium dodecyl sulphate, 62.5 mM tris-HC1 pH 6.6, 
0.01 % w/v bromophenol blue). Aliquots of 3 µl of the resuspended bacteria were then 
added to 30 µl aliquots of the mixture and incubated at 100 °C for 5-10 minutes. 
The gel was loaded with 8 µl of each sample along with 8 µl of high range rainbow 
molecular weight marker (Amersham Biosciences, UK) (Appendix: 3. ). Electrophoresis 
was carried out in SDS-PAGE running buffer (Glycine 1.44 % (w/v), SDS 0.1% (w/v), 
Tris-HC10.36 %) at 120 V for approximately 2 hours. 
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2.3.8.1. Staining with Coomassie Brilliant Blue. 
Following SDS-PAGE, proteins were visualised by staining with Coomassie Brilliant Blue 
(Coomassie Brilliant Blue 5 g/l, methanol 40 % (v/v), glacial acetic acid 10 % (v/v), dH2O 
500 ml). Gels were soaked in Coomassie blue solution for 1-2 hours with constant gentle 
agitation on a rotary platform. Unbound dye was removed by repeated washing with 
destain solution (methanol 400 ml, glacial acetic acid 100 ml, dH20 500 ml). The gels were 
subsequently photographed using an Olympus C-3030 Zoom digital camera on alight box 
and the resulting images adjusted for colour balance using the computer programme 
Microsoft photo editor version 3.0. 
2.3.8.2. Western blotting. 
A section of Immobilon-P (Polyvinylidene Difluoride. PVDF) membrane (Sigma-aldridge, 
UK) was then pre-cut to the size of the gel and activated by soaking in methanol for 30 
seconds and washed in dH2O. Two sheets of blotting paper were also cut to the size of the 
SDS-PAGE gel and soaked in transfer buffer (150 mM glycine, 25 mM tris-HC1,10 % v/v 
methanol, pH 8.3) for 5 minutes. One sheet of pre-soaked blotting paper was laid on the 
transfer surface of a BioRad-transblot SD-semidry transfer cell (BioRad, UK) and the SDS- 
PAGE gel placed on top followed by the second piece of blotting paper. The proteins were 
then transferred to the membrane for 20 minutes at maximum volts and 200 mA. 
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After transferral of the proteins, the membrane was blocked in 5% blotto (50 g/l - 
Skimmed milk powder in PBS) for 5 minutes. The membrane was then washed a further 3 
times in 0.1 % blotto for 10 minutes. After washing, the primary antibody diluted 1 in 500 
in 0.1 % blotto was added to the membrane and allowed to bind for 1 hour at room 
temperature. The primary antibody solution was then discarded and the membrane washed 
again in 0.1 % blotto 3 times for 10 minutes. 
The secondary antibody diluted 1 in 2000 in 0.1 % blotto was then added to the washed 
membrane and allowed to bind at room temperature for 45 minutes. The secondary 
antibody solution was then also discarded and the membrane washed 3 times for 10 
minutes in 0.1 % blotto followed by a further 3 times for 10 minutes in PBS to remove any 
excess blotto. 
Then membrane was then developed by washing in 3,3'-Diaminobenzine (DAB) 
peroxidase substrate (Sigma-aldridge fast DAB with metal enhancer, Sigma-Aldridge, 
UK. ) following the manufacturers instructions. Once developed the membrane was washed 
in distilled water and allowed to air dry overnight. 
2.3.8.3. Silver staining. 
Electrophoresed gels were fixed for 0.5 hours - overnight in a solution containing 40 
(v/v) methanol, 5% acetic acid and 55 % deionised water. Gels were oxidised for 5 
minutes in the fixing solution with 0.7 % (w/v) periodic acid. Gels were washed with 3 
changes of dH2O each of 15 minutes. Gels were then stained for 10 minutes with silver 
staining solution (2 ml of ammonium hydroxide [specific gravity 0.88] was added to 28 ml 
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of 0.1 M sodium hydroxide with stirring and 1g of silver nitrate dissolved in 5 ml of 
distilled water was added dropwise while stirring). After staining the gels were then again 
washed 3 times for 15 minutes in distilled water and developed with 0.05 % (v/v) formalin 
and 0.005 % (w/v) citric acid in distilled water. The developing solution was then removed 
and stop solution (5 % acetic acid) was added and allowed to incubate at room temperature 
for 15 minutes. Prior to visualisation, gels were soaked in distilled water for a minimum of 
0.5 hours. 
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2.4. Assays using nematodes. 
2.4.1. The plate-based mortality assay. 
Bacterial lawns were first created by placing 10.1 of an overnight culture of a pathogen 
onto the centre of each of three 3.5 cm petri-dishes (Coming, NY) containing NGM media. 
This was also carried out for E. coli OP50 for use as a control. The plates were then 
incubated at 37 .C overnight. Groups of 10-15 
IA larvae were transferred to the centre of 
each lawn under microscopy at x 40 magnification, using a, .1 inoculation loop. The 
plates were then incubated at 25 °C for a total of 96 hours. The numbers of dead nematodes 
on the plates containing pathogen and E. coli OP50 were recorded daily. This allowed the 
mortality in each population over time to be calculated. Worms that had inadvertently stuck 
to the side of the plate and died were discounted from the experiment. Worms were scored 
as dead if they met the criteria described below 
I. No spontaneous movement 
H. No response to physical stimuli- knocking the plate 
III. Cessation of pharyngeal pumping 
IV. Cessation of defecation 
V. Appearance as compared to control population 
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2.4.2. The feeding inhibition assay. 
An overnight culture of the bacterial strain of interest was centrifuged at 3000 xg for 15 
minutes. The resulting pellet was resuspended in K-medium to an OD550 of approximately 
1.2. An overnight culture of E. cola 0P50 was prepared in the same way for use as a 
feeding control. Two or three 9 cm petri-plates of C. elegans were each washed with 5 ml 
of K-medium and the worm suspension allowed to settle at 4 °C for 15 minutes. The 
supernatant was removed to leave 2.5 ml of solution containing the nematode worms. The 
amount of nematodes in three 20.1 aliquots of the worm suspension was then counted, 
and the mean calculated. This allowed the number of nematodes in the sample to be 
enumerated and the volume of K-medium in which 50-100 worms were present to be 
calculated. The suspension was then stored at 4 °C until needed. 
The feeding inhibition assay was conducted in 24 well cell culture trays (Costar, Coming. 
NY). Aliquots of 900.1 of bacterial suspension of the challenge organism was placed into 
8 wells, to which was added a volume of gently vortexed worm suspension to give 50-100 
nematodes per well. K-medium was then added if necessary to a final volume of 1 ml. A 
feeding control consisted of 900.1 of E. coli OP50 suspension, 50-100 worms in K- 
medium, again in a final volume of lml. A non-feeding control consisted of 850.1 of E. 
coli OP50 suspension, 50-100 worms in 100.1 of K-medium and 50.1 of a2 M-sodium 
salicylate solution. Feeding in P. aeruginosa PA14 was also often used as a non-feeding 
control. These wells were set up as described for the test organism or E. coli 0P50. Three 
wells without added nematodes were also prepared. These allow the natural degradation of 
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the bacteria in K-medium to measured and contained K-medium with either the challenge 
organism, E. coli OP50, E. cola OP50 and sodium salicylate or P. aeruginosa PA14 where 
necessary. The plates were then incubated at 25 °C on a rocking platform for a total of 48 
hours. 
At 24 hour intervals, 1 ml samples were transferred from each well into a sterile disposable 
cuvette (Sigma-aldridge, UK). Cuvettes were incubated at 4 °C for 10 minutes to ensure no 
worms remained in suspension and the OD550. of the bacterial suspension measured and 
recorded. The samples were then returned to their relevant wells through pipetting. 
2.5. Investigation of B. pseudomallei using C. elegans. 
2.5.1. Investigation of B. pseudomallei interaction with the C. elegans gut by electron 
microscopy 
The interaction of B. pseudomallei 576 with the C. elegans N2 intestine was investigated 
through the use of TEM (Section: 2.2.2.1. ). Overnight cultures of B. pseudomallei 576 
were centrifuged for 15 minutes at 3000 x g. The pellet was then resuspended in K-medium 
to a final OD of approx 1.0 at 600nm. This was also performed for E. coli OP50 which 
served as a control. 
C. elegans N2 were synchronised to the L4 stage using the method described in section: 
2.2.1.4. Ten 9 cm plates of synchronously growing C. elegans N2 were washed with 6 ml 
of K-medium and 5 ml of worm suspension removed. This was completed for the 
remaining 9 plates to give a total of 50 ml containing the nematodes. The worm suspension 
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was then centrifuged at 1000 xg at 4C for 10 minutes to pellet the suspended nematodes. 
45 ml of the supernatant was then carefully removed to leave 5 ml of concentrated worm 
suspension. This was stored at 4 .C until needed. 
To each well of a six well cell culture cluster (Corning, NY) 800.1 of B. pseudomallei 
576 was added along with 200.1 of nematode suspension. This was also carried out for E. 
coli OP50. The plates were incubated at 25 C for a total of 24 hours after which the 
samples were fixed in situ through the addition of 3 ml of 5% v/v glutaraldehyde. The 
sample was then transferred to a glass universal bottle and allowed to incubate at room 
temperature overnight to ensure complete penetration of the fixative. 
Samples were washed in phosphate buffer (pH 6) (Taab Laboratories Equipment Ltd., UK) 
by repeated centrifugation at 1000 xg for 10 minutes. This was repeated a total of four 
times to remove any remaining glutaraldehyde. The samples were then prepared for 
visualization by Mr. A. B. Dowsett (Microbial imaging department, Health Protection 
Agency, Porton down, UK). Examination of the gut lumen may reveal how B. 
pseudomallei interacts with C. elegans on a cellular level. Importantly it may also show if 
the bacterial cells become intracellular during the course of the infection, which may 
contribute to the pathogenesis in the nematode. 
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2.5.2. Screening of B. pseudomallei transposon mutants using C. elegans for a 
reduction in virulence. 
The use of the C. elegans nematode model for the investigation of bacterial mutants was 
explored. A library of transposon mutants of B. pseudomallei 576 were investigated using a 
modified version of the plate-based mortality assay. 
Ninety six well cell clusters (Corning, NY) containing 50 µl volumes of LB-broth were 
inoculated with pools of B. pseudomallei 576 transposon mutants using a replica plating 
tool. These were then allowed to incubate overnight at 37 °C. The resulting cultures were 
then used to replicate the pools to further 96 well cell clusters containing 50 µl volumes of 
NGM agar which were again incubated overnight at 37 °C. 
Four 9 cm plates containing C. elegans N2 previously synchronised to the IA larval stage 
were washed with 5 ml of K-medium. The resulting nematode suspension was then 
allowed to incubate at 4 °C for 20 minutes. After incubation 18 ml of K-medium was 
removed leaving 2 ml containing the nematodes. Aliquots of 5 gl containing 5-10 worms 
were then added to each well of the 96 well cell cluster. After incubation at 25 °C for a 
total of 96 hours, each well was inspected for live worms using an inverted microscope. 
The presence of live worms after 96 hours indicated attenuation in the nematode model of 
infection. 
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2.5.3. Screening of B. pseudomallei cosmid libraries using C. elegans. 
A B. pseudomallei cosmid library was obtained in E. coli XLl-Blue MR, which was 
screened for increased pathogenicity phenotypes using the feeding inhibition assay. Single 
colonies were obtained by plating 100.1 of 10'5,10-6 and 10'7 serial dilutions of an 
overnight culture of the library onto LB-agar plates containing ampicilin at a concentration 
of 25 . g/ml. 
The supercos-1 cosmid vector (Stratagene, UK) contains an ampicillin 
resistance gene (Appendix: 1. ). Thus, the selective pressure induced by the addition of the 
antibiotic ensures the continued presence of the cosmid within the bacterial cells. 
After incubation at 37 C overnight individual cosmid clones were used to challenge C. 
elegans N2 and the mutant C. elegans phm-2 in the form of a simplified feeding inhibition 
assay. Four plates of C. elegans N2 were washed with 6m1 of K-medium and 5 ml of liquid 
removed to give a total volume of 20 ml. This was allowed to settle at 4. C for 20 minutes 
and 15 ml of the supernatant discarded to give a final volume of 5ml containing the 
nematodes. 
A selection of 18 cosmid clones was selected and grown at 37 C overnight. After 
incubation bacteria were centrifuged at 2000 xg and the supernatant discarded. The 
resulting pellets were resuspended in K-medium to an approximate OD SSA, of 1.2. 
The strain XL: cos-1 contains the supercos-1 cosmid vector but without a B. pseudomallei 
576 genomic insert. Hence, XL: cos-lwas prepared in the same way for use as a control. 
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The experiment was carried out in six well culture clusters (Corning, NY). Into each of 18 
wells 1.7 ml of the cosmid clone, 200.1 of nematode suspension, 100.1 of K-medium 
and 4.1 of ampicillin at a concentration of 25 mg/ml was added. A further 3 wells 
contained XL: cos-1 along with identical volumes of nematodes, K-medium and ampicillin 
for use as a feeding control. Finally a non-feeding control was set up in triplicate through 
the addition of 1.7 ml of XL: cos-1,200.1 of nematode suspension, 4.1 of ampicillin and 
100.1 of a 2M sodium salicylate solution in place of K-medium. 
The plates were incubated at 25 .C for a total of 
48 hours. At 24 hour intervals, 1 ml 
samples were transferred from each well into a sterile disposable cuvette (Sigma-aldridge, 
UK). Cuvettes were incubated at 4 °C for 10 minutes to ensure no worms remained in 
suspension and the ODsso. of the bacterial suspension measured. After the results had 
been recorded the samples were returned to their relevant wells for the remainder of the 
experiment. 
Any of those clones seen to inhibit feeding were selected for further study in a standard 
feeding inhibition assay. Sequencing of fragments from the cosmid insert of interest may 
allow the identification of those genes or virulence determinants responsible for feeding 
inhibition and pathogenicity in C. elegans. 
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2.6. Mouse infections and competition assays. 
Overnight cultures of the mutant 6H2 and the wildtype strain B. pseudomallei 576 grown in 
LB-broth were centrifuged at 3000 xg for 15 minutes. The supernatant was discarded and 
the resulting pellets washed in PBS twice. The resulting suspensions were the serially 
diluted to obtain challenge doses of 103 and 104 colony forming units (cfu) per 100.1 of 
bacterial suspension (104 and 105 cfu/ml). This equated to 10 x and 100 x the mean lethal 
dose (MLD) for B. pseudomallei 576 in BALB/c mice respectively. 
To confirm titres of bacteria to be administered before animal infections took place, 100.1 
aliquots of each suspension were plated out onto LB-agar plates at 10'4,10"S and 10-6 
dilutions and then incubated at 37 .C overnight. The resulting colonies were counted and 
bacterial titres calculated to obtain the exact numbers of bacteria within the challenge 
doses. 
Two groups of five 6-8 week-old female BALB/c mice were infected by intraperitoneal 
(IP) injection with 100.1 of bacterial suspension containing the mutant B. pseudomallei 
6H2 or B. pseudomallei 576 at 10 x and 100 x MLD (103 and 104 cfu/ml respectively). 
Each group was then monitored for 21 days and the mortality in each group noted. 
Any attenuation of the selected mutant was further investigated and quantified through the 
use of a mouse competition assay. The mutant B. pseudomallei 6H2 and B. pseudomallei 
576 were grown separately in LB-broth at 37 .C overnight. Bacteria were then washed 
through repeated centrifugation and resuspension in PBS as already described. Aliquots of 
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0.5 ml of the mutant and wildtype containing approximately 104 cfu/ml were then mixed 
and added to 9 ml of LB-broth (108 cfu total bacteria). Serial dilutions of this suspension 
were then plated out onto LB-agar at 10"3,10-4,1075 and 10-6 dilutions to measure total 
cfu/ml. Additionally as the mutant carried a kanamycin selectable marker aliquots were 
also plated out onto LB-agar containing 700. g/ml of kanamycin to determine the mutant 
cfu/ml. From this the exact input ratio of mutant to wildtype was calculated. 
Aliquots of 100.1 of the mixed suspension containing approximately 104 cfu (102 cfu/ml 
of mutant and 102 cfu/ml of wildtype) were then used to infect 5 female 6-8 week-old 
BALB/c mice by IP injection. After 48 hours spleens were recovered through the method 
described by Pepe and Miller (Pepe 1993). Homogenates were diluted and plated out onto 
selective and non-selective media to determine the output ratio of the mutant to the 
wildtype. The competitive index is defined as the output ratio (mutant/wildtype) divided by 
the input ratio (mutant/wildtype). Regression analysis was then used to determine whether 
the wildtype/mutant ratio recovered from infected spleens was significantly different from 
the wildtype/mutant ratio present in the original challenge inoculum. 
To exclude the possibility of general growth defects under optimal laboratory conditions an 
in vitro competition assay was also performed. A volume of 4 ml of LB-broth was 
inoculated with 0.5 ml aliquots of bacterial suspension containing 1x 104 cfu/ml of the 
mutant 6H2 and 1x 104 cfu/ml of the wildtype (1 x 104 total cfu). The input ratio was then 
determined again through selective plating on LB media and LB media supplemented with 
kanamycin as already described. The mixture was then incubated at 37 .C overnight with 
constant shaking at 200 rpm. After incubation the output ratio was determined by selective 
plating and the competitive index calculated as detailed above. 
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2.7. Statistical analyses. 
Students t-tests to assess significant differences between data were performed on the 
statistical package MS Exel 97 (P = 0.05). Probit analysis to obtain the time at which 50 % 
of animals die (TD50), regression analyses and analysis of variance (ANOVA) were 
performed using the statistical package Mini Tab version 13.0 with an assumed log 
distribution where appropriate unless otherwise stated. 
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3.1. Introduction. 
The study of bacterial disease in a suitable animal model is a necessary requirement for the 
study of bacterial pathogenesis. However the use of higher order animal models is limited 
by moral and ethical concerns, the logistics and cost of animal husbandry and safety 
concerns associated with the infection of animals with pathogens such as B. pseudomallei. 
The use of cell culture models may provide a suitable alternative to whole animal model 
systems. However, the vast majority of these can only provide information on particular 
aspects of bacterial pathogenesis such as attachment or intracellular survival. Furthermore 
these systems are not truly representative of the whole animal. They consist of discreet 
populations of individual cell types and not co-ordinated networks of different tissues 
working synergistically as would be found in a whole animal (Wallis 1998). Moreover 
eukaryotic cells are not amenable to facile genetic analysis making the dissection of host- 
pathogen interactions difficult. An animal model that is cost effective, easy to use and 
readily genetically manipulated would be preferable, these requirements are met by the 
nematode C. elegans. Thus the nematode has become a widely used alternative model host 
systems for the study of developmental biology, ageing and bacterial pathogenesis. 
Current assay methodologies rely on the observation of mortality of a population of 
nematodes exposed to lawns of pathogenic bacteria on a solid matrix. However this may 
not detect small changes that result from an intermediate level of pathogenicity. Jones and 
Candido (Jones and Candido 1999) first reported a response in C. elegans where feeding 
on a bacterial suspension was inhibited by a variety of chemical stressors. These included 
alcohols, heavy metals, sulfhydryl-reactive agents such as the fungicide captan and 
salicylic acid (Jones and Candido 1999). This response provides the nematode with a rapid 
120 
Chapter: 3. Establishment of a nematode model of bacterial infection. 
means of reducing the intake of detrimental chemicals or toxins thus minimising any 
damage that may be incurred. The reduction in feeding rate was due to the cessation of 
pharyngeal pumping used by the nematode to ingest its bacterial food supply. Hence the 
reduction in feeding rate could be measured by simply monitoring the change in optical 
density (OD) of the bacterial suspension in which the nematodes feed over time. 
I reasoned that the feeding inhibition observed might also occur if nematodes were allowed 
to feed on pathogenic bacteria. This would then allow the model to be exploited as an 
assay that would not only rely on the observation of mortality in a small population of 
nematodes but the response of a large population to a pathogen as a whole. Thus the 
greater sample size would give an increase in sensitivity and give a quantitative result not 
open to interpretation by the experimenter, as would be the plate-based mortality assay 
already described. 
The aim of the work reported in this thesis was to investigate the usefulness of the 
nematode C. elegans as an alternative model of bacterial infection for the dangerous 
human pathogen B. pseudomallei. However to allow the establishment of a model of 
nematode killing by bacterial pathogens, the killing by P. aeruginosa PA14 in the standard 
plate-based mortality assay was initially investigated. 
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3.2. Killing of C. elegans by P. aeruginosa PA14. 
The killing of C. elegans on solid media reported by Tan et al (Tan 2002) was first 
investigated. Wildtype C. elegans N2 (var Bristol) were allowed to feed on lawns of P. 
aeruginosa PA14, which had been grown over-night on NGM media. The mortality in the 
original cohort of 10-15 L4 stage worms over time was noted and the percentage mortality 
in the population at each time point calculated. This was then compared to the percentage 
mortality when nematodes fed on E. coli OP50. 
When fed on P. aeruginosa PA14 the first nematode death had occurred at 48 hours post 
infection. By 96 hours all nematodes had died. This was in contrast to that seen on E. cola 
OP50 which only caused a small increase in percentage mortality over the course of the 
experiment (Figure: 3.1. ). 
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Figure: 3.1. Death of C. elegans N2 after exposure to P. aeruginosa PA14 or E. coli 
OP50 for 96 hours at 25 °C. Each experiment contained a total number of 9 replicates 
for each organism, containing 10-15 L4 stage worms. Error bars are the standard error 
of the mean % mortality.   -E. coli OP50, f -P. aeruginosa PA14. 
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The difference in killing rate observed was highly statistically significant as shown by a 
paired students t-test assuming equal variance (P value <0.001). The TD50 value while 
feeding on each bacterium was also calculated. TD50 values were 73 hours ± 1.4 standard 
error and 164 hours ± 0.1 standard error for P. aeruginosa PA14 and E. cola OP50 
respectively. This shows that the mortality rate in the population which fed on P. 
aeruginosa PA14 was in excess of that of those feeding on E. coli OP50. It additionally 
indicates that the bacterium also had an adverse effect on population growth as a whole. 
Microscopic examination of worms after feeding on P. aeruginosa PA14 revealed that the 
intestinal tract was grossly distended (Figure: 3.2b. ) when compared to worms which had 
only fed on E. coli OP50 (Figure: 3.2a). The phenotype was extremely prominent and was 
ubiquitous through out the population in varying degrees of severity. No such phenotype 
was seen in those worms feeding on E. coli OP50 which suggests that the distension was 
mediated by P. aeruginosa PA14 and may be due to bacterial replication in the nematode 
intestine. 
124 
Chapter: 3. Establishment of a nematode model of bacterial infection. 
a b 
Figure: 3.2. Comparison of the C. elegans N2 intestine after feeding on E. colt OP50 (a) or 
P. aeruginosa PA14 (b) for 72 hours at 25°C. Arrows delineate the diameter of the 
intestinal tract. Scale bar represents 50 µm. 
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The eggs of nematodes exposed to P. aeruginosa PA14, were seen to hatch internally 
before deposition causing death of the worm. This so-called "bag of worms" phenotype 
was observed in a large majority of those worms killed. This suggests that the phenomenon 
was bacterially mediated and a consequence of bacterial infection. 
3.3. Feeding of C. elegans N2 in liquid media 
The response of C. elegans N2 when fed on lawns of P. aeruginosa PA14 showed that the 
nematode could be killed by the organism on solid media as previously reported (Tan 
2002). This represents the standard method for assessment of bacterial virulence using C. 
elegans that will be used in this study. To allow the investigation of novel methods for the 
measurement of virulence based on the observations of Jones and Candido (Jones and 
Candido 1999) the response of C. elegans when fed P. aeruginosa PA14 in suspension was 
also assessed. 
Initially, to allow the level of normal nematode feeding in liquid media to be studied, the 
feeding of C. elegans N2 on bacterial suspensions of E. coil 0P50 was investigated. The 
inhibitory effect of 100 mM sodium salicylate solution on bacterial consumption was also 
assessed. Groups of 100-200 worms were allowed to feed for 48 hours at 25 °C in 2 ml of 
a bacterial suspension containing either E. coli OP50 or E. coli OP50 and 100 mM sodium 
salicylate in K-medium (section: 2.4.2). At 24 hour intervals samples were taken and the 
OD at 550 nm (OD55Onm) of the suspension recorded. 
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Figure: 3.3. Decline in OD55onm of 2 ml suspensions of E. coli OP50 in K-medium at 25 
°C due to the feeding of C. elegans N2. f- feeding on E. coli OP50 alone,  - feeding 
on E. coli OP50 and 100 mM sodium salicylate. 10 replicates were performed for each 
condition containing between 100-200 worms. Error bars are the standard error of the 
mean OD55Onm of the 10 replicates performed. 
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The ODssonm of each bacterial suspension declined over time due to the feeding action of 
the nematodes (Figure: 3.3. ). This indicates that C. elegans can feed in suspension and 
cause a concomitant drop in OD of the bacterial suspension. The ODssonm of the suspension 
containing only E. coli fell by 0.51 OD units whereas the OD550nm of the suspension 
containing E. coli OP50 and sodium salicylate only declined by 0.19 OD units. The 
difference in the change in OD55ünm over time was significant with aP value of 0.006. This 
shows that 100 mM sodium salicylate was sufficient to cause stress in C. elegans and 
effectively inhibit normal nematode feeding, as reported by Jones and Candido (Jones and 
Candido 1999). 
3.4. Feeding inhibition of C. elegans N2 by P. aeruginosa PA14. 
As P. aeruginosa PA14 caused significant mortality in the plate-based mortality assay the 
change in ODssonm when worms were incubated with P. aeruginosa PA14 at 25 °C was 
investigated. Groups of 100-200 nematodes were allowed to feed in suspensions of either 
E. coli OP50 or P. aeruginosa PA14 in K-medium for 48 hours and the OD55 m recorded 
at 24 hour intervals (Figure: 3.4. ). 
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Figure: 3.4. Decline in OD55om of bacterial suspensions containing E. coli OP50 ( ) or P. 
aeruginosa PA14 (") due to feeding by C. elegans N2 at 25 °C. 40 replicates were 
performed for each strain, containing between 100-200 worms. Error bars are the standard 
error of the 40 replicates performed. However the standard error only ranges from 0.02 - 
0.09 for each strain and hence the error bars are not visible. 
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Over the course of the experiment the ODS5Onm of both bacterial suspensions decreased 
(Figure: 3.4. ). By 48 hours the rate of decline of ODsso, n, between organisms was different. 
At 48 hours the OD550nm of P. aeruginosa PA14 suspensions had declined by 0.37 OD 
units and the OD550nm of suspensions of E. coli OP50 had declined by 0.47 OD units. 
This difference was significant with aP value of 0.003. Hence feeding in suspensions 
containing E. coli OP50 was faster. 
It was noted that at the start of the experiment it was difficult to achieve an exactly 
identical ODsso for each of the bacterial suspensions used. To allow all results to be 
presented in a uniform manner, the rate of bacterial clearance over time was calculated. 
This was achieved by deducting the final OD550 from the original OD55o and dividing the 
result by the time taken between readings (0D550 at time 0- OD55o at final time point/ n, 
where n is the number of days). An adjusted value is then obtained which represents the 
absorbance units consumed per day (AUCD) by the growing nematode population feeding 
in suspension. 
It was also reasoned that due to the different characteristics of the bacterial strains used the 
lysis of the bacteria in K-medium would be different. This would effectively cloud any real 
reduction in feeding attributable to the pathogen as differences in background cell lysis in 
suspension would give a false picture of the rate of consumption of bacterial cells. To 
assess the possibility of different rates of bacterial lysis overnight cultures of P. aeruginosa 
PA14 and E. coli OP50 resuspended in K-medium were incubated at 25 °C for a total of 48 
hours and the OD550i, n, of each suspension recorded at 24 hour intervals. 
130 
Chapter: 3. Establishment of a nematode model of bacterial infection. 
Decline in ODssom of bacterial suspensions in K-medium. 
1.2 
1 
0.8 { 
E 
0.6 
0 
0.4- 
0.2- 
24 48 
Time (h) 
Figure: 3.5. Reduction in OD550nm of suspensions of E. coli OP50 ( ) or P. aeruginosa 
PA14 (") in K- medium at 25 °C over 48 hours. Error bars are the standard error of the 
mean OD for the 5 replicates performed for each organism. 
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The rate of reduction in OD5s0, m of P. aeruginosa PA14 in K-medium at 25 °C was faster 
than E. coli OP50 (Figure: 3.5. ). The difference in reduction of OD550m was significant 
with aP value of 0.0001 at 48 hours. The ODssom of suspensions containing P. aeruginosa 
PA14 fell over the course of the experiment giving a total decrease of 0.43 OD units at 48 
hours. However E. coli OP50 was relatively stable in suspension and only declined by 0.08 
OD units over 48 hours. This indicated that differences in degradation rates due to natural 
cell lysis in K-medium do occur between P. aeruginosa PA14 and E. coli OP50. 
To give a better representation of the results and to take any natural background cell lysis 
into account, results obtained for C. elegans N2 feeding in both E. cola OP50 and P. 
aeruginosa PA14 suspensions were recalculated to give AUCD. The relevant values from 
calibration wells containing only bacteria and no worms were then subtracted to give an 
adjusted value that incorporated any decrease in ODsso,,,,, due to background bacterial cell 
lysis in K-medium (Figure: 3.6. ). 
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Feeding rates of C. elegans N2 in suspensions of P. aeruginosa PA14 and E. coli 
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Figure: 3.6. Consumption rates of C. elegans N2 on suspensions of E. coli OP50 ( ) or P. 
aeruginosa PA14 (") at 25 °C over 48 hours. 40 replicates were performed each 
containing 100-200 worms. Results obtained in OD units have been recalculated to give 
AUCD and further adjusted to allow calibration for background cell lysis in K-medium. 
Error bars are the standard error of the fully adjusted values of the 40 replicates performed. 
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The consumption rate on E. coli OP50 was seen to increase steadily over 48 hours. Feeding 
rates were maximal at 48 hours with a mean AUCD of 0.141. However consumption of P. 
aeruginosa PA14 increased until 24 hours where feeding rate decreased (Figure: 3.6. ). 
Feeding on P. aeruginosa PA14 was markedly slower than seen with E. coli OP50 with a 
mean AUCD at 48 hours of 0.035 which was only 25% of that seen with E. coli OP50. The 
difference in feeding rates was significant with aP value of 0.018. 
3.5. A mutant of C. elegans N2 increases the sensitivity of the feeding inhibition assay. 
The C. elegans mutant phm-2 has a mutation in allele ad597 (Avery 1993) which causes a 
deformation of the food processing apparatus of the nematode called the grinder, which is 
situated in the pharynx (Figure: 3.7. ). In the wildtype nematode the three lobes of the 
grinder converge with a rhythmic pumping motion that acts to disrupt its bacterial food 
supply before releasing it into the intestine for digestion. However in C. elegans phm-2 the 
grinder cannot come to its full forward position (Avery 1993). This aberrant functioning 
allows a larger number of viable bacterial cells to enter the intestine. Hence the mutant 
phm-2 is concomitantly more sensitive to bacterial infection than the wildtype nematode, 
as colonisation of the intestine is not hampered by the mechanical disruption of the grinder. 
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Figure: 3.7. A diagrammatic representation of the pharynx of C. elegans. Bacterial cells are 
passed from the buccal cavity through the metacorpus using rhythmic pumping motion of 
the attending pharyngeal muscles. Cells are finally disrupted by the grinder within the 
terminal bulb before being released by the pharyngeal-intestinal valve into the intestine for 
digestion. Adapted from Wood et al 1988 (White 1988). 
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The mutant phm-2 has previously been shown to be more sensitive to killing by S. enterica 
servoar Typhimurium (Labrousse, Chauvet et al. 2000). The possibility of this mutation 
also causing an increase in susceptibility of C. elegans phm-2 to infection by P. aeruginosa 
PA14 was investigated through comparison to E. coli OP50 in both the plate-based 
mortality assay and the feeding inhibition assay. 
Groups of 10-20 L4 larval stage C. elegans N2 and C. elegans phm-2 worms were placed 
on lawns of P. aeruginosa PA14 and the mortality at 25 °C in each population monitored 
over 96 hours. Death of C. elegans N2 began at 48 hours and continued until 96 hours 
when no nematodes remained alive. Similarly the percentage mortality of C. elegansphm- 
2 also increased over the course of the experiment and all nematodes were dead by 96 
hours (Figure: 3.8. ). However mortality of C. elegansphm-2 increased sharply at 24 hours 
whereas mortality of C elegans N2 only increased markedly at 48 hours. Percentage 
mortality at 48 hours between the strains was significantly different with aP value of 
0.024. This suggests that the mutant C. elegans phm-2 is killed at a faster rate than that of 
the wildtype strain C. elegans N2. 
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Comparison of percentage mortality of C. elegans N2 and C. elegans phm-2 when 
feeding on P. ae<vginosa PA14. 
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Figure: 3.8. Percentage mortality of C. elegans N2 and C. elegans phm-2 in the plate-based 
mortality assay when feeding on P. aeruginosa PA14. Feeding on E. coli OP50 was used 
as a control. f-C. elegans N2 feeding on P. aeruginosa PA14,  -C. elegans N2 feeding 
on E. coli OP50, A-C. elegans phm-2 feeding on P. aeruginosa PA14 and X-C. 
elegans phm-2 feeding on E. coli OP50. Error bars are the standard error of the mean 
mortality from 3 replicates performed each containing 10-20 worms. 
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TD50 values for C. elegans N2 and C. elegans phm-2 were 73 hours ± 2.9 standard error 
and 65 hours ± 2.9 standard error respectively. This indicates that the percentage mortality 
of the wildtype C. elegans N2 and the mutant C. elegansphm-2 is different when feeding 
on lawns of P. aeruginosa PA14 and that C. elegans phm-2 may be more sensitive to 
killing by this organism. 
The response of C. elegans N2 and C. elegans phm-2 to P. aeruginosa PA14 was also 
compared in the feeding inhibition assay. Groups of 100-200 worms were allowed to feed 
in suspensions of P. aeruginosa PA14 and E. cola OP50 at 25 °C and the OD550nm recorded 
every 24 hours. A lag in feeding rate of C. elegansphm-2 was observed at 24 hours on 
both E. coli OP50 and P. aeruginosa PA14 in the feeding inhibition assay. However the 
effect was more pronounced when feeding in P. aeruginosa PA14 suspensions. After 24 
hours feeding rates on both organisms increased with the fastest occurring in E. cola 0P50. 
Feeding rates of C. elegansphm-2 on E. coli OP50 and P. aeruginosa PA14 were slower 
than C. elegans N2 over all. Feeding on E. coli OP50 was 64 % slower than that observed 
for C. elegans N2 and 29 % slower compared to wildtype feeding rates on P. aeruginosa 
PA14 (Figure: 3.9. ). 
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Comparison of feeding rates of C. elegans N2 and the mutant C. elegans phm -2 when 
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Figure: 3.9. Feeding rates of C. elegans N2 and C. elegans phm-2 on P. aeruginosa PA 14 
in the feeding inhibition assay at 25 °C. Feeding on E. coli OP50 was used as a control. 
- C. elegans N2 feeding on P. aeruginosa PA14,  -C. elegans N2 feeding on E. coli 
OP50, A-C. elegans phm-2 feeding on P. aeruginosa PA14 and X-C. elegans phm-2 
feeding on E. coli OP50. Error bars represent the standard error of the mean AUCD from 6 
replicates each containing 100-200 worms. 
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Consumption rates in P. aeruginosa PA14 at 48 hours were 0.12 AUCD and 0.03 AUCD 
for wild type and mutant nematode strain respectively indicating a difference in feeding 
rates between the nematode strains used. The difference in feeding rates observed in the 
feeding inhibition assay was significantly different with aP value of <0.001. 
3.6. Investigation of P. aeruginosa strain PA01 in the C. elegans nematode model. 
To further explore the possible increase in sensitivity of C. elegans phm-2 to bacterial 
infection, the effect of P. aeruginosa PAO1 in the plate-based mortality assay and feeding 
inhibition assay was investigated. P. aeruginosa PA01 has been shown to cause the death 
of C. elegans through a cyanide mediated mechanism when grown on BHI media. Hence 
any increase in mortality or decrease in feeding rates between C. elegans N2 and C. 
elegans phm-2 would indicate an effect of P. aeruginosa PAO1 and further indicate any 
increase in sensitivity of the mutant under these assay conditions. 
Groups of 50-100 worms were allowed to feed on suspensions of either P. aeruginosa 
PAO1, P. aeruginosa PA14 or E. coli OP50 in K- medium at 25 °C for 48 hours and the 
change in OD55Onm was recorded daily. Feeding of the wildtype and mutant worms on P. 
aeruginosa PAO1 was slower when compared to feeding on E. coli OP50. Feeding rates of 
C. elegans phm-2 on all bacterial strains tested was again slower than that of C. elegans N2 
(Figures: 3.10. and 3.11. ). At 48 hours, consumption rates of C. elegans N2 on P. 
aeruginosa PA01was only 66.6% of that seen on E. cola OP50. Furthermore feeding of C. 
elegans phm-2 on P. aeruginosa PA01 was only 52 % of that observed for E. cola OP50. 
However the difference between consumption rates of C. elegans phm-2 on E. coli 0P50 
and P. aeruginosa PAO1 was not significant (P value = 0.09). 
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Figure: 3.10. Consumption rates of C. elegans N2 when feeding on P. aeruginosa PAO1 
("), P. aeruginosa PA14 ( ) or E. coli OP50 (A) over 48 hours at 25 °C in the feeding 
inhibition assay. Feeding on P. aeruginosa PA14 and E. coli OP50 were used as controls. 
Error bars are the standard error of the mean feeding rate (AUCD) of 6 replicates each 
containing 50-100 worms. 
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Figure: 3.11. Consumption rates of C. elegans phm-2 when feeding on P. aeruginosa PAO1 
("), P. aeruginosa PA14 (a) or E. coli OP50 (A) over 48 hours at 25 °C in the feeding 
inhibition assay. Feeding on P. aeruginosa PA14 and E. coli OP50 were used as controls. 
Error bars are the standard error of the mean feeding rate (AUCD) of 6 replicates each 
containing 50-100 worms. 
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The effect P. aeruginosa PAO1 on C. elegans N2 and C. elegans phm-2 was also assessed 
in the plate-based mortality assay. Groups of 10-20 L4 stage wildtype and mutant 
nematodes were allowed to feed on lawns of P. aeruginosa PAO1 for 96 hours at 25 °C and 
the mortality in each population recorded at 24 hour intervals. 
After 96 hours there was no difference between the mortality caused in either population (P 
value = 0.76). However killing of both nematode strains did occur (Figure: 3.12. and 
3.13. ). Killing of C. elegans N2 due to P. aeruginosa PAO1 began at 72 hours. Conversely 
the death of C. elegans phm-2 began earlier at 24 hours. At 96 hours the percentage 
mortality of C. elegans N2 feeding on P. aeruginosa PAO1 was 40 % with a calculated 
TD50 value of 99 hours ± 3.39 standard error, while the percentage mortality of C. elegans 
phm-2 under the same experimental conditions was 40.45 % with a TD50 value of 104 
hours ± 11.51 standard error. This further indicates that there was no difference in the 
effect of P. aeruginosa PAO1 on C. elegans N2 and C. elegans phm-2 in the plate-based 
mortality assay. 
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Figure: 3.12. Mortality of C. elegans N2 when feeding on P. aeruginosa PA01 ("), P. 
aeruginosa PA14 ( ) or E. coli OP50 (A) over 96 hours at 25 °C in the plate-based 
mortality assay. P. aeruginosa PA14 and E. coli OP50 were used as controls. Error bars 
are the standard error of the mean percentage mortality of 3 replicates each containing 10- 
20 worms. 
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Figure: 3.13. Mortality of C. elegans phm-2 when feeding on P. aeruginosa PAOI ("), P. 
aeruginosa PA14 ( ) and E. coli OP50 (A) over 96 hours at 25 °C in the plate-based 
mortality assay. P. aeruginosa PA14 and E. coli OP50 were used as controls. Error bars 
are the standard error of the mean percentage mortality of 3 replicates each containing 10- 
20 worms. 
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3.7. Discussion. 
The results of the experiments reported in this chapter were in accordance with those 
previously described (Tan, Miklos et al. 1999). Worms initially appeared healthy and 
reproduction occurred normally. However after 24 hours post infection mortality in the 
original cohort of nematodes exposed to P. aeruginosa PA14 began to increase. From 
microscopic examination of nematodes a severely distended gut and a generally starved 
appearance was observed (Figure: 3.2. ). Various authors have described how P. 
aeruginosa PA14 is able to accumulate and proliferate within the nematode gut (Tan, 
Miklos et al. 1999; Tan, Rahme et al. 1999; Rahme, Ausubel et al. 2000). The growth of 
bacteria in the intestinal lumen may then account for the distended appearance observed. In 
this assay P. aeruginosa PA14 was the only food source for the nematodes. This organism, 
instead of being digested by the worms as occurs with their standard bacterial food supply 
E. coli OP50 colonises and proliferates within the intestine. This would hinder digestion 
and nutrient up take across the intestine giving the starved appearance that was observed. 
The starvation would then be a by-product of Pseudomonas infection. However the 
mechanism of killing of C. elegans by P. aeruginosa PA14 is not completely understood 
and may occur through an as yet unidentified mechanism. Thus the possibility that the 
proliferation of P. aeruginosa PA14 within the nematode gut is a consequence rather then 
the cause of killing of C. elegans cannot be discounted. 
A small increase in the percentage mortality of those worms feeding on E. coli OP50 was 
also noted. This may reflect the normal population dynamic of a growing nematode 
population under experimental conditions. These observations have been previously 
reported by Vaupel et al (Vaupel, Johnson et al. 1994) who showed that the rate of death in 
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a population of nematodes increases over time. This may then be a factor involved in the 
increase in mortality in the control population. Moreover it is now thought that as 
nematodes age they become more susceptible to bacterial infection. Thus in older worms 
E. coli OP50 can become deleterious to health under the standard conditions employed 
within the killing assay (Garigan 2002). Near death E. coli OP50 is seen to accumulate 
within the nematode pharynx and intestinal tract in a similar fashion to that seen with many 
of the currently identified pathogens of C. elegans (Table: 1.1. ). Growth of C. elegans on 
strains of E. coli, which are unable to proliferate, has shown that an increase in mean life 
span of 30-40 % can be achieved (Garigan 2002). This shows that any increase in mortality 
observed within control populations may be due in part to the natural ageing process of the 
nematodes. This would degrade the function of the C. elegans innate immune system 
(Section: 1.5.4.5. ) allowing bacterial colonisation and an eventual bacterially mediated 
death of the worm. These data then also suggest that E. cola may not be an ideal food 
source for C. elegans as it may not be as benign under the conditions employed in the 
plate-based mortality assay as is widely accepted. 
As an adjunct to the commonly used plate-based mortality assay a novel method of 
assessment of bacterial virulence was also investigated. An assay developed by Jones and 
Candido (Jones and Candido 1999) exploited the inhibitory effect of chemicals on 
nematode feeding. This method has been modified in this study to give a novel method for 
the evaluation of bacterial virulence towards C. elegans. The feeding inhibition assay relies 
on the ingestion and breakdown of bacteria by nematodes with a resultant reduction in the 
OD550 of the bacterial suspension in which they feed. 
P. aeruginosa PA14 caused a slowing of normal nematode feeding rates in suspension 
when compared to feeding rates on E. coli OP50. This decrease in consumption rate when 
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compared to a suitably non-pathogenic control can then be interpreted as an indication of 
pathogenicity. 
In contrast to the plate-based mortality the feeding inhibition assay is able to supply 
quantitative data that is not open to operator-induced variation due to differences in the 
criteria used to identify dead worms. Additionally the feeding inhibition assay also gives a 
more rapid result compared to other agar pate-based methods. This is shown through 
comparison of the time to any observable effect in both assay methods. In the plate-based 
mortality assay, mortality caused by P. aeruginosa PA14 is only observable after 48 hours 
(Figure: 3.1. ). However an effect on feeding rate in the feeding inhibition assay can be seen 
after 24 hours (Figure: 3.6. ) therefore allowing a more rapid decision on an organisms 
pathogenicity to be obtained. 
Although the feeding inhibition assay is more rapid than the plate-based mortality assay 
the mechanism of how an external physical stimulus is converted to a behavioural response 
in C. elegans is unclear and the actual mechanism of feeding inhibition has not been 
characterised. This then may limit the feeding inhibition assay to the identification of 
bacterial species that do or do not cause feeding inhibition. It also suggests that unlike the 
plate-based mortality assay it may not be useful for the identification specific bacterial 
virulence factors important in mammalian pathogenesis (Miklos, Tan et al. 1999; Tan, 
Rahme et al. 1999; Hendrickson, Plotnikova et al. 2001; Gan 2002; Tan 2002). 
To augment the rapidity of the C. elegans model of infection in the plate-based mortality 
assay and the feeding inhibition assay the mutant C. elegansphm-2 was investigated. 
When tested in the plate-based mortality assay killing of the mutant by P. aeruginosa 
PA14 began at 24 hours. Conversely killing of the wildtype C. elegans N2 began at 48 
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hours. This shows that C. elegans phm-2 is killed more rapidly by P. aeruginosa PA14 
than the wildtype strain. Furthermore the decrease in time to an observable effect indicates 
that the mortality of both worm strains is indeed mediated in part by an infectious process. 
As C. elegansphm-2 has a defective feeding apparatus an enhanced susceptibility to 
pathogens that colonise the intestinal tract is expected. Thus the increase in mortality rates 
observed in the plate-based mortality assay indicates a role for infection in killing of C. 
elegans. 
When C. elegans phm-2 was assessed in the feeding inhibition assay a decrease in the time 
to an effect caused by P. aeruginosa PA14 was noted when compared to feeding rates of 
the wildtype C. elegans N2. Feeding rates of the mutant were severely reduced by 48 
hours (Figure: 3.9. ). However, over all feeding rates of C. elegans phm-2 in the feeding 
inhibition assay were slower than C. elegans N2 on both E. coli OP50 and P. aeruginosa 
PA14. Due to the mutation in C. elegansphm-2 an increased number of whole bacterial 
cells are allowed to pass into the gut. The action of the nematode intestine is rapid and the 
entire gut content is expelled approximately every 45 seconds (Avery 1993). Thus during 
defecation C. elegans phm-2 passes large quantities of intact bacterial cells back into 
suspension. The increased rate of deposition of whole bacterial cells therefore gives 
feeding rates that are not truly representative of feeding inhibition by pathogens. This 
would be in part due to the nature of the mutation as smaller quantities of cells are 
removed from suspension by the feeding action of the nematode. 
As C. elegansphm-2 has been shown to be infected more rapidly by P. aeruginosa PA14 
we reasoned that it might be of use for the investigation of other pathogens not normally 
capable of causing mortality in the wildtype worm. P. aeruginosa PA01 grown on BHI 
media kills C. elegans N2 rapidly through the release of HCN. However when grown on 
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NGM media mortality is not normally observed (Gallagher and Manoil 2001). To further 
investigate the increase in sensitivity afforded by C. elegans phm-2 the response to P. 
aeruginosa PAO1 was assessed using the plate-based mortality assay and the feeding 
inhibition assay. 
When fed on P. aeruginosa PAO1 in the plate-based mortality assay, mortality of C. 
elegans phm-2 increased at 24 hours in a similar fashion to that seen when C. elegans phm- 
2 fed on P. aeruginosa PA14. However killing of the nematodes was incomplete by 96 
hours with only 40 % mortality in the population (Figure: 3.13. ). Surprisingly P. 
aeruginosa PAO1 also killed C. elegans N2 in the plate-based mortality assay although the 
effect was delayed compared to that seen for C. elegans phm-2. Killing of C. elegans N2 
began at 72 hours and reached 40 % by 96 hours (Figure: 3.12. ). Calculated TD50 values 
for both mutant and wildtype were also similar. TD50 values for mutant and wild type were 
104 hours ± 11.51 SE and 99 hours ± 3.39 SE respectively. This indicates no difference in 
overall killing rate when feeding on P. aeruginosa PAO1 between the two nematode strains 
investigated. 
These data then suggest an increase in time to an effect of P. aeruginosa PAO1 infection in 
C. elegans phm-2 as seen with P. aeruginosa PA14. This also indicates that the killing 
observed by P. aeruginosa PAO1 in the plate-based mortality assay on NGM is mediated at 
least in part by an infectious process as the mutant is affected earlier when compared to the 
wildtype strain. 
Thus P. aeruginosa PAO1 is able to cause mortality of both C. elegans N2 and the mutant 
C. elegansphm-2 in the plate-based mortality assay at similar rates. Since P. aeruginosa 
PA01 possesses some of the genes implicated in the killing of nematodes by P. aeruginosa 
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PA14 (Stover, Pham et al. 2000) it is then possible that under some conditions P. 
aeruginosa PAO1 can also display a killing phenotype similar to that of P. aeruginosa 
PA14. This may then be responsible for the increased mortality of both C. elegans N2 and 
C. elegans phm-2 in this assay. 
Consumption rates of C. elegans phm-2 when feeding on pathogen and non-pathogen in 
the feeding inhibition assay were slower than that of the wildtype strain C. elegans N2 
(Figures: 3.10. and 3.11. ). The slower feeding rates observed for C. elegans phm-2 
resulting from small changes in OD55Onm over time allows a large amount of statistical error 
to be introduced, hence the lack of statistical significance between feeding rates on either 
pathogen or non-pathogen at 48 hours. However, the over all trend in this assay was that P. 
aeruginosa PAO1 caused a decrease in feeding rates in both C. elegans phm-2 and C. 
elegans N2 compared to normal feeding on E. coli OP50. This suggests a similar 
mechanism might be responsible for both feeding inhibition in the feeding inhibition assay 
and the mortality caused in the plate-based mortality assay as both mutant and wild type 
were affected, albeit to different extents. 
No comparable increase in sensitivity to P. aeruginosa PA01 was noted between C. 
elegans N2 and C. elegans phm-2 as seen for P. aeruginosa PA14. Indeed P. aeruginosa 
PAOIappeared to cause a greater decrease in feeding rates in C. elegans N2 when 
compared to P. aeruginosa PA14. This again may exemplify a limitation of the feeding 
inhibition assay in that it can only show that a particular strain is more virulent than 
another towards C. elegans. 
Taken together these results indicate that C. elegans phm-2 may be used to increase the 
sensitivity of plate-based assay methods for bacterial virulence. It may also be useful for 
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the identification of organisms not previously seen to be pathogenic to C. elegans under 
the culture conditions described. Furthermore this would hypothetically allow the 
expansion of the C. elegans model of infection to other bacterial species capable of causing 
infections in the mammalian host that do not normally cause infections in the wildtype 
strain C. elegans N2. However, the use of C. elegans phm-2 in conjunction with the 
feeding inhibition assay has shown that nematode strains carrying mutations that affect the 
feeding apparatus may not be suitable for use in this assay due to the generally reduced 
feeding rates observed. 
The investigation of P. aeruginosa pathogenesis in the C. elegans model has allowed the 
optimisation and modification of commonly utilised methods for the investigation of 
bacterial virulence using nematodes. This includes the establishment of standard culture 
and manipulation techniques essential for the experimental use of C. elegans. 
Furthermore it has also allowed the development of novel assay methodologies 
exemplified by the feeding inhibition assay which may provide a further level of sensitivity 
to this already versatile model 
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4.1. Introduction. 
In chapter 3a nematode model of infection by P. aeruginosa was successfully established 
on solid and in liquid media. However the main aim of this thesis was to investigate the 
usefulness of the C. elegans model for the investigation of B. pseudomallei pathogenesis a 
member of the Burkholderia genus. Therefore, to address this a C. elegans - Burkholderia 
infection model was established through investigation of a variety of strains from the 
Burkholderia genus. 
The Burkholderia genus contains a large number of strains, some of which can be 
pathogenic to humans and other animals. Many of these strains have been assessed for 
their virulence in both nematode and murine models of infection (0' Quinn, Wiegand et al. 
2001; Gan 2002; Kothe 2003). Although these studies have reported a number of 
interesting findings such as the involvement of particular virulence factors in C. elegans 
pathogenesis, a screen of Burkholderia species utilising a representative number stains has 
so far not been undertaken. Such a screen would allow the clinical relevance of the 
nematode model for study of strains from the Burkholderia genus to be assessed. 
Comparison of these closely related strains may also reveal common features that would 
allow a better understanding of the pathogenicity of B. pseudomallei in C. elegans as a 
whole. This information could then be utilised to give a further insight into the 
pathogenesis of this organism in the mammalian host. 
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4.2. The B. cepacia complex. 
The effect of a panel of 20 strains from the B. cepacia complex comprising of a variety of 
clinical and environmental isolates was investigated (Table: 4.1. ). These represented B. 
cepacia, Burkholderia multivorans, Burkholderia cenocepacia sp. nov, Burkholderia 
stabilis and Burkholderia vietnamiensis (genomovars IN respectively). 
Each strain was initially investigated in the plate-based mortality assay. Groups of 10-20 
L4 stage nematodes were fed on lawns of each strain at 25 °C for a total of 96 hours and 
the mortality in each population recorded at 24-hour intervals. The percentage mortality in 
each group of worms at 96 hours was then calculated and compared to the mortality of 
nematodes on E. coil OPSO. Any increase in percentage mortality compared to that 
observed when fed on E. coli OP50 would indicate a detrimental effect in the nematode 
model. 
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Table: 4.1. B. cepacia complex isolates selected for investigation in the C. elegans model 
of infection. 
T. Type strain for that genomovar. 
1. American Type Culture Collection. 
2 Belgium Coordinated Collections of Microorganisms/ Laboratorium Microbiologie 
Ghent (BCCM/LMG) http: //www. belspo. be/bccm. 
t. These strains were obtained from Dr. J. Govan. CF Laboratory, Department of Medical 
Microbiology, University of Edinburgh medical school. Edinburgh. UK. 
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Species Strain Site of 
Genomovar Source 
Name Number isolation 
ATCC 25416 Environmental 
ATCC 17759 Environmental 
t J2540 Environmental 
t C2970 Clinical 
B. cepacia t C3159 Clinical 
t C1963 Clinical 
t C1964 Clinical 
BCCM/ 
LMG Z 
6860 Environmental 
BCCM/ 
B. 13010T Clinical 
II LMG 
multivorans 
ATCC 17616 Environmental 
BCCM/ 
16656 T Clinical 
LMG 
BCCMJ 
16654 Clinical 
LMG 
B . t C1394 Clinical 
cenocepacia 
t J2956 Clinical 
III 
t C2836 Clinical 
BCCM/ 
18863 Clinical 
LMG 
BCCMJ 
14294 T Clinical 
LMG 
IV B. stabilis 
BCCMJ 
14086 Clinical 
LMG 
BCCMJ 
10929 T Environmental 
B. LMG 
V 
vietnamiensis BCCM/ 
18836 Clinical 
LMG 
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No single genomovar tested contained more virulent representatives in the plate-based 
mortality assay than the others tested and only 9 of the strains investigated resulted in 50 
mortality or over at 96 hours. B. cepacia (genomovar I) and B. cenocepacia sp. nov. 
(formerly B. cepacia complex genomovar III) contained the most virulent strains. However 
when these were compared the strains tested from B. cenocepacia sp nov. resulted in the 
highest degree of nematode mortality over time. B. cenocepacia sp. nov. C2836 (Figure: 
4.1. Strain number 16) was the most virulent strain tested causing 100 % mortality at 96 
hours. This was equal to that caused by P. aeruginosa PA14. Conversely B. cenocepacia 
sp. nov. 18863 (Figure: 4.1. Strain number 13), did not cause nematode death after 96 
hours. 
The strains tested from the B. stabilis group (strains numbers 19 and 20, LMG 14294 and 
LMG 14086 respectively) had a reduced virulence towards C. elegans N2 in the plate- 
based mortality assay causing only 3.33 % and 5.34 % mortality respectively at 96 hours. 
Those strains investigated from both the B. multivorans group (genomovar II) and B. 
vietnamiensis (genomovar V) had virulent and less virulent representatives. The type strain 
of each of these genomovars caused the smallest degree of mortality at 96 hours where as 
the second strain tested caused a large increase in the mortality observed (Figure: 4.1. ). 
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Figure: 4.1. Mortality of C. elegans N2 after feeding on lawns of bacteria from 
genomovars I-V of the B. cepacia complex at 25 °C at 96 hours post-infection grown on 
NGM. Strains tested were B. cepacia ATCC 25416 (3), B. cepacia C3159 (4), B. cepacia 
ATCC 17759 (5), B. cepacia J2540 (6), B. cepacia LMG 6860 (7), B. cepacia C2970 (8), 
B. cepacia C1963 (9), B. cepacia C1964 (10), B. multivorans LMG 13010 (11), B. 
multivorans ATCC 17616 (12), B. cenocepacia LMG 18863 (13), B. cenocepacia J2956 
(14), B. cenocepacia C1394 (15), B. cenocepcia C2836 (16), B. cenocepcia LMG 16654 
(17), B. cenocepacia LMG 16656 (18), B. stabilis LMG 14294 (19), B. stabilis LMG 
14086 (20), B. vietnamiensis LMG 10929 (21), B. vietnamiensis LMG 18836 (22). The 
mortality at 96 hours on P. aeruginosa PA14 (2) and E. coli OP50 (1) has been included as 
controls. Error bars are the standard error of the mean % mortality at 96 hours of the 3 
replicates performed for each strain tested containing between 10-20 IA stage worms. 
Some error bars are not visible as the error is too small to display. 
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The panel of 20 B. cepacia strains were also tested in the feeding inhibition assay. Any 
reduction in feeding compared to feeding rates in suspensions of E. coli OP50 would 
indicate a detrimental effect on the nematodes. Groups of 50-100 C. elegans nematodes 
were allowed to feed in 1 ml suspensions of each B. cepacia complex strain at an 
approximate starting OD55on, of 1.2 for 48 hours and the OD55 m recorded at 24 hour 
intervals. 
All strains tested caused a reduction in feeding rate to a greater extent than that of the non- 
pathogenic control E. coli OP50. B. cepacia LMG 6860 (Figure: 4.2. strain number 6) and 
B. vietnamiensis LMG 10929 (Figure: 4.2. strain number 21) caused the lowest feeding 
rates indicating a high degree of feeding inhibition. At 48 hours the feeding rate on these 
strains was - 0.023 and -0.004 AUCD respectively showing a complete inhibition of 
nematode feeding. The highest feeding rates occurred in suspensions of B. cepacia ATCC 
17759, B. cepacia J2540 and B. stabilis LMG 14086 (Figure: 4.2. strain numbers 5,6 and 
20 respectively) and consequently exhibited the lowest feeding inhibition over all at 48 
hours. However feeding rates on these strains were still significantly reduced when 
compared to normal feeding rates on E. coli OP50 (Figure. 4.2. strain number 1). 
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Figure: 4.2. Change in OD5sonm at 48 hours of bacterial suspensions of strains from 
genomovars I-V of the B. cepacia complex at 25 °C. Each 1 ml sample of bacterial 
suspension in K-medium had a starting OD550. of approximately 1.2. Strains tested were 
B. cepacia ATCC 25416 (3), B. cepacia C3159 (4), B. cepacia ATCC 17759 (5), B. 
cepacia J2540 (6), B. cepacia LMG 6860 (7), B. cepacia C2970 (8), B. cepacia C1963 (9), 
B. cepacia C1964 (10), B. multivorans LMG 13010 (11), B. multivorans ATCC 17616 
(12), B. cenocepacia LMG 18863 (13), B. cenocepacia J2956 (14), B. cenocepacia C1394 
(15), B. cenocepcia C2836 (16), B. cenocepcia LMG 16654 (17), B. cenocepacia LMG 
16656 (18), B. stabilis LMG 14294 (19), B. stabilis LMG 14086 (20), B. vietnamiensis 
LMG 10929 (21), B. vietnamiensis LMG 18836 (22). The feeding rates at 48 hours on P. 
aeruginosa PA14 (2) and E. coli OP50 (1) were included as controls. Error bars are the 
standard error of the mean AUCD for the 8 replicates performed for each strain tested 
containing 50-100 L4 stage worms. 
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In an attempt to determine the relevance of the C. elegans model to the study of the B. 
cepacia virulence the relationship between genomovar status, biological origin and the 
effect in the plate-based mortality assay was investigated through comparison of the data 
using the statistical package Mini-Tab version 13.0. 
The ability to cause mortality of nematodes and the genomovar of each strain were 
compared using a one-way ANOVA analysis (Figure: 4.3. ). This revealed that there was no 
association of genomovar with the ability to cause nematode death. No statistically 
significant difference was noted between the killing abilities of each genomovar when 
compared to the genomovar status of each strain (P value = 0.4). 
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Comparison of the percentage mortality of C. elegans N2 
caused by strains from genomovars IN of the B. cepacia 
complex 
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Figure: 4.3. Comparison of the percentage mortality observed in populations of C. elegans 
N2 at 96 hours when feeding on strains from genomovars I-V of the B. cepacia complex at 
25 °C and the genomovar status of each group. Filled squares show the mean percentage 
mortality for that genomovar. Bars denote the individual 95% confidence intervals based 
on pooled standard deviations from each genomovar. 
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To show if the origin of the infecting strain could influence the effect in either assay a 
comparison was also performed between the origin of the infecting strain and the effect in 
both the plate-based mortality assay and the feeding inhibition assay using a two-sample t- 
test. This indicated that there was no statistically significant difference between the effect 
of strains from either environmental or clinical sources in the plate based mortality assay or 
the feeding inhibition assay with P values of 0.5 and 0.7 respectively. 
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4.3. Aberrant movement of C. elegans induced by members of the B. cepacia complex. 
During screening of the 20 strains from the B. cepacia complex an unusual phenotype was 
observed that was induced by some of the strains tested. This phenotype was characterised 
by an increased side to side flexion of the body which formed trails in the bacterial lawn 
that were distinct from the normal sinusoidal pattern made by worms fed on either P. 
aeruginosa PA14 or E. coli OP50. In some cases this resulted in a loss in the ability of the 
nematodes to effectively translocate across the bacterial lawn (Figure: 4.4. ). 
Strains causing aberrant movement included B. cepacia strains ATCC 25416, ATCC 
17759, J2540, and C2970; B. cenocepacia sp. nov strains J2956, LMG 16654 (J415) and 
C2836. B. vietnamiensis strains LMG 10929 and LMG 18836 also caused difficulties in 
nematode translocation across the bacterial lawn. None of the strains tested from either B. 
multivorans or B. stabilis caused aberrant movement after 96 hours at 25 °C. 
When feeding on the above strains the aberrant movement phenotype appeared as early as 
24 hours post-exposure and persisted throughout the experiment with varying degrees of 
severity. B. cenocepacia sp. nov strains J2956, LMG 16654 and B. vietnamiensis LMG 
10929 caused the most severe phenotype. Microscopic examination showed that worms 
feeding on these strains became completely immobilised. Furthermore no particular larval 
stage displayed the aberrant movement phenotype more than any other in the growing 
population as all larval stages appeared to be affected. However the larger L4, young adult 
and adult stages were observed to have less difficulty in translocation across the bacterial 
lawn. 
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Figure: 4.4. Photomicrographs of NGM agar plates seeded with bacterial cells cultured at 
37 °C on which C. elegans N2 has been allowed to feed for 72 hours at 25 T. A; normal 
trails on E. coli OP50 after 72 hours. B; normal trials left on the pathogenic P. aeruginosa 
PA14 after 72 hours. C; a C. elegans N2 nematode displaying a severe aberrant movement 
phenotype and partially immobilised on a lawn of B. cepacia ATCC 17759 after 72 hours. 
D; evidence of severe aberrant movement seen after 72 hours feeding on B. vietnamiensis 
LMG 18836. Scale bar represents 250 µm. 
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4.4. Effect of B. cenocepacia sp. nov strain LMG 16654 in the C. elegans model. 
During the course of the investigation one particular strain from B. cenocepacia sp. nov. , 
LMG 16654 (J415) was observed to induce a second phenotype in addition to aberrant 
movement that was distinct from the other strains tested. J415 is the index strain for 
cepacia syndrome in the CF community (Dr. J. Govan, Pers. Comm. ). It has both the cable 
pilin (Cbl+) and B. cepacia epidemic strain marker (BCESM) genetic elements, which are 
linked with the transmission of epidemic strains (Clode, Kaufmann et al. 2000). 
After 24 hours feeding on J415 it was noted that the organism as well as inducing the 
aberrant movement phenotype also caused the formation of adherent structures on the head 
of nematode that further hindered nematode locomotion (Figure: 4.5. ). In populations of C. 
elegans N2 feeding on J415 the presence of this "nose-glob" phenotype, as shown by the 
percentage of worms on which a nose glob formed (%NGF) peaked at 24 hours and 
subsequently decreased in prevalence over the course of the experiment. This continued 
until 96 hours after which no nematodes could be observed to retain any nose-globs and 
normal locomotive ability had returned to those previously affected. (Figure: 4.6. ). 
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Figure: 4.5. Photomicrograph of C. elegans N2 with a nose-glob after feeding for 24 hours 
at 25 °C on B. cenocepacia sp. nov. J415 grown on NGM. The arrow shows the 
accumulation at the head of the nematode that impedes locomotion. Scale bar = 200 µm 
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Figure: 4.6. Occurrence of the nose-glob phenotype in populations of C. elegans N2 when 
feeding on B. cenocepacia sp. nov J415 grown on NGM. Worms were fed at 25 °C for 96 
hours and observed through daily microscopic examination of plates. Error bars are the 
standard error of mean %NGF of the 9 replicates performed each containing 10-20 IA 
stage. worms. 
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4.4.1. Affect of cuticle structure on formation of nose-globs. 
The C. elegans mutants srf-2, srf-3 and srf-5 posses mutations that effect the cells which 
form the hypodermis. These cells are in turn, responsible for the secretion of the highly 
impermeable cuticle (Politz 1990). Although wildtype in appearance, these mutants have 
an ability to bind lectins such as wheat germ agglutinin which is different to that observed 
in the wildtype strain C. elegans N2. Surface components normally hidden in the adult N2 
strain are unmasked, giving a different lectin binding profile and surface structure for each 
mutant (Politz 1987; Politz 1990; Link 1992). 
These mutants have previously been shown to be refractory to infection by a number of 
fungal and bacterial species, which are pathogeic for wildtype C. elegans N2 (De Gives 
1999). It has also recently been demonstrated that they are resistant to the blockage and 
nose-glob formation induced by Y. pseudotuberculosis (Section: 1.5.4.6). The differences 
in cuticle structure displayed by these mutants allow resistance to the accumulation of Y. 
pseudotuberculosis cells in the form of biofilms on the cuticular surfaces of nematode 
body. These impede normal nematode feeding and locomotion and are a factor in causing 
the precocious death of the worm (Joshua 2003). 
As the nose-glob phenotype observed in C. elegans N2 when feeding on B. cenocepacia 
sp. nov. J415 was similar to that observed when feeding on Yersinia species the 
susceptibility of srf-2,3 and 5 to the nose-glob formation induced by B. cenocepacia sp. 
nov. J415 was investigated using a modified plate-based mortality assay. This would show 
if a similar mechanism of nose-glob formation occurring between the two bacterial species. 
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Groups of 10-20 C. elegans srf 2,3 and 5 and N2 wildtype worms were allowed to feed on 
lawns of B. cenocepacia sp. nov. J415 for a total of 96 hours and the number of worms 
which were observed to possess nose-globs was recorded at 24 hour intervals. All srf- 
mutant strains tested displayed the adherent nose-glob phenotype at 24 hours (Figure: 4.7. ). 
When compared to C. elegans N2 there was no significant difference in the ability to cause 
nose-globs between any of the mutant strains tested. However at 24 hours the mutant srf-5 
appeared to be most resistant to nose-glob formation with only 28 % NGF. Nose-globs 
were seen to persist longer in this strain than the other strains tested. The mutant srf-3 was 
the most susceptible strain over all with 47 % NGF at 24 hours (Figure: 4.7. ). 
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Figure: 4.7. Nose-glob formation in the C. elegans srf-mutants 2,3 and 5 on B. 
cenocepacia sp. nov. J415 grown on NGM. Worms were fed at 25 °C over 96 hours and 
observed by microscopy. Nose-glob formation in C. elegans N2 was used as a control. f- 
nose-glob formation in C. elegans srf-2,  -C. elegans srf-3, f-C. elegans srf-5 and 
finally X- in C. elegans N2. Error bars are the standard error of the mean % NGF for the 9 
replicates performed for each strain each containing 10-20 L4 stage worms. 
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4.4.2. Investigation of mortality caused by B. cenocepacia sp. nov. J415. 
The mortality caused by B. cenocepacia sp. nov. J415 in populations of the C. elegans sr, f' 
mutants 2,3 and 5 was also assessed in a plate-based mortality assay. Groups of 10-20 
mutant and wildtype worms were fed on lawns of B. cenocepacia sp. nov. J415 grown on 
NGM at 25 °C and the mortality in each population recorded at 24 hour intervals over a 96 
hour period. 
From microscopic examination of nematodes the phenotype associated with death of the 
both mutant strains and the wildtype C. elegans N2 was a distension of the gut, similar in 
appearance to that observed in P. aeruginosa PA14 infection of C. elegans. The gut was 
seen to fill the entire pseudocelomic cavity causing the eventual premature death of the 
worm in as little as 24 hours. All worm strains tested also exhibited an aberrant movement 
phenotype but this did not persist through out the experiment. By 48 hours post-exposure 
only the mutant srf-3 still displayed the phenotype. 
After 96 hours there was no statistical difference between the percentage mortality of C. 
elegans N2 and the percentage mortality of mutant strains srf-2 and srf-5 (Figure: 4.8. ). 
However as previously observed with nose-glob formation the C. elegans mutant srf-3 was 
most susceptible to killing by J415. When compared to wildtype levels of mortality the 
difference was significant (P value = <0.001). 
The TD50 for each mutant was also calculated using the statistical package Minitab version 
13.1 through probit analysis with an assumed log distribution. TD5ovalues for srf-2,3,5 
mutant nematodes and the wild type C. elegans N2 were 104 hours +/- 4.2 standard error, 
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74 hours +/- 3.2 standard error, 113 hours +/- 6.4 standard error and 111 hours +/- 7.4 
standard error respectively. The decrease in TD50 shows that of the mutant strains tested 
srf-3 was the most susceptible to killing by B. cenocepacia sp. nov. J415. 
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Percenatge mortality of C elegans srf mutants 2,3 and 5 when feeding on a cenocepacia 
sp. nov. J415. 
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Figure: 4.8. Mortality of C. elegans srf mutants 2 ("), 3 (. ), 5 (A) or the wildtype N2 
(X) when feeding on the B. cenocepacia sp. nov. J415 grown on NGM. Nematodes were 
fed at 25 °C for 96 hours. Error bars are the standard error of the mean of 9 replicates 
performed for each strain each containing 10-20 L4 stage worms. 
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The mutant C. elegans srf- 3 was the only mutant that displayed a significant increase in 
percentage mortality on B. cenocepacia sp. nov. J415 when compared to C. elegans N2, in 
the plate-based mortality assay. The possibility of the mutation in C. elegans srf-3 causing 
a general increase in the susceptibility of this strain to bacterial infection was investigated. 
Groups of 10-15 C. elegans srf-3 or C. elegans N2 worms were fed on P. aeruginosa PA14 
for 96 hours and the mortality in each population observed at 24 hour intervals through 
microscopy (Figure: 4.9. ). Any difference in the mortality between mutant and wildtype 
populations would then show any effect of the srf-3 mutation. 
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Figure: 4.9. Mortality rates of C. elegans N2 and the C. elegans mutant srf-3 when fed on 
P. aeruginosa PA14 grown on NGM. Worms were allowed to feed for a total of 96 hours 
at 25 °C. Worms fed on E. coli OP50 were used as a control. f-C. elegans srf-3 feeding 
on P. aeruginosa PA14,  -C. elegans srf-3 feeding on E. coli OP50, A-C. elegans N2 
feeding on P. aeruginosa PA14 and X-C. elegans N2 feeding on E. coli 0P50. Error bars 
are the standard error of the mean of 3 replicates performed for each condition, each 
containing 10-15 L4 stage worms. 
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After 96 hours there was no significant difference observed between mortality rates of the 
mutant C. elegans srf-3 or C. elegans N2 when fed on P. aeruginosa PA14 (P value = 
0.3). TD50 values for C. elegans N2 and C. elegans srf-3 when fed on P. aeruginosa PA14 
were 79 hours ± 2.1 standard error and 76 hours ± 2.8 standard error respectively, which 
indicates no difference in mortality between each nematode strain tested. 
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4.5. Comparison of B. pseudomallei and B. thailandensis to the B. cepacia complex. 
B. pseudomallei, B. thailandensis and those strains comprising the B. cepacia complex are 
related phenotypically and genetically (Kanai and Kondo 1994). Furthermore different 
strains of B. pseudomallei and B. thailandensis have been reported to have different 
abilities to kill C. elegans as has been observed for strains of the B. cepacia complex in 
this study (0' Quinn, Wiegand et al. 2001). Thus, strain-specific differences in 
pathogenicity are evident in all three species. The ability to discern these strain specific 
differences in virulence between isolates is important for the fulfilment of the aims of this 
study. If any differences in B. pseudomallei virulence observed in C. elegans correspond to 
those seen in mammalian models of infection, this would reveal the clinical relevance of 
the C. elegans model. Hence the nematode would be found to be a good model of B. 
pseudomallei pathogenesis in the mammalian host. However, to begin the investigation of 
B. pseudomallei pathogenesis a model of nematode killing under containment, at biological 
safety level III was first established. This was achieved through the investigation of the 
wildtype B. pseudomallei 576 in the plate-based mortality assay and the feeding inhibition 
assay. 
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4.5.1. Killing of C. elegans N2 by B. pseudomallei 576. 
Groups of 10-20 L4 stage C. elegans N2 worms were fed on lawns of B. pseudomallei 576 
or E. coli strain OP50 grown on NGM. The percentage mortality in each population was 
then recorded at 24 hour intervals over 96 hours at 25 T. After 96 hours there was no 
mortality observed when nematodes had fed on E. coli OP50. However when fed on B. 
pseudomallei 576 there was 100% mortality of nematodes by 48 hours (Figure: 4.10. ). The 
TD50 when feeding on B. pseudomallei 576 was 28 hours ± 1.3 standard error. The 
difference in mortality caused between B. pseudomallei 576 and E. coli OP50 was highly 
significant with aP value of <0.001 at 24 hours. 
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Percentage mortality of C. elegans N2 when feeding on B. pseudomallei 576. 
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Figure: 4.10. Mortality of C. elegans N2 in the plate-based mortality assay at 25 °C when 
fed on overnight cultures of B. pseudomallei 576 (") grown on NGM. Mortality on E. coli 
OP50 (M) at 25 °C was used as a control. Error bars are the standard error of the mean of 
the 9 replicates performed each containing 10-20 L4 stage nematodes. 
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Feeding inhibition of C. elegans N2 by B. pseudomallei 576 was also investigated in the 
feeding inhibition assay. Groups of 50-100 nematodes were allowed to feed in suspensions 
of either B. pseudomallei 576 or E. coli OP50 at 25 °C and the change in OD550nm over 
time recorded. The rate of feeding in E. coli OP50 increased from 0.160 AUCD at 24 hours 
to 0.26 AUCD at 48 hours. However after 48 hours feeding rates in B. pseudomallei 576 
were slowest when compared to feeding rates shown for E. coil 0P50 (Figure: 4.11. ). 
Feeding rates in suspensions of B. pseudomallei 576 were 0.04 AUCD and 0.04 AUCD at 
24 and 48 hours respectively indicating an inhibition of feeding by B. pseudomallei 576. 
186 
Chapter: 4. Investigation of the effect of the Burkholderia genus in C. elegans. 
Feeding inhibition of C. elegans N2 by B. pseudomallei 576 
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Figure: 4.11. Feeding rates of C. elegans N2 in 1 ml suspensions of B. pseudomallei 576 
(") in K-medium at 25 °C over 48 hours. Feeding in E. coli OP50 ( ) suspensions at 25 
°C was used as a control. Error bars are the standard error of the mean of 40 replicates 
performed for each organism each containing 50-100 L4 stage nematodes. 
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4.5.2. Investigation of B. pseudomallei and B. thailandensis strains. 
To investigate the susceptibility of C. elegans N2 to killing and feeding inhibition by 
strains of B. pseudomallei and B. thailandensis nematodes were exposed to 9 strains of B. 
pseudomallei and 4 strains of B. thailandensis in the plate-based mortality assay and the 
feeding inhibition assay. 
Groups of 10-20 IA stage worms were fed on lawns of each B. pseudomallei strain grown 
on NGM for a total of 96 hours and the mortality in each population recorded at 24 hour 
intervals. After 96 hours of exposure, 8 strains of B. pseudomallei tested caused 100% 
mortality and one strain displayed partial killing (Figure: 4.12. ). 
B. pseudomallei K96243 caused 100 % mortality at 96 hours in the plate-based mortality 
assay. However at 24 hours the difference in killing rates between B. pseudomallei 576 and 
strain K96243 was highly significant (P = <0.001). The calculated TD50 value was 35 
hours ± 1.5 standard error. This was in excess of that calculated for B. pseudomallei 576 
which was 28 hours ± 1.3 standard error. All of the other fully virulent strains assessed had 
TD50 values of less than 24 hours. This indicates a difference in virulence in the C. elegans 
model between B. pseudomallei K96243 and B. pseudomallei 576. 
B. pseudomallei 42 caused 41 % mortality of C. elegans N2 at 96 hours post exposure in 
the plate-based mortality assay. When compared to killing by B. pseudomallei 576 the 
difference in killing rate was statistically significant with aP value of <0.001. The TD50 
values of strain 42 and 576 were 107 hours ± 8.1 standard error and 28 hours ± 1.3 
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standard error respectively. This further indicates a difference in virulence between the 
strains tested. 
When the same B. pseudomallei strains were assessed in the feeding inhibition assay 8 
strains induced a high degree of feeding inhibition. The OD550 of the bacterial 
suspension was also often seen to increase by 48 hours indicating growth of the organism 
within the assay. This is represented graphically after processing of data as feeding rates 
with negative values (Figure: 4.13. ). The level of inhibition was also greater than that seen 
for many of the B. cepacia complex strains investigated. 
In the feeding inhibition assay B. pseudomallei ATCC 23343 was the only strain that failed 
to significantly reduce feeding. The feeding rate on B. pseudomallei ATCC 23343 at 48 
hours was 0.19 AUCD, which was 59 % of that seen for E. cola 0P50 (0.32 AUCD at 48 
hours). When compared to rates of feeding on B. pseudomallei 576 the difference in 
feeding rate on B. pseudomallei ATCC 23343 at 48 hours was highly significant (P value = 
<0.001). 
As a more stringent statistical comparison a one-way ANOVA with a Dunnetts comparison 
was carried out. This allows feeding rates on one strain to be compared to feeding rates on 
the others. The comparison revealed that feeding rates on B. pseudomallei ATCC 23343 
was not significantly different to those on B. pseudomallei 576 or B. pseudomallei 52 
(P=<0.05). However significant differences in feeding rate did exist between B. 
pseudomallei ATCC 23343 and the remaining strains tested indicating strain dependant 
differences in the effect on feeding rate in the feeding inhibition assay. 
189 
Chapter: 4. Investigation of the effect of the Burkholderia genus in C. elegans. 
Figure: 4.12. Mortality of C. elegans N2 at 25 °C over 96 hours when fed on wildtype 
strains of B. pseudomallei grown on NGM. Strains tested were B. pseudomallei strain 4845 
("), strain 52 ( ), strain 204 (A), ATCC 23343 (*), strain BRI ("), strain 42 (I), strain 
2889 (x) or strain K96243 ("). The mortality caused by each strain was compared to B. 
pseudomallei 576 (-) and E. coli OP50 (- ), which were chosen to serve as controls. Error 
bars are the standard error of the mean AUCD of 3 replicates performed for each strain 
each containing 50-100 L4 stage worms. 
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Figure: 4.13. Feeding inhibition of C. elegans N2 after 48 hours at 25 °C in suspensions of 
B. pseudomallei in K-medium. Strains tested were B. pseudomallei strain 4845 (1), strain 
52 (2), strain 204 (3), strain ATCC 23343 (4), strain BRI (5), strain 42 (6), strain 2889 (7) 
and strain K96243 (8). Feeding rates were compared to those in suspensions of B. 
pseudomallei 576 (9) or E. coli OP50 (10), which were chosen to serve as controls. Error 
bars are the standard error of the mean AUCD at 48 hours of 8 replicates containing 50- 
100 IA worms 
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As a comparison to the B. pseudomallei strains already tested 4 B. thailandensis strains 
were also investigated. Groups of 10-20 worms were fed at 25 °C for 96 hours on lawns of 
each B. thailandensis strain and the mortality in each population monitored at 24 hour 
intervals. All B. thailandensis strains caused 100 % mortality by 96 hours. However the 
rate at which these strains killed C. elegans N2 was different depending on the strain used. 
B. thailandensis E125 gave the fastest rate of killing and caused 92 % mortality by 48 
hours. Conversely B. thailandensis E254 gave the slowest rate of killing and only caused 
55 % mortality by 48 hours. B. thailandensis strains E135 and E132 displayed mortality 
rates falling between these values giving 87 % and 77 % mortality respectively at 48 hours 
(Figure: 4.14. ). 
Calculation of TD50 values for B. thailandensis E125 confirmed that this strain was the 
most pathogenic of those tested with a TD50 value of 28 hours ± 1.6 standard error. TD50 
values for B. thailandensis strains E132, E135 and E254 were 37 hours ± 1.8 standard 
error, 38 hours ± 2.3 standard error and 43 hours ± 3.0 standard error respectively. This 
indicates that B. thailandensis E254 was the least virulent of the strains investigated and 
strains E132 and E135 had intermediate levels of virulence in the plate-based mortality 
assay. 
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Figure: 4.14. Mortality of C. elegans N2 when fed at 25 °C for 96 hours on lawns of 
different wildtype B. thailandensis strains grown on NGM. Strains tested were B. 
thailandensis strain E125 ("), strain E132 (0), strain E135 (A) or strain E254 (X). The 
mortality on each strain was compared to B. pseudomallei 576 (*) and E. coli OP50 ("), 
which were chosen as controls. Error bars are the standard error of the mean percentage 
mortality of 3 replicates for each strain each containing 10-20 L4 stage worms. 
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Figure: 4.15. Feeding inhibition of C. elegans N2 after 48 hours at 25 °C in suspensions of 
wildtype strains of B. thailandensis in K-medium. The strains tested were B. thailandensis 
strain E125 (1), strain E132 (2), strain E135 (3) and strain E254 (4). Feeding rates were 
compared to those in suspensions of B. pseudomallei 576 (5) or E. coli OP50 (6). Error 
bars are the standard error of the mean of 8 replicates performed for each strain, each 
containing 50-100 L4 stage worms. 
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When compared to feeding rates on E. coli 0P50 all strains of B. thailandensis caused 
feeding inhibition (Figure: 4.15. ) The highest nematode feeding rates were observed with 
B. thailandensis E125, with 0.07 AUCD at 48 hours. This was only 21 % of the feeding 
rate observed for E. coli 0P50. B. thailandensis E132 caused the largest decrease in 
feeding rate with -0.02 AUCD at 48 hours. Differences in feeding rates between B. 
thailandensis strains were small. Regression analysis revealed that there was no 
statistically significant difference between feeding rates on any of the B. thailandensis 
strains tested and B. pseudomallei 576 (P value = 0.9 at the 95 % level). 
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4.6. Discussion. 
A C. elegans model of bacterial infection was established using P. aeruginosa. The 
methods devised and developed were then used to establish a C. elegans-Burkholderia 
infection model. In addition to expanding the nematode model to other important bacterial 
species this also allowed the relevance of the model to mammalian pathogenesis to be 
assessed using a variety of Burkholderia strains. 
The virulence of 20 Burkholderia isolates from a number of sources representing 
genomovars I-V of the B. cepacia complex, were assessed for their affect in the C. elegans 
model of infection. B. cenocepacia sp. nov. (formerly B. cepacia genomovar III) and B. 
cepacia (genomovar I) appeared to contain the most pathogenic strains in the C. elegans 
model. Those strains from B. cenocepacia sp. nov. which have been described as medically 
important such as B. cenocepacia sp. nov. J2315 and B. cenocepacia sp. nov. J415 (Govan, 
Brown et al. 1993) did cause a significant quantity of mortality in the plate-based mortality 
assay and also affected feeding rates in the feeding inhibition assay. However these did not 
induce the most severe responses in either assay. This suggests that virulence factors 
important in the colonisation and persistence in the CF lung that these strains posses may 
not be of major importance in nematode killing. 
Nine strains From the B. cepacia complex caused z50% mortality of nematodes after 96 
hours. From these only three were environmental isolates with the remaining six being 
clinical isolates. This then may indicate that clinical isolates of the B. cepacia complex 
may be better equipped for nematode killing. However those isolates that gave the slowest 
feeding rates in the feeding inhibition assay were environmental, suggesting a decrease in 
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palatability of these strains to the nematode. This result might be expected, as 
hypothetically the nematode would be adapted to avoid pathogenic organisms present in 
the same habitat. Hence strains of clinical origin may be better at killing C. elegans as they 
have adaptations that allow them to survive within animal hosts. However the origin 
(clinical or environmental) of the infecting strain was not related to the effect seen in either 
the plate-based mortality assay or the feeding inhibition assay. Thus a more complex 
relationship between these bacterial strains and virulence in C. elegans may possibly exist 
based on the genetic complement of virulence factors that these strains produce. Also those 
genomovars investigated had a small representative sample size. This may then account for 
the variability in pathogenic effect seen between strains and why no particular genomovar 
had more pathogenic representatives than another. 
From the data presented, the C. elegans model does not provide an indication of the 
virulence of B. cepacia complex strains in mammalian hosts. A further study comparing 
data obtained from the screening of more strains from each genomovar in nematode and 
mammalian models may be required to elucidate the clinical relevance of nematodes, for 
studying B. cepacia complex pathogenesis in the mammalian host. 
During observation of C. elegans N2 feeding on some strains from the B. cepacia complex 
a distinctive phenotype was noted. This was observed after 24 hours and was characterised 
by an increased side to side flexion of the body with an eventual concomitant loss in the 
ability to translocate across the bacterial lawn. The aetiology of this effect is presently 
unknown but the phenotype was reminiscent of that induced through infection of C. 
elegans with some strains of Y. pseudotuberculosis and Y. pestis. These also cause C. 
elegans to move in an aberrant manner and cause a reduction in the translocational ability 
of the nematode (Darby 2002). This was found to be mediated in part through the 
201 
Chapter: 4. Investigation of the effect of the Burkholderia genus in C. elegans. 
colonisation of the nematode cuticle by the organism. (Joshua 2003). It has been suggested 
that this process may be interactive involving both bacterial and host recognition. This 
allows biofilm formation on the biotic surface of the nematode cuticle (Joshua 2003). Thus 
the aberrant movement phenotype seen during infection, from strains of the B. cepacia 
complex might also arise as a result of colonisation of the nematode cuticle in the form of a 
biofilm. Moreover this may also be an interactive process involving both bacterial and host 
recognition molecules as seen in Yersinia infection of C. elegans. This hypothesis is 
further supported by the fact that one B. cepacia complex strain tested also caused the 
formation of nose-globs. 
After feeding on B. cenocepacia sp. nov. J415 (LMG 16654) the majority of nematodes 
introduced to the lawn displayed a nose-glob phenotype. All worms displaying this 
phenotype also moved in an aberrant manner. Nose-globs persisted until 72 hours where 
the phenotype was lost and worms regained normal movement indistinguishable from 
worms feeding on E. coli OP50. This suggests that the presence of nose-globs was 
responsible for the change in locomotive ability as normal movement was regained once 
nose-globs were removed. Thus, if the aberrant movement phenotype is a consequence of 
adherence of particles to the nematode, then it might be a behavioural mechanism designed 
to dislodge these from the cuticle. These would be removed by the sheer forces that would 
be experienced through an increase in the sinusoidal movement of the worm thus allowing 
the worm to regain normal movement as seen in B. cenocepacia sp. nov. J415 infection. 
After assessment of C. elegans srf mutants for resistance to nose-globs no strain was found 
to be refractory. Nose-glob formation occurred in all mutants and wildtype nematodes with 
equal frequency. As these mutant C. elegans strains are reported to be resistant to the nose- 
glob phenotype caused by Yersinia species, the formation of nose-globs by B. cenocepacia 
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sp. nov. J415 must then occur through a different mechanism. This might involve an initial 
interaction with a cuticular surface antigen common in each worm strain. Alternatively the 
nose-globs caused by B. cenocepacia sp. nov. J415 may require no initial specific antigenic 
association and may simply be due to non-specific adherence of bacterial cells to the 
nematode head as the nematode moves through the bacterial lawn. 
Although no srf mutant tested was less susceptible to nose-glob formation, C. elegans srf-3 
was generally more susceptible to nose-glob formation (Figure: 4.7. ). This strain was also 
shown to be more susceptible to mortality caused by B. cenocepacia sp. nov. J415 (Figure: 
4.8. ). Thus the mutation in C. elegans srf-3 may allow an enhanced susceptibility to B. 
cenocepacia sp. nov. J415 infection. Comparison of mortality rates when fed on P. 
aeruginosa PA14 over 96 hours revealed no difference in the mortality between either 
nematode strain. This suggests that the interaction observed between C. elegans srf-3 and 
B. cenocepacia sp. nov. J415 is a specific one that apparently results in an increase in 
mortality. 
A C. elegans-Burkholdeia infection model was established through investigation of the B. 
cepacia complex. This was then was then used to investigate wildtype strains of B. 
pseudomallei and B. thailandensis in both the plate-based mortality assay and the feeding 
inhibition assay. This allowed a comparison to be made to the Burkholderia strains already 
tested and facilitated the investigation of any similar strain dependant differences in 
pathogenicity as observed for strains of the B. cepacia complex. 
Worms killed by strains of B. pseudomallei and B. thailandensis were indistinguishable 
through microscopic examination and no specific phenotypes associated with particular 
strains were noted as described for strains from the B. cepacia complex. Killing appeared 
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to progress as previously reported (0' Quinn, Wiegand et al. 2001; Gan 2002) and 100 % 
of nematodes were killed by 96 hours by the majority of both species with the exception of 
B. pseudomallei 42, which killed only 41 % of nematodes by the same time-point. The 
reason for this difference in killing rate when compared to B. pseudomallei 576 is presently 
unknown. The possibility exists that B. pseudomallei strain 42 represents a naturally 
occurring mutant defective in toxin production. The production of a paralytic toxin has 
been implicated in the rapid onset of mortality in C. elegans-B. pseudomallei interactions 
(0' Quinn, Wiegand et al. 2001). Thus the lack of production of this toxin may produce 
results that are similar to those seen with the B. cepacia complex, for which only infection- 
mediated death is important. Alternatively, as B. pseudomallei 
42 gave similar results to that of strains from the B. cepacia complex this strain may 
indeed be a strain from the B. cepacia complex that has been wrongly classified as a B. 
pseudomallei isolate. These species are very similar both genotypically and phenotypically 
and differentiation on a physical and chemical basis is difficult. This has lead to the 
misidentification of B. pseudomallei strains as B. cepacia complex isolates on a number of 
occasions (Kanai 1994). No further effort to characterise this strain has been made. 
However it may warrant further investigation as the lack of toxin production may facilitate 
dissection of C. elegans -B. pseudomallei interactions. Killing through toxin-mediated 
processes is rapid; this may hide any other effects of the infection caused by the organism. 
Thus a toxin-negative strain of B. pseudomallei would allow the reported intestinal 
infection of C. elegans to be studied over a longer period. 
B. pseudomallei K96243 caused 100 % mortality at 96 hours in the plate-based mortality 
assay. However it was the only other strain that displayed a significantly different rate of 
killing at 24 hours when compared to B. pseudomallei 576. The calculated TDSO value of 
35 hours ± 1.5 standard error was also higher than the other wildtype B. pseudomallei 
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strains assessed. This suggests a decrease in virulence in the C. elegans nematode model of 
infection. B. pseudomallei K96243 has been shown to be less virulent in mammalian 
models of infection than B. pseudomallei 576 (Dr. T. Atkins, Dstl. Pers. Comm. ). This 
then indicates that strain-dependent differences in virulence observed in mammalian 
models of infection may also be mirrored in the C. elegans-Burkholderia infection model. 
When tested in the feeding inhibition assay strain-dependant differences in virulence were 
also observed between B. pseudomallei strains. However these did not mirror those seen in 
the plate-based mortality assay as different strains displayed increased feeding rates and 
hence reduced levels of virulence in the assay. Hence the order of virulence seen in the 
plate-based mortality assay is not observed in the feeding inhibition assay. This suggests 
that strains that cause significant mortality do not always cause a reduction in feeding rate. 
Furthermore this also shows that different mechanisms may be responsible for mortality 
and feeding inhibition in C. elegans-Burkholderia interactions. 
When investigated in the plate-based mortality assay all strains of B. thailandensis caused 
100% mortality by 96 hours. When TD50 values were calculated for each strain these were 
found to be very similar to that of the B. pseudomallei strains tested. This indicates that 
some cross-over in virulence is apparent between B. thailandensis and B. pseudomallei in 
C. elegans as shown by the similarities in TDSO values. The factors responsible for 
nematode killing have so far been poorly characterised. Hence there may be a subset of 
virulence factors important in nematode pathogenicity that are possessed by some strains 
of both B. pseudomallei and B. thailandensis but not others. This would then account for 
the similarities in pathogenicity seen between these species in the nematode model of 
infection. 
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0' Quinn et al have showed previously that B. thailandensis was more pathogenic than B. 
pseudomallei in a plate-based mortality assay (O' Quinn, Wiegand et al. 2001). However 
Gan et al have shown B. thailandensis to be less pathogenic than B. pseudomallei in a 
similar assay (Gan 2002). The majority of B. thailandensis strains assessed in this 
investigation were less virulent than B. pseudomallei in C. elegans, under the plate-based 
mortality assay conditions used in this study. These data then support the findings of Gan 
et al and show that B. thailandensis is indeed less virulent in the C. elegans model of 
infection. When the same strains of B. thailandensis were tested in feeding inhibition assay 
the order of virulence was markedly different from that noted in the plate-based mortality 
assay. Differences in feeding rate between strains were very small and statistical analysis 
showed that there were no observable differences in the feeding inhibition caused by each 
strain. 
B. thailandensis is believed to be relatively avirulent and is less virulent in animal models 
than B. pseudomallei (Smith, Angus et al. 1997; Brett, Deshazer et al. 1998; Gan 2002). 
Although B. thailandensis kills nematodes it was also found to be less virulent overall than 
then B. pseudomallei in the C. elegans-Burkholderia infection model. Thus these results 
are akin to the order of virulence displayed in vertebrates. This again shows that C. elegans 
may be a suitable model for the study of B. pseudomallei pathogenesis in the mammalian 
host. 
The discrepancies observed between the plate-based mortality assay and the feeding 
inhibition assay may be due to the differences in media used in both assays as C. elegans- 
pathogen interactions have been shown to be heavily media dependant (Darby, Cosma et 
al. 1999; Tan, Miklos et al. 1999; Gan 2002; Tan 2002). In the plate-based mortality assay 
bacteria are grown on a low osmolarity nutrient-agar (NGM), which allows normal 
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bacterial growth. Conversely the feeding inhibition assay utilises K-medium which is an 
isotonic solution that contains no nutrients for bacterial growth. Hence bacterial cells may 
become stressed and possibly respond differently to their nutritionally replete counterparts 
grown on NGM. Additionally the difference in infectious dose received may cause the 
differences observed. In the feeding inhibition assay worms are introduced to a relatively 
dilute bacterial suspension and allowed to feed (starting OD of approximately 1.2). 
However in the plate-based mortality assay worms are introduced to a bacterial lawn and 
crawl through it as they feed. Thus the worms would be exposed to and ingest many more 
bacterial cells at any one time. This then may also account for the difference in response 
seen in both assays. 
Screening a large panel of Burkholderia genus isolates has shown that C. elegans N2 is 
susceptible to a variety of B. cepacia complex, B. pseudomallei and B. thailandensis 
strains. A number of strain-dependant differences in pathogenicity in the nematode model 
have also been noted and are particularly prevalent between the B. cepacia complex 
isolates tested. These differences are also seen in B. pseudomallei and B. thailandensis 
strains but to a lesser extent. Importantly for this study, the differences in virulence seen in 
the plate-based mortality assay within B. pseudomallei strains compared to strains of B. 
thailandensis mimics that seen in conventional animal models of infection. This shows that 
C. elegans is an applicable and relevant model of B. pseudomallei infection and may be 
used to study further the basis of B. pseudomallei pathogenesis in the mammalian host. 
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5.1. Introduction. 
One of the most basic methods for the study of host-pathogen interactions is the direct 
observation of the pathogenic process in situ. This can be achieved through the use of 
microscopic techniques including electron microscopy. Such methods allow the study of the 
discrete binding events that lead to colonisation of a host and provide valuable information 
concerning the early events of the infection such as the cellular localisation of bacterial cells 
within infected host tissues. It also permits the examination of the histopathology induced by 
the action of virulence factors produced by bacterial pathogens, which is often the route cause 
of disease. 
5.2. Investigation of host-pathogen interaction in C. elegans using TEM. 
To compliment the other methods that will be used to study B. pseudomallei pathogenesis in 
C. elegans, the interaction between host and pathogen at the cellular level was assessed using 
TEM. Approximately 1000-2000 C. elegans N2 worms were allowed to feed on either B. 
pseudomallei 576 or E. coli OP50 for a total of 24 hours at 25 °C. The samples were then 
fixed overnight in situ through the addition of 5% (v/v) glutaraldehyde. Fixed samples were 
washed to remove residual glutaraldehyde before final processing and visualisation by thin 
section TEM (Section: 2.2.2. ). 
After 24 hours of feeding in suspension, thin section TEM revealed that both intact E. coli 
0P50 and B. pseudomallei 576 cells were present within the intestinal lumen of the nematode 
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(Figure: 5.1 and 5.2. ). No bacterial invasion of tissues surrounding the intestine by B. 
pseudomallei 576 cells were seen in any sample investigated. There was also no observable 
tissue damage caused by the pathogen when compared to feeding on E. coli OP50. However a 
large amount of what may be bacterial debris was observed in the interstitial spaces 
surrounding B. pseudomallei 576 cells. Amongst this darkly staining material a number of 
what appeared to be membrane bound vesicular structures of approximately 100-200 nm in 
diameter were also observed (Figure: 5.2. ). These vesicles were not evident when nematodes 
were allowed to feed on E. coli OP50 (Figure: 5.1. ). 
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MEM 
Figure: 5.1. Electron-micrograph showing a transverse cross-section through the lumen of the 
C. elegans N2 intestine. Approximately 1000-2000 L4 stage nematodes were fed on 
suspensions of E. coli strain OP50 with an approximate OD550 of 1.2 for 24 hours at 25 T. 
Samples were then fixed in situ through the addition of 3 volumes of 5% glutaraldehyde (v/v) 
before processing for thin section TEM. Intact E. coli (B); gut mucosa (GM); gland cell duct 
(GD); motor neurones (MN). Section thickness 70 nm. Scale bar represents 2 µm. 
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Figure: 5.2. Electron-micrograph showing a transverse cross-section through the lumen of the 
C. elegans N2 intestine. Approximately 1000-2000 L4 stage nematodes were fed on 
suspensions of B. pseudomallei 576 with an approximate OD550 Mn of 1.2 for 24 hours at 25 
°C. Samples were then fixed in situ through the addition of 3 volumes of 5% glutaraldehyde 
(v/v) before processing for thin section TEM. Intact B. pseudomallei cells (B); bacterial debris 
(D); gut mucosa (GM); gland cell duct (GD); motor neurones (MN). White arrowheads 
indicate unidentified membrane bound vesicular structures. Section thickness 70 nm. Scale bar 
represents 4 µm. 
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Figure: 5.3. Electron-micrograph showing a transverse cross-section through the lumen of the 
C. elegans N2 intestine. Approximately 1000-2000 nematodes were fed on suspensions of B. 
pseudomallei 576 with an approximate 0D550 nm of 1.2 for 24 hours at 25 °C. Samples were 
then fixed in situ through the addition of 3 volumes of 5% glutaraldehyde (v/v) before 
processing for thin section TEM. Intact B. pseudomallei cells (B); gut mucosa (GM); gland 
cell duct (GD); motor neurones (MN). Grey arrowhead indicates an unidentified double 
membrane bound vesicular structure and large black arrowhead indicates a dividing B. 
pseudomallei cell. Section thickness 70 nm. Scale bar represents 2.5 µm. 
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Figure: 5.4. Thin Layer electron-micrograph showing division of B. pseudomallei 576 in the 
intestinal lumen of a C. elegans L4 stage nematode. Approximately 1000-2000 L4 stage 
nematodes were fed on suspensions of B. pseudomallei 576 with an approximate OD550 nm of 
1.2 for 24 hours at 25 °C. Samples were then fixed in situ through the addition of 3 volumes of 
5% glutaraldehyde (v/v) before processing for thin section TEM. Intact B. pseudomallei (B); 
gut mucosa (GM); musculature (M). White arrows indicate dividing B. pseudomallei. Section 
thickness is 70 nm. Scale bar represents 2 µm. 
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On further examination of thin sections some B. pseudomallei 576 cells were seen to be in the 
process of cellular division (Figure: 5.3. and 5.4. ). In contrast this was not observed for those 
samples where worms had only fed on E. coli OP50. These samples contained whole cells but 
no evidence of bacterial replication as exemplified by figure: 5.1. 
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5.3. Discussion. 
The nematode C. elegans has been suggested to be a good model of B. pseudomallei 
pathogenesis in mammals. Use of the model has allowed the characterisation of novel 
virulence factors at the molecular level that are also apparently important in mammalian 
pathogenesis (0' Quinn, Wiegand et aL2001; Gan 2002). However these studies have not 
investigated the host-pathogen interactions occurring at the microscopic level that may 
contribute to pathogenesis in both nematodes and mammalian species. This was addressed in 
this investigation through the use of TEM. 
After 24 hours of feeding in suspensions of both B. pseudomallei 576 and E. coif OP50 whole 
bacterial cells were observed within the gut lumen (Figures: 5.1. and 5.2. ). This suggests that 
disruption of bacterial cells by the grinder within the pharynx is incomplete regardless of the 
pathogenic potential of the organism, and that viable bacterial cells enter the gut. 
In sections of worms which had been feeding on B. pseudomallei 576 (Figures: 5.3. and 5.4. ), 
a number of bacterial cells were identified which appeared to be in the process of cellular 
division. No dividing bacterial cells were observed when worms had fed on E. cola OP50 
(Figure: 5.1. ). Thus although whole E. coli OP50 cells pass the grinder and enter the gut no 
replication was observed. The ability to survive and replicate within the nematode intestine 
may then represent a fundamental difference between B. pseudomallei and E. coli that would 
in part account for the differences in virulence observed. After 24 hours feeding on B. 
pseudomallei 576 no bacterial cells were observed within cells immediately surrounding the 
nematode gut. Also, no multi-nucleate giant cells were observed which are a characteristic of 
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B. pseudomallei infection in mammalian cell culture (Harley 1998). Additionally no cells were 
seen adhering to the surface of the gut mucosa (Figure: 5.2. ). This suggests that cells lining the 
gut may be refractory to B. pseudomallei 576 infection. The mucosa of the C. elegans gut 
appears as a thick darkly staining layer (Figure: 5.2. ) in TEM thin sections, which may 
represent an impermeable barrier to the invasion efforts of the organism. The refractory nature 
of the cells lining the C. elegans intestine to bacterial infection would be expected. As C. 
elegans has only a rudimentary non-specific immune system (Section: 1.5.4.5. ) The ability to 
deny potentially detrimental intracellular pathogens access into underlying tissues could then 
be a requirement for nematode survival. This is supported by recent studies by Herndon et al 
(Herndon 2003) who showed that the intestine is impermeable to many bacterial pathogens 
and invasion of underlying tissues rarely occurs until after nematode death. Furthermore, 
although no intracellular bacterial cells were noted in thin sections, this may imply that none 
were present in the samples analysed. 
When studying the relationship of a bactivourous nematode with its food source the obvious 
place to examine for any pathogenic interaction would be in the intestine. However this 
assumption may be misplaced and invasion of other areas of the body may occur. It has been 
shown recently that some pathogens can invade the vulva and uterus of infected worms and 
may even invade the sensory organs of the head and pharyngeal muscles (Hemdon 2003). 
Thus intracellular bacterial cells may not have been evident in these samples simply due to the 
localisation of the sections through the intestinal lumen. Inspection of thin-sections through 
other areas of the nematode body was not possible in this study due to time constraints. 
However a further study screening thin-sections taken through other areas of the nematode 
body, such as the head and vulva may reveal intracellular or invading bacterial cells missed in 
the original screen. 
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An interesting observation made during this study was the presence of what appeared to be 
membrane-bound vesicular structures surrounding bacterial cells within the C. elegans 
intestinal lumen (Figure: 5.3. ). This phenomenon was only observed in those samples where 
nematodes were allowed to feed on B. pseudomallei 576 and not E. coli 0P50. The origin of 
these structures is elusive but they may be bacterially derived. The cell wall in Gram-negative 
bacteria is a dynamic structure that has features not seen in Gram-positive species. During 
bacterial growth vesicles are constantly discharged from the outer-membrane. These are 50 to 
250 nm-diameter structures that are spherical, bilayered membranous structures. They posses 
outer-membrane proteins, LPS, phospholipids and periplasmic constituents that are situated as 
they would normally be found in the parent bacterium (Beveridge 1999). Membrane vesicles 
are found emanating from Gram-negative bacteria growing on solid media, in liquid media, in 
swanning cultures and also in natural environments. 
The vesicular structures observed in thin sections of worms fed on B. pseudomallei 576 appear 
to be spherical, posses a double membrane and range between 100 and 200 nm in diameter 
(Figure: 5.3. ). Thus these conform to the general observations made of membrane vesicles 
from other Gram-negative bacterial species. As the production of membrane vesicles is only 
observed in actively growing bacterial cultures (Beveridge 1999) this further indicates that the 
B. pseudomallei 576 cells present in electron-micrographs were viable at the point of fixation. 
Conversely as no vesicle production was noted in samples containing E. coli OP50 this also 
further demonstrates that these cells may have been non-viable. 
In some species such as P. aeruginosa, membrane vesicles have been shown to function in the 
killing of other Gram-negative and Gram-positive bacterial species, through the delivery of 
degradative hydrolytic enzymes to the cell surface of target organisms (Li 1998). However it 
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has also been suggested that they may function in pathogenicity in the mammalian host 
through delivery of virulence factors (Beveridge 1999). For example, the membrane vesicles 
of P. aeruginosa, P. mirabilis and S. marcescens can package phospholipase C, proteases, and 
hemolysins. These are protected from the host serum constituents that act to inactivate them 
by the lipid bilayer of the vesicle. They can then be delivered to their site of action in an 
undiluted form where they cause a variety of histopathological changes (Beveridge 1999). 
Death of C. elegans through B. pseudomallei infection is reported to be mediated in part 
through the action of a diffusible toxin that may effect L-type voltage-gated Ca2+ channels 
resulting in eventual muscular paralysis and death (0' Quinn, Wiegand et al. 2001). This has 
been shown to be an active process and require the presence of live bacteria for a maximal 
killing effect. As membrane vesicle production only occurs in actively growing bacteria the 
toxin may then be delivered within these structures and cause the eventual paralysis observed. 
Additionally B. pseudomallei produces a wide variety of degradative enzymes (Ellis 1999). 
However the secretion of digestive exoenzymes through the general secretion machinery has 
been shown to not be important in killing (0' Quinn, Wiegand et al. 2001; Kothe 2003). Thus 
other methods of secretion may be involved in the delivery of these enzymes to affected 
tissues including membrane vesicles. Techniques such as immune electron microscopy, using 
antibodies raised against the B. pseudomallei 576 outer membrane might allow the origin of 
these structures to be determined and help to provide information on their role in B. 
pseudomallei pathogenesis in nematodes. 
Taken together these observations suggest that B. pseudomallei 576 infection of C. elegans 
does not mimic that seen in the mammalian host. Bacteria entering the intestine appear viable 
but no invasion of intestinal cells is observed. Also no change in nematode tissues surrounding 
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the gut is observable after 24 hours of exposure to the organism. Death may then occur 
through the co-ordinated action of toxic factors that act to paralyse and eventually degrade 
tissues liberating nutrients for bacterial growth, which possibly involves the production of 
membrane vesicles. Further studies would be needed to assess the importance of these 
observations to B. pseudomallei pathogenesis in the nematode C. elegans. 
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6.1. Introduction. 
Relatively little is known concerning the molecular basis of virulence of B. pseudomallei in 
the mammalian host. A number of potential virulence factors have been identified 
including capsular polysaccharide, pili, toxins and degradative enzymes (Ellis 1999). 
However many of these remain poorly characterised and their role in the pathogenicity of 
the organism is unclear. 
The C. elegans-Burkholderia infection model was established in this study using a variety 
of Burkholderia strains. The results suggest that C. elegans is a relevant model for the 
study of B. pseudomallei virulence in the mammalian host. This finding allowed the 
nematode model to be used for the investigation of the molecular basis of B. pseudomallei 
virulence. Initially this involved the screening of B. pseudomallei mutants that have 
already been shown to be attenuated in mammalian models of infection, in the C. elegans- 
Burkholderia model. This would show if the C. elegans-Burkholderia model was capable 
of detecting mutations that lead to a decrease in virulence in both nematodes and 
mammalian models, thus validating the screening method to be used. 
Following validation the nematode model was used to screen a pool of transposon mutants 
already available at Porton for those that displayed an attenuated phenotype. Any mutants 
isolated in C. elegans may also show a reduced virulence in mammalian models of 
infection. Thus, characterisation of mutations responsible for this phenotype, might 
provide additional and important information regarding the molecular basis of B. 
pseudomallei pathogenesis in the mammalian host. 
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6.2. Screening of B. pseudomallei mutants for a reduction of virulence in a nematode 
model of infection. 
In Chapter 4, the C. elegans-Burkholderia infection model was shown to be able to detect 
differences in virulence between wildtype strains of B. pseudomallei. These differences 
were also shown to mirror the differences in virulence of these strains in mammalian 
models of infection. In this chapter, the ability of the C. elegans-Burkholderia infection 
model to detect bacterial mutants with reduced virulence in nematodes was assessed. 
6.2.1. Screening of an attenuated B. pseudomallei K96243 mutant in C. elegans N2. 
A B. pseudomallei mutant strain (OpilA) was obtained that had been previously shown to 
have a reduced virulence in mammals when compared to its parent strain B. pseudomallei 
K96243. This mutant carries a mutation in the pilin structural subunit of the type IV pili. 
These structures have a role in DNA uptake, protein secretion, and adherence. They are 
also involved in a form of movement called twitching motility (Christie 2000). 
The mutant ApilA was tested for its virulence towards nematodes in the plate-based 
mortality assay. Groups of 10-20 L4 stage C. elegans N2 worms were fed for 96 hours at 
25 °C on lawns of B. pseudomallei ApilA grown on NGM and the mortality in the 
population recorded daily. Both B. pseudomallei K96243 and B. pseudomallei OpiL4 
caused 100 % mortality of nematodes by 72 hours post-exposure (Figure: 6.1. ). However 
the mutant strain 4pilA killed C. elegans N2 at a slower rate than that of B. pseudomallei 
K96243 (Figure: 6.1. ). 
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Figure: 6.1. Assessment of differences in virulence between B. pseudomallei K96243 ( ) 
and the mutant strain B. pseudomallei ApilA ("). Groups of 10-20 L4 stage worms were 
fed at 25 °C for 96 hours on lawns of either mutant or wildtype strain and the mortality 
recorded at 24 hour intervals. Feeding on E. coli OP50 (I) was used as a control. Error bars 
are the standard error of the mean of three replicates performed for each strain tested. 
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6.2.2. Screening of attenuated B. pseudomallei 576 mutants in C. elegans N2. 
A selection of B. pseudomallei 576 mutants that have been previously shown to have a 
reduced virulence in mammalian models of infection were also tested for their virulence 
using the C. elegans-Burkholderia infection model. The mutants tested were B. 
pseudomallei 1E1O which is a mutant in capsule biosynthesis, B. pseudomallei 4D6, which 
is a mutant in serine biosynthesis and B. pseudomallei 4E6 which carries a mutation in a 
putative glycosyl transferase gene. 
Groups of 10-20 L4 stage C. elegans N2 worms were fed for 96 hours at 25 °C on lawns of 
each mutant grown on NGM and the mortality in each population recorded daily. All 
mutants tested in the plate-based mortality assay caused 100 % mortality of nematodes by 
72 hours post-exposure (Figure: 6.2. ). Mutants 1E10,4D6 and 4E6 killed C. elegans more 
quickly than B. pseudomallei strain 576. 
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Figure: 6.2. Assessment of differences in virulence between wildtype and mutant strains of 
B. pseudomallei 576. Groups of 10-20 L4 stage worms were fed at 25 °C for 96 hours on 
lawns of either B. pseudomallei strain 576 (*) or B. pseudomallei mutant strains 
previously shown to have a reduced virulence in mammals. The mutant strains tested were 
B. pseudomallei MO ( ), B. pseudomallei 4D6 (A) or B. pseudomallei 4E6 (X). Feeding 
on E. coli OP50 (") was used as a control. Error bars are the standard error of the mean of 
three replicates performed for each strain tested. 
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6.3. Screening of B. pseudomallei 576 transposon mutants using C. elegans N2. 
The C. elegans-Burkholderia model of infection was shown to be capable of detecting 
mutations that result in a decrease in virulence in nematodes. Thus, a panel of B. 
pseudomallei 576 transposon mutants were assessed individually for their virulence in C. 
elegans. This utilised a modified 96 well version of the plate-based mortality assay, which 
facilitated high through-put screening of the mutants (Section: 2.5.2. ). Briefly, 5 µ1 
aliquots of K-medium containing 5-10 IA stage worms were added to lawns of each 
transposon mutant grown on NGM agar in a 96 well microtiter plate. The presence of live 
nematodes after 96 hours incubation at 25 °C indicated attenuation in the nematode model 
of infection. 
After screening 960 individual B. pseudomallei 576 STM mutants in C. elegans N2,14 
putatively attenuated mutants were identified that did not cause the death of worms after 96 
hours. To confirm the attenuated phenotype, each of these mutants was compared to the 
wildtype B. pseudomallei 576 in a plate-based mortality assay. Groups of 10-20 L4 stage 
nematodes were fed on lawns of each mutant grown on NGM. The plates were then 
incubated at 25°C and the mortality in each population monitored at 24 hour intervals for a 
total of 96 hours. 
All of the mutants tested caused the death of C. elegans N2 by 72 hours post infection and 
were virulent when compared to E. coli OP50. One mutant showed a reduced rate of 
killing. At 24 hours post exposure, the rate of killing by the mutant B. pseudomallei 6H2 
was significantly reduced in comparison to the rate of killing by the wildtype B. 
pseudomallei 576, with aP value of 0.037. The mutant B. pseudomallei 6H2 was selected 
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for further study through a comparison to B. pseudomallei 576 in the plate-based mortality 
assay and the feeding inhibition assay. 
Groups of 10-20 IA stage C. elegans N2 nematodes were fed at 25 °C, for a total of 92 
hours, on lawns of B. pseudomallei 576 or B. pseudomallei 6H2 grown on NGM. Both B. 
pseudomallei 6H2 and B. pseudomallei 576 caused 100% mortality by 92 hours. At 32 
hours post-exposure a difference in the rate of killing was observed between the strains 
(Figure: 6.3. ). However the difference was not significantly different when compared using 
a students t-test (P value = 0.131) or regression analysis (P value = 0.119). 
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Peroerrtage mortality of C eleceans N2 after feecing on the B pseudarmilei mutant 6H2 or B 
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Figure: 6.3. Mortality of C. elegans N2 at 25 °C while feeding on B. pseudonrallci 6112 or 
B. pseudomallei 576 grown on NGM at 32 hours. Feeding on lawns of E. coli 0P50 was 
used as a control. Error bars are the standard error of the mean percentage mortality of 3 
replicates performed for each strain containing 10-20 L4 stage worms. 
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The virulence of B. pseudomallei 6H2 and the wildtype B. pseudomallei 576 was 
compared in the feeding inhibition assay. Aliquots of 50-100 IA stage nematodes were fed 
in 1 ml suspensions of each strain at an approximate starting OD550n of 1.2 for 48 hours at 
25 °C and the OD55o of each suspension measured at 24 hour intervals. When compared 
to feeding rates on E. coli OP50, feeding on both B. pseudomallei 6H2 and B. 
pseudomallei 576 was inhibited (Figure: 6.4. ). However when feeding rates on B. 
pseudomallei 6H2 were compared to feeding rates in B. pseudomallei 576 at 48 hours, 
feeding rates on-B. pseudomallei 6H2 were shown to be significantly faster (P value = 
0.026) suggesting that B. pseudomallei 6H2 was less virulent than B. pseudomallei 576. 
235 
Chapter: 6. Screening for attenuated B. pseudomallci mutants using C. clegan . 
Feeding inhibition of C. elegans N2 by the B. pseudomallei 576 or B. 
pseudomallei mutant 6H2 
0.35 
0.3 
0.25 
0.2 
U 
D 
0.15 
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0.05 
0 
Time (h) 
Figure: 6.4. Feeding inhibition of C. elegans N2 in suspensions of B. pseudomallei 6H2 
(") or B. pseudomallei 576 (0) in K-medium at 25 °C. Feeding in E. coli OP50 was used 
as a control (A). Error bars are the standard error of the mean AUCD of 8 replicates for 
each strain each containing 50-100 L4 stage worms. 
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6.4. Virulence of transposon mutant B. pseudomallei 6112 or B. pseudomallei 576 in 
BALB/c mice. 
To assess any differences in growth rates between B. pseudomallei 6H2 and B. 
pseudomallei 576 before animal challenges, which could account for the difference in 
virulence observed, the in vitro competition index was first determined. A sample of 500 
µl of B. pseudomallei 6H2 at 104 cfu/ml was mixed with 500 µ1 of B. pseudomallei 576 at 
the same concentration to obtain a total volume of 1 ml. This was added to 4 ml of LB 
broth and the suspension incubated at 37 °C overnight with constant shaking. Plating out of 
samples onto non-selective media and media containing 700 µg/ml of kanamycin before 
and after incubation and counting of the resulting colonies, allowed the calculation of the 
in vitro competition index (Section: 2.6. ). The in vitro competition index was calculated as 
1.03. 
, 
To determine whether B. pseudomallei 6H2 was attenuated in a mammalian model of 
disease, the virulence of this strain was compared to the virulence of B. pseudomallei 576 
in BALB/c mice. Two groups of five 6-8 week old female BALB/c mice were challenged 
intra-peritoneally with 103 cfu or 104 cfu of B. pseudomallei 6H2 or B. pseudomallei 576. 
This equated to 10 MLD or 100 MLD respectively of B. pseudomallei 576. The survival in 
each group was then monitored for a total of 21 days post-challenge (Table: 6.1. ). 
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Challenge strain Challenge dose Survivors at day 21 Mean time to death 
(cfu) (days ± SE) 
B. pseudomallei 576 1 10' 1315±3.2 
B. pseudomallei 6H2 103 2 15.5 ± 1.9 
B. pseudomallei 576 104 06±0.8 
B. pseudomallei 6H2 104 2 8.6 ± 2.0 
Table: 6.1. Survival of BALB/c mice after intraperitoneal injection with the mutant B. 
pseudomallei 6H2 or B. pseudomallei 576. Four groups of five 6-8 week old female 
BALB/c mice were inoculated with doses of either 103 cfu or 104 cfu of B. pseudomallei 
6H2 or 103 cfu and 104 cfu of B. . pseudomallei 576. Mice were observed for a total of 21 
days and the survivors in each group recorded at 24 hour intervals. 
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After 4 days post challenge only 3 mice that had received 10 cfu of B. pseudomallei 576 
remained alive. No further deaths were recorded in this group for the remainder of the 
experiment. No mice which had received 103 cfu of B. pseudomallei 6H2 died until day 14 
when 2 mice died. At day 15 one further mouse in this group died leaving 2 survivors until 
the end of the experiment at day 21 (Table: 6.1. ). The mean time to death for mice 
receiving 103 cfu of B. pseudomallei 6H2 and B. pseudomallei 576 was 15.5 days and 5 
days respectively. 
After 5 days post-challenge 3 mice had died in the group receiving 104 cfu of B. 
pseudomallei 576. The remaining 2 mice in this group died by day 7 resulting in a mean 
time to death of 6 days. At day 5 in the group receiving 104 cfu of B. pseudomallei 6H2 2 
mice died. A further 1 mouse died at day 15 and no further deaths were recorded. (Table: 
6.1. ). The mean time to death of mice given 104 cfu of B. pseudomallei 6H2 was 8.6 days. 
As a further comparison to elucidate any differences in colonisation ability between the 
wildtype B. pseudomallei 576 and the mutant B. pseudomallei 6H2 in vivo the competitive 
index was also calculated in BALB/c mice (Section: 2.5. ). Five mice were inoculated 
through intra-peritoneal injection with 102 cfu of mutant and 102 cfu wildtype bacteria 
(total 104 cfu). After 48 hours the spleens of each animal were removed, homogenised and 
dilutions plated onto selective media and non-selective media as already described. These 
were incubated at 37 °C overnight and the colonies counted. This allowed the calculation 
of the ratio of mutant and wildtype organisms within the spleen. 
At 48 hours post-challenge the competitive index was calculated as 0.69. However, when 
the titres of B. pseudomallei 576 and B. pseudomallei 6H2 recovered from spleens were 
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compared using regression analysis, the difference between the titres was not statistically 
significant (P value = 0.22). 
6.5. Characterisation of the transposon mutant B. pseudomallei 6H2. 
To identify the gene interrupted by the transposon in B. pseudomallei 6H2, genomic DNA 
was isolated (Section: 2.3.1. ) and digested with the restriction endonuclease enzyme Sacl. 
The recognition site for this enzyme is absent from the miniTn5 transposon. Digested DNA 
was then cloned into the plasmid vector pUC18 which had been pre-digested with Sacl. 
Recombinant plasmids were transformed into E. coli XL10 Gold cells and plated onto LB- 
agar supplemented with kanamycin. Plasmids were isolated from kanamycin resistant 
clones and nucleotide sequenced using the primers M13 forward and M13 reverse 
(Appendix: 4. ). 
Sequence data obtained using the M13 forward primer was used to perform a blast search 
for homologes nucleotide sequences (BLASTn) in the National centre for Biotechnology 
Information (NCBI) sequence database. The sequence from the M13 forward primer 
matched the transposon delivery vector pUTKM1 a derivative of the miniTn5 transposon 
(Fang 2002) used to create the B. pseudomallei 576 transposon mutants (97% identity in 
488 of 501 bases, E value 0.0). 
Sequence data obtained using the pUC18 M13 reverse primer was subjected to a Blastn 
search using the Sanger centre online B. pseudomallei BLAST server 
(http: //www. sanger. ac. uk/cgi-bin/blast/submitblast/b pseudomallei). This resulted an 89 
identity in 670 of 747 bases, from the 791 base sequence used in the query to a gene on 
chromosome II of the B. pseudomallei K96243 genome (E value 4.4e-124). The gene was 
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identified as putative member of the aldehyde dehydrogenase family with the accession 
number BPSS1466 (Figure: 6.5. ). 
The DNA sequence of the gene BPSS1466 was translated in silico using the DNAstar 
computer program Editseq version 5.05. This amino acid sequence was then used to 
perform a search of the Sanger institute protein families database of alignments and hidden 
Markov models (PFAM) (http: //www. sanger. ac. uk/Soflware/Pfam/) for similarities to 
proteins of known structure and function. This resulted in a high scoring match (E value 
1. le-140) to proteins from the aldehyde dehydrogenase family. 
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1 kb 
... BPSS1464 
BPSS1465 BPSS1466 BPSS1467... 
1998000 1999000 2000000 2001000 2002000 
B. pseudomallei chromosome 2 
(1997000 to 2002000 bp) 
Figure: 6.5. The location of the transposon in B. pseudomallei 6H2. The insertion was 
identified in a gene described as a member of the aldehyde dehydrogenase family with the 
accession number BPSS 1466. Genes immediately upstream and downstream of BPSS1466 
include BPSS1464 a putative transmembrane NADPH flavoprotein, BPSS1465 a putative 
thiamine biosynthesis lipoprotein precursor and BPSS 1467 a putative aminotransferase 
protein. The approximate position of miniTn5 transposon insertion in BPSS1466 is shown 
in red. 
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6.6. Discussion. 
The C. elegans-Burkholderia infection model described in Chapter: 4, was assessed for its 
usefulness in screening B. pseudomallei mutant strains for those displaying attenuated 
phenotypes. Initially a number of mutants that had previously been shown to be attenuated 
in mammals were screened using the plate-based mortality assay (Section: 6.2). This 
indicated that some mutants that were less virulent in mammalian models were also less 
virulent in nematodes. 
The B. pseudomallei K96243 mutant B. pseudomallei ApilA was shown to have a reduced 
virulence towards C. elegans N2 in the plate-based mortality assay. As this mutant was 
also less virulent in mouse models of infection the product of the deleted gene must then be 
important in killing both mice and nematodes. The pilA gene is involved in the production 
of type IV pili in other organisms, such as P. aeruginosa and is also thought to be involved 
in type II secretion (Lu 1997). Hence the deletion of these genes may not only prevent the 
formation of type N pili but also hinder secretion of virulence factors that could be 
important in killing of mammalian and nematode species by B. pseudomallei. 
A number of B. pseudomallei 576 transposon mutants were also tested in C. elegans N2. 
No strain was attenuated indicating that not all mutants that have reduced virulence in 
mammals also have a decreased virulence towards nematodes. This would be expected, as 
all genes important in mammalian pathogenesis would not be useful in killing of 
nematodes due to the large phylogenetic differences observed between species. 
For example the mutant B. pseudomallei 1E10 has a mutation in a biosynthetic gene 
responsible for the production of the polysaccharide capsule (Atkins 2002). This functions 
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in mammalian pathogenesis to inhibit phagocytosis and prevent killing of the bacterium by 
bactericidal serum components (Corbett 2003). Hence in mammals the mutant is less 
virulent as it has limited defences against these mechanisms. However, as C. elegans does 
not posses phagocytic cells such macrophages or have serum, the capsule is not required 
for protection and therefore the mutant is fully virulent in nematodes. 
Over all this data suggests that genes important for virulence in both nematode and 
mammalian models of infection would be those that have a broad function, such as the 
secretion of virulence factors or the regulation of these processes. These could then be 
called "universal virulence factors", as they would allow an organism to be virulent in a 
variety of host species from different genera. These observations have already been 
reported in P. aeruginosa infection of different host species. A selection of genes were 
found to be important for pathogenesis of this organism in plants, nematodes and mice 
(Tan 2002) and thus the same maybe the case for a set of B. pseudomallei genes such as 
pilA. 
In this chapter the C. elegans-Burkholderia model was shown to be capable of identifying 
mutations that cause a decrease in virulence in nematodes and mammalian models of 
infection. This validated the use of the model for screening pools of mutants for those with 
an attenuated phenotype. Thus, the infection model was used to screen 960 B. 
pseudomallei 576 transposon mutants for mutations that affected virulence in nematodes. 
Initially 14 mutants were identified as having reduced virulence towards C. elegans N2 in 
a modified plate-based mortality assay. However, further investigation revealed that only 
one was less virulent when compared to the wildtype strain. Worms fed on B. pseudomallei 
6H2 were found to exhibit a decreased rate of death in the plate-based mortality assay 
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(Figure: 6.3. ) and an increased rate of feeding in the feeding inhibition assay (Figure: 6.4. ) 
indicating a reduction in virulence of the mutant. 
The results from the investigation of B. pseudomallei 6H2 in the plate-based mortality 
assay were similar to those obtained by other authors using similar assay methods to 
investigate B. pseudomallei mutants (Gan 2002). In these studies, attenuated B. 
pseudomallei mutants caused 100% death of nematodes. However worms were killed more 
slowly when compared to a fully virulent control. The mutants identified were 
subsequently found to also be attenuated in mammals. Hence the reduction in the rate of 
nematode killing was indicative of a reduction of virulence in mammalian models of 
infection (O' Quinn, Wiegand et al. 2001; Gan 2002). Thus, the reduction in the rate of 
nematode killing when fed on B. pseudomallei 6H2, compared to that seen on B. 
pseudomallei 576 may have also indicated that B. pseudomallei 6H2 was attenuated in 
mammals. 
To assess this possibility the virulence of B. pseudomallei 6H2 and B. pseudomallei 576 
was compared in BALB/c mice. This indicated that B. pseudomallei 6H2 was less virulent 
than the wildtype B. pseudomallei 576. The in vivo and in vitro competitive indices were 
also calculated. This revealed that the mutant B. pseudomallei 6H2 appeared to colonise 
the murine spleen less efficiently (competition index 0.69). The reduction in virulence of 
B. pseudomallei 6H2, observed in both nematode and mammalian models was small. 
However, overall the results indicated that B. pseudomallei 6H2 was less virulent than B. 
pseudomallei 576 in both these model systems. Thus, the C. elegans-Burkholderia 
infection model was found to be suitable for screening large groups of mutants for 
mutations that affect virulence in both nematodes and mammalian host species. 
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The interrupted gene in B. pseudomallei 6H2 was identified as a member of the aldehyde 
dehydrogenase family. How the interruption in this gene can result in the decrease in 
virulence observed for B. pseudomallei 6H2 is unclear. However in other organisms the 
role of these enzymes is the oxidation and detoxification of aldehydes to their 
corresponding carboxylic acid form, during the intracellular catabolism of some sugars (Xu 
1995; Schrader 2001). Thus the inactivation of BPSS1466 might allow the build up of 
toxic intermediates, that cause a reduction in the ability of B. pseudomallei 6H2 to colonise 
in vivo. 
Alternatively, this gene may play a role in the virulence of B. pseudomallei through other 
mechanisms as seen in V. cholerae. In this organism the gene aldA encodes a co-enzyme A 
dependent aldehyde dehydrogenase. Once thought to only function in metabolic pathways 
the enzyme is now thought to function in virulence through an unknown mechanism 
(Karaolis 1998). The gene aldA is found in a 39.5 kb pathogenicity island called VPI that 
includes other virulence related genes such as the toxin-co-regulated pilus, which is an 
essential colonisation factor in human and animal models of infection. Also adjacent to 
aldA and oppositely transcribed is the gene tagA, which encodes a lipoprotein. The 
presence of these genes has been associated with epidemic and pandemic strains of V. 
cholerae and thus they may have a role in virulence of this organism (Karaolis 1998). 
However, a definite role for this gene in the virulence of V. cholerae has never been 
determined. To my knowledge, this study represents the first occasion that the inactivation 
of an aldehyde dehydrogenase gene, from a bacterial pathogen has been shown to cause a 
decrease in virulence in either nematodes or mammals. 
The possibility of the inactivation of BPSS1466 having polar effects on other genes that 
would result in a decrease in virulence must also be considered. Genes immediately 
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upstream and downstream of BPSS1466 include BPSS1464 a putative transmembrane 
NADPH flavoprotein, BPSS 1465 a putative thiamine biosynthesis lipoprotein precursor 
and BPSS1467 a putative aminotransferase protein. These genes have roles in various 
essential metabolic processes within the bacterial cell such the catabolism of amino acids 
and the catalysis of various redox reactions (Stryer 1996; Hetti 2003). Thus interference 
with these genes may cause defects in growth both in vitro and in vivo. 
A search of chromosome II, up and down-stream of BPSS1466 indicated that no genes 
previously recognised to be involved in virulence are present in this area of the genome. 
The region was composed of genes encoding putative metabolic and regulatory functions. 
Thus, polar effects on more distant genes that result in a decrease in virulence are also 
unlikely. 
The net result of the interruption of the aldehyde dehydrogenase gene BPSS1466 in B. 
pseudomallei 576 was a reduction in virulence in the nematode C. elegans and in BALB/c 
mice. Further work, including the complementation of the interrupted gene in an attempt to 
restore wildtype levels of virulence, would be needed to determine a definite role for 
BPSS 1466 in the virulence of B. pseudomallei 576. 
In a similar study to that reported here Gan et al (Gan 2002) screened 3400 B. 
pseudomallei transposon mutants for those with reduced virulence in C. elegans N2. From 
these, 5 were isolated that were attenuated in nematodes and mice. Hence the success rate 
in the identification of attenuated mutants was 1 mutant in every 680 tested. The success 
rate for the screen performed here was I mutant in every 960 mutants. This suggests that 
the high-throughput screening method used in this study was not of comparable efficiency 
to the method reported by Gan. However a number of differences exist between the 
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methodology used in these studies that may account for the apparent reduction in 
efficiency. This includes differences in the growth media used, which has been shown to 
effect the kinetics of B. pseudomallei-C. elegans interactions (0' Quinn, Wiegand et al. 
2001) and the use of a different B. pseudomallei strain for construction of the transposon 
library. Furthermore, approximately 3 times as many mutants were screened in Gan's 
study than in the study reported here. Therefore the possibility remains that through the 
screening of a comparable number of mutants a similar quantity displaying attenuated 
phenotypes may have been isolated. However, when the isolation rate of mutants 
displaying a reduced virulence in both nematodes and mammalian models is calculated, the 
isolation rate for Gan's study and the investigation reported here was the same at 0.1%. 
This indicates that both screening methods were of comparable efficiency thus validating 
the high through-put method used in this thesis. 
The isolation rate of attenuated mutants from pools of transposon mutants in mammalian 
models ranges between 1-5% (Hensel, Shea et al. 1995; Chiang and Mekalanos 1998; 
Foulongne, Bourge et al. 2000; Fuller, Martin et al. 2000; Atkins 2002). As discussed 
above the use of a nematode model of infection for isolation of mutants attenuated in mice 
is less efficient. This would be expected as when using a mammalian model to identify 
mutations that cause a reduction of virulence in mammals, only genes that reduce virulence 
in one animal species is considered. However, when using the C. elegans model, genes 
that attenuate virulence in two different animal species must be identified. Thus the 
probability of isolating a single gene that reduces virulence in both nematodes and mice 
would be less, hence the difference in efficiency shown between screens in mammalian 
and worm models of infection. 
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Although shown to be less effective, screens using C. elegans for the isolation of B. 
pseudomallei mutants that are attenuated in mammals have been successful. Moreover the 
genes identified in such screens are often not previously thought to function in virulence 
(Gan 2002). Thus the use of the nematode model of infection in these applications may 
provide valuable information regarding the virulence of B. pseudomallei that would not be 
obtainable in a conventional mammalian model system. 
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7.1. Introduction. 
The work presented in chapter: 6 showed that the C. elegans-B. pseudomallei infection 
model could be used to identify B. pseudomallei mutants with reduced virulence. This 
prompted an investigation of other molecular methods for the identification of bacterial 
virulence factors. Cosmid libraries, carrying fragments of genomic DNA from a pathogen 
of interest, can be expressed in a non-pathogenic host such as E. coli. Virulence related 
genes contained within the cloned DNA of cosmids can then be identified through the 
increase in virulence of the host strain. This approach has been used successfully for the 
identification of virulence genes in S. enterica serovar Typhimurium (Robey 2002). A 
cosmid library was constructed from fragments of the genome of a fully virulent and 
invasive strain of this organism. The library was then introduced into an avirulent strain 
and the resulting clones screened for intestinal invasiveness in a rabbit ileal loop assay 
(Robey 2002). This resulted in the isolation of one recombinant strain that had increased 
invasiveness compared to a control. The cloned DNA fragment responsible for the increase 
in virulence was sequenced and mapped to a region of the S. enterica serover Typhimurim 
chromosome close to the Salmonella pathogenicty island 5 (SPI-5) (Robey 2002). The 
cloned genes are thought to encode pleiotrpic regulators of genes involved in gastro-enteric 
virulence and adaptation to the in vivo gut environment. This work suggested that 
virulence-associated genes from other bacterial species could be identified using a similar 
method. Hence the usefulness of the C. elegans infection model for the isolation of cosmid 
clones carrying fragments of B. pseudomallei DNA with an increased virulence was 
assessed. 
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7.2. Screening of a B. pseudomallei E504 cosmid library using C. elegans N2. 
A B. pseudomallei E504 cosmid library created using the cosmid vector supercos-1 
(Stratagene, UK Appendix: 1. ) was obtained in E. coli XL1 -blue MR (Stratagene, UK) 
from Dr. C. Winstanley, Department of medical microbiology and GU medicine, 
University of Liverpool. On receipt, the library was validated for the presence of different 
cloned sequences. An overnight culture of the B. pseudomallei E504 cosmid library was 
diluted and plated onto media containing ampicilin, to obtain single colonies. Ten colonies 
were selected and cosmid isolated from overnight cultures of each clone using a Quiagen 
miniprep kit. The vector was then digested overnight with the restriction endonuclease 
enzyme Not 1. The multiple cloning site of the vector supercos-1 is flanked by unique Not 
1 restriction enzyme recognition sites (Appendix: 1. ). This allowed the excision of cloned 
DNA fragments while leaving the vector intact. From the 10 E. coli clones selected, all 
were shown to carry the supercos-1 vector and 9 were found to have DNA fragments. 
However, one clone was shown to contain no inserted sequence and only supercos-1 was 
present. Thus, approximately 90 % of the cosmid library could be expected to contain 
different cloned B. pseudomallei DNA fragments (Figure: 7.1). 
To serve as a control in subsequent experiments, an E. coli XL1-Blue MR strain was 
transformed with empty supercos-1 cosmid vector (Section: 2.3.7. ). This strain was named 
E. coli XL: cos-1 (Figure: 7.1). 
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Figure: 7.1: Agarose del showing DNA isolated from randomly selected E. coli XL I -Blue 
MR clones digested with the restriction enzyme Not 1. Cosmid was extracted from 10 
randomly selected clones and digested with the restriction endonuclease Not 1. This was 
compared to supercos-1 supplied by the manufacturer (Stratagene. UK) through agarose 
gel electrophoresis at 80v. Lanes I and 15 molecular mass markers, lanes 3-12 digests and 
lane 13 contains supercos-1. 
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Figure: 7.2. Comparison of purified supercos-1 cosrnid vector (Stratagenc, LK) supplied 
by the manufacturer (lane 2) and supercos-1 cosmid vector extracted from transformed E. 
coli XL1-blue cells (lane 3) on a 0.7 % agarose gel at 80v. The white arrow denotes a 7.9 
kb band corresponding to the circular form of supercos-1. A band can also be seen with an 
approximate size of 4.0 kb, which represents the supercoiled form of the vector. 
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An overnight culture of the B. pseudomallei E504 cosmid library in E. coli XL-1 Blue MR 
was diluted and plated onto media containing ampicilin, to obtain single colonies. A 
selection of 150 cosmid clones were then chosen and investigated for their effect on 
feeding rates of C. elegans N2 in a feeding inhibition assay (Section: 2.4.6. ). 
Groups of 100-200 C. elegans N2 nematodes were fed in suspensions of each clone at an 
approximate starting OD55o of 1.2 at 25 °C for a total 48 hours. The ODS50rm of each 
suspension was recorded at the beginning of the experiment and at 48 hours. Clones were 
said to have a negative effect on nematode feeding if results after conversion into AUCD 
were less than the average of all of the clones minus 2.25 times the standard deviation of 
all the results obtained for the other clones. This ensured a high degree of confidence that 
any clone identified significantly inhibited feeding. 
After screening all 150 cosmid clones, one clone (clone 93) was found that gave a negative 
effect on feeding rate of C. elegans N2 according to the criteria described above. To assess 
the degree of the feeding inhibition induced, clone 93 was investigated further in the 
feeding inhibition assay over 48 hours. 
Groups of 50- 100 C. elegans N2 worms were fed on suspensions of clone 93 with an 
approximate starting OD550mn of 1.2, for 48 hours at 25 °C, and the OD550m monitored at 
daily intervals (Figure: 7.3 ). At 48 hours, consumption rates on clone 93 and XL-cos-1 
were 0.46 AUCD and 0.3 AUCD respectively. Hence feeding was faster in suspensions of 
clone 93. This indicated no-inhibition of nematode feeding by the clone and therefore this 
strain was not investigated further. 
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Figure: 7.3. Feeding inhibition of C. elegans N2 at 25 °C over 48 hours in suspensions of 
clone number 93 (") in K-medium with an approximate stating OD55 nm of 1.2. Feeding in 
suspensions of E. coli XL: cos-1 ( ) or XL: cosl with the addition of 100 mM sodium 
salicylate (A) were used as controls. Error bars are the standard error of the mean of 8 
replicates performed for each condition each containing 50-100 L4 stage worms. 
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7.3. Screening of a B. pseudomallei E504 cosmid library using C. elegans phm-2. 
Since no cosmid clones were identified as having a detrimental effect on feeding in C. 
elegans N2 a further 150 clones were tested for increases in virulence in the C. elegans 
mutant phm-2. As shown in chapter: 3, the increased sensitivity of this mutant to feeding 
inhibition might have allowed the identification of E. coli clones that would not cause an 
effect in wildtype C. elegans. 
After screening 150 E. coli clones in C. elegansphm-2 four clones (28,57,105 and 119) 
were putatively identified as negatively affecting feeding when compared to E. coli 
XL: cos-1. These clones were tested in more detail in the feeding inhibition assay. Groups 
of 50-100 worms were fed at 25 °C for 48 hours, in suspensions of each cosmid clone in 
K-medium, with an approximate starting OD55 m of 1.2. The OD550nm was measured at 24 
hour intervals. 
After testing all four E. coli clones in the feeding inhibition assay no strain was seen to 
significantly reduce feeding when compared to feeding rates observed on E. coli XL: cos-1 
(Figure: 7.4. ). 
257 
Chapter: 7. Identification of B. pseudomallei virulence factors using cosmid libraries. 
Figure: 7.4. Feeding rates of C. elegansphm-2 at 25 °C over 48 hours while feeding in 
suspensions of E. cola clones number 28 (+), 57 ( ), 105 (A) or 119 (X) in K-medium 
with an approximate stating OD55o of 1.2. Feeding in suspensions of E. coil XL: cos-1 
(*) and XL: cosl with the addition of 100 mM sodium salicylate (") were used as controls. 
Error bars are the standard error of the mean of 8 replicates performed each containing S0. 
100 IA stage worms. 
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7.4. Assessment of cloned gene expression from supercos-1. 
Since none of the tested clones reduced feeding rates of C. elegans N2, or the mutant strain 
C. elegansphm-2 in the feeding inhibition assay, one possibility was that the level of 
protein expression from cloned B. pseudomallei E504 genes may have been insufficient to 
cause an effect in the feeding inhibition assay. To investigate this the level of gene 
expression from each of the clones putatively identified using the C. elegans N2 or C. 
elegans phm-2 screening assay was assessed. This was achieved through the use SDS- 
PAGE in conjunction with Western blotting, Coomassie blue staining and silver staining of 
SDS-PAGE gels. 
After Western blotting with polyclonal antisera raised against heat-killed B. pseudomallel 
576 (section: 2.3.8.2. ) no bands were visualised, which would indicate a lack of expression 
of B. pseudomallei E504 genes carried supercos-1 (Figure: 7.5. ). 
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Figure: 7.5. Western blot of an SDS-PAGE gel containing boiled samples of E. coli clones 
previously putatively identified as having a negative effect on feeding rates in the feeding 
inhibition assay on C. elegans N2 and the mutant C. elegans phm-2. Developed 
membranes were visualised and recorded using a Multigenius Bio-imaging system 
(Syngene, Cambridge, UK). To give an indication of molecular weight samples were ran 
against a high range rainbow molecular weight marker (Amersham, UK). 
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To further assess levels of expression of cosmid inserts from each clone, SDS-PAGE gels 
were stained using Coomassie brilliant blue. This method allows the visualisation of all 
proteins contained within samples and avoids many of the problems of "background noise" 
experienced with Western blotting (Gooderham 1984). This then would allow a more clear 
protein expression profile to be obtained that may show differences between each of the 
clones investigated and show expression of proteins specific to B. pseudomallei E504 
(Section: 2.3.8.1. ). 
No bands were observed in any of the E. coli clones assessed that were additional to those 
seen in E. coli XL: cos-1 further suggesting a lack of cloned gene expression in E. coli XL1 
Blue MR. (Figure: 7.6. ). 
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Figure: 7.6. Coomassie stain of an SDS-PAGE gel containing boiled samples of cosmid 
clones previously identified as having a negative effect on feeding rates in the feeding 
inhibition assay on C. elegans N2 and the mutant C. elegans phm-2. Gels were visualised 
and recorded using a Multigenius Bio-imaging system (Syngene, Cambridge, UK). To give 
an indication of molecular weight samples were ran against a high range rainbow 
molecular weight marker (Amersham, UK). 
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Finally, SDS-PAGE gels were subjected to silver staining to visualise proteins after 
electrophoresis. Silver staining of proteins is considered to be 20 and 200 times more 
sensitive than that of Coomassie brilliant blue, which is of limited sensitivity when 
compared to methods utilising silver containing compounds (Gooderham 1984). The 
increase in sensitivity that this method affords may then allow the visualisation of proteins 
that had previously remained undetected by the other techniques so far employed. 
As observed previously using Western-blotting and Coomassie staining of SDS-PAGE gels 
no additional bands were observed in any of the cosmid clones investigated compared to E. 
coli XL: cos-1, which would indicate expression of cloned B. pseudomallei E504 genes 
(Figure: 7.7). 
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Figure: 7.7. Silver stain of an SDS-PAGE gel containing boiled samples of cosmid clones 
previously identified as having a negative effect on feeding rates in C. elegans N2 and the 
mutant C. elegansphm-2. Gels were visualised and recorded using a Multigenius Bio- 
imaging system (Syngene, Cambridge, UK). To give an indication of molecular weight 
samples were ran against a high range rainbow molecular weight marker (Amersham, UK). 
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7.5. Discussion. 
A panel of 300 B. pseudomallei E504 cosmid clones were screened in either C. elegans N2 
or the mutant C. elegans phm-2 for increased pathogenicity phenotypes. From these a total 
of 5 clones were putatively identified as having a detrimental effect on feeding rate in the 
feeding inhibition assay. However on analysis using the feeding inhibition assay no clone 
was found to reduce feeding rates to below that observed in suspensions of E. cola XL: cos- 
1. Thus no clone exhibiting an increase in virulence in the C. elegans model of infection 
was identified in this study. 
A possible reason why no clones with increased virulence were identified may be that 
insufficient numbers of clones had been screened. To assess this possibility the 
approximate number of clones needed to be tested in the nematode model, to ensure 
complete coverage of the B. pseudomallei E504 genome was calculated through the use of 
the Clarke and Carbon formula. That is N= In (1 - P) / In (1 - 1/n) where P is the 
probability a given DNA sequence is present, n is the ratio of insert size to genome size 
and N is the number of clones needed to ensure each sequence of a particular size is 
represented at least once in a panel of clones (Medhora, Phadnis et al. 1983). B. 
pseudomallei has approximate genome size of 7 Mb 
(http: //www. sanger. ac. uk/Projects/B_pseudomallei/) and the supercos-1 cosmid vector has 
an average insert size of approximately 36 kb 
(http: //www. stratagene. com/displayProduct. asp? productld=275). Therefore for a 99 % 
chance of screening the entire genome for genes that give rise to an increase in virulence 
an estimated 892 clones, all containing cloned sequences, would be needed to be tested in 
nematodes (Figure: 7.7. ). A total of only 300 clones were screened in either C. elegans N2 
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or C. elegansphm-2, giving only a 78 % probability of the whole genome being 
represented a least once in the form of 36 kb segments. The fact that only 90 % of the 
cosmid library were expected to contain cloned fragments of DNA must also be taken into 
account. Thus, the probability of complete coverage was reduced by a further 10 % to 
68%. This indicates that the sample size used may not have been sufficiently large enough 
and that there remains a probability that some regions of the genome would have been 
missed from the screen. This may then account for the lack of clones identified with 
increased virulence in C. elegans. 
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Figure: 7.8. Probability of whole B. pseudomallei E504 genome coverage using the cosmid 
vector supercos-1 (Stratagene, UK). Values were calculated through the use of the Clarke 
and Carbon formula N =1n (1 - P) / In (1 - 1/n). This assumes a genome size of 7 Mb, an 
average supercos-1 insert size of 36 kb and a 99 % confidence of complete genome 
coverage. 
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A second possibility of why no effect was seen in the nematode model may due to the size 
of sequences that can be cloned into the supercos-1 vector. Bacterial virulence factors such 
as the TTS system (Cornelis 2002) and adhesisns are formed from different components 
encoded by genes organised into large operons. The upper size limit for cloned sequences 
in supercos-1 is 42 kb (http: //www. stratagene. com/displayProduct. asp? productId=275). 
Thus functional virulence factors consisting of large co-ordinated collections of genes 
could not be cloned into supercos-1 due to the size limitations imposed by the multiple 
cloning site. Further more, these structures must be assembled correctly and localised in 
the outer membrane. This often requires the use of chaperone molecules and secretory 
signals that may not be present in the cloned sequence (Cornelis 2002). More over the 
regulatory mechanisms needed to control the production of these structures may also be 
absent. Thus, it is likely that fragments of such operons, consisting of single or few genes 
would be cloned. Hence fully functional virulence factors may not be produced and would 
have no effect towards C. elegans in the feeding inhibition assay. 
A further possibility is that levels of expression of protein from the cloned sequences may 
be very low. This is supported by the fact that no expression of B. pseudomallei protein 
was detected in any clones investigated through Western blotting, Coomassie staining or 
silver staining of SDS-PAGE gels. This suggests that amounts of protein expressed from 
cloned sequences in supercos-1 were below the detection level of these methods. 
The transcription and translation of proteins from other bacterial species in E. coli is often 
hampered by problems inherent when using E. coli host cells to express foreign genes. For 
example codon usage at the level of translation may present a problem due to codon bias. 
Often a number of different codons can encode the same amino acid (Brown 1994). 
However, particular codons may be more important in protein translation in different 
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MM- bacterial species due to their relative abundance within the cell. For example, one of the 
four codons that encode the amino acid alanine is GCG (Table: 7.1. a. ). In E. coli K12 the 
frequency of this codon per thousand codons is 29.2 (http: //www. kazusa. or jp/codon/cgi- 
bin/showcodon. cgi? species=Escherichia+coli+[gbbct]). However, in B. pseudomallei 
K96243 (Table: 7.1. b. ) the frequency of the same codon is 80.0 
(http: //www. kazusa. or jp/codon/cgi- 
bin/showcodon. egi? species=Burkholderia+pseudomallei+[gbbet]) indicating that this 
codon is used more frequently and is more important in B. pseudomallei. Hence proteins 
that contain alanine, encoded by genes containing the GCG codon would not be expressed 
efficiently when introduced into E. coli K12. This would be due to the relative lack of the 
corresponding tRNA molecules needed to form the protein from the codons present within 
the host cell. Thus the net result would be inefficient translation of the B. pseudomallel 
gene. 
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UUU 22.2( 82893) UCU 10.8( 40338) UAU 17.8( 66278) UGU 5.2( 19594) 
UUC 15.9( 59326) UCC 9.3( 34896) UAC 12.1( 45113) UGC 6.0( 22429) 
UUA 14.4( 53828) UCA 9.4( 35189) UAA 2.0( 7362) UGA 1.0( 3821) 
UUG 12.8( 47667) UCG 8.5( 31755) UAG 0.3( 1060) UGG 13.8( 51464) 
CUU 12.1( 45176) CCU 7.6( 28496) CAU 12.5( 46664) CGU 19.6( 73065) 
CUC 10.1( 37754) CCC 5.4( 20205) CAC 9.1( 34072) CGC 19.1( 71169) 
CUA 4.3( 16072) CCA 8.6( 32003) CAA 14.4( 53581) CGA 3.9( 14537) 
CUG 47.4(177073) CCG 20.1( 75226) CAG 28.4(106132) CGG 6.2( 23004) 
AUU 29.6(110665) ACU 10.8( 40452) AAU 21.4( 79985) AGU 10.3( 38461) 
AUC 23.3( 87013) ACC 21.8( 81518) AAC 21.5( 80233) AGC 15.0( 56137) 
AUA 7.5( 27837) ACA 10.0( 37331) AAA 35.2(131606) AGA 4.0( 14945) 
AUG 26.0( 97214) ACG 13.7( 51308) AAG 12.8( 47643) AGG 2.3( 8675) 
GUU 20.0( 74656) GCU 17.4( 64843) GAU 32.8(122564) GGU 25.3( 94598) 
GUC 14.2( 53076) GCC 24.1( 89946) GAC 19.2( 71549) GGC 26.5( 98914) 
GUA 11.7( 43741) GCA 21.4( 79944) GAA 38.5(143639) GGA 10.0( 37357) 
GUG 23.9( 89076) GCG 29.2(108870) GAG 18.7( 69898) GGG 11.4( 42715) 
Table: 7.1. a. E. coli K12 codon usage. The fields shown are; the three letter triplet 
corresponding to a particular amino acid, the frequency of that codon per thousand codons 
and finally the number of that particular codon per cell is shown in parentheses. 
U=- 36 66) UCU 2.1( 115) UAU 9.6( 513) UGU 1.5( 79) 
UUC 28.7( 1539) UCC 8.1( 435) UAC 14.4( 769) UGC 7.7( 412) 
UUA 0.9( 46) UCA 2.1( 110) UAA 0.6( 31) UGA 2.0( 105) 
UUG 10.7( 575) UCG 29.4( 1577) UAG 0.3( 17) UGG 13.3( 711) 
CUU 6.7( 360) CCU 2.8( 148) CAU 8.1( 435) CGU 7.6( 405) 
CUC 36.9( 1976) CCC 9.7( 521) CAC 12.2( 654) CGC 41.8( 2238) 
CUA 1.6( 86) CCA 1.9( 103) CAA 9.6( 515) CGA 5.7( 303) 
CUG 43.8( 2347) CCG 33.0( 1769) CAG 27.3( 1465) CGG 15.3( 818) 
AUU 8.0( 427) ACU 2.0( 107) AAU 8.3( 445) AGU 2.3( 125) 
AUC 38.0( 2036) ACC 14.8( 794) AAC 22.8( 1221) AGC 16.2( 867) 
AUA 1.9( 104) ACA 2.5( 132) AAA 5.9( 314) AGA 1.5( 82) 
AUG 22.5( 1206) ACG 34.8( 1867) AAG 24.7( 1324) AGG 2.7( 144) 
GUU 6.3( 335) GCU 6.6( 352) GAU 18.5( 992) GGU 6.0( 321) 
GUC 32.0( 1717) GCC 33.5( 1795) GAC 36.1( 1932) GGC 56.6( 3033) 
GUA 3.8( 205) GCA 11.2( 602) GAA 19.8( 1063) GGA 5.6( 300) 
GUG 32.5( 1742) GCG 80.0( 4284) GAG 29.4( 1576) GGG 11.0( 587) 
Table: 7.1. b. B. pseudomallei codon usage. The fields shown are; the three letter triplet 
corresponding to a particular amino acid, the frequency of that codon per thousand codons 
and finally the number of that particular codon per cell is shown in parentheses. 
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If correctly translated by an E. coli host strain a further obstacle to the correct function of 
many proteins is that some may require covalent processing through post-translational 
modification to become active or reach their correct localisation within the cell (Mann 
2003). These modifications change the properties of a protein by proteolytic cleavage or 
addition of a modifying group to one or more amino acids. Common post-translational 
modifications include phosphorylation, which may activate or inactivate enzymatic activity 
or modulate molecular interactions and glycosylation that may be used in the stabilisation 
of excreted proteins and in cell-to-cell signaling (Mann 2003). 
Some bacterial toxins including diphtheria toxin must undergo post-translational 
modification before becoming fully active. Diphtheria toxin is produced as a single peptide 
that must be proteolytically cleaved to form the A and B subunits necessary for toxic 
activity. Without this modification no toxic activity is seen (Middlebrook and Dorland 
1984). Hence protein translated from putative B. pseudomallei virulence genes, expressed 
in E. coli may not function due to a lack of essential post-translational modifications that 
confer full activity. 
In this study the search for E. coli clones with an increased virulence using the C. clegans 
model of infection has not proven effective. However levels of protein expression may be 
insufficient to cause an affect in this assay. Hence a further study utilising a B. 
pseudomallei E504 cosmid library, re-packaged and expressed in host cells where 
possibilities of codon bias and other factors that encumber protein expression arc 
minimised, such as BL21-codon plus (Stratagene, UK) is needed. These host cells have 
been specially engineered to express codons suitable for the expression of GC-rich 
genomes thereby ameliorating problems of codon bias that may be experienced. This may 
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help to increase the level of B. pseudomallei E504 transcript present and allow the 
identification of clones with increased virulence using the feeding inhibition assay. 
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8.1. A nematode model of bacterial infection using C. elegans. 
The aim of the work reported in this thesis was to develop and exploit techniques for the 
investigation of bacterial pathogenicity using the nematode C. elegans. A C. elegans- 
Burkholderia infection model was used to investigate the virulence of a range of 
Burkholderia strains. The cellular interactions that occur in the C. elegans gut during 
infection with B. pseudomallei were studied using TEM. Two molecular approaches for the 
study of bacterial virulence were also investigated; the screening of B. pseudomallei 
transposon mutants for reduced virulence and the screening of a genomic cosmid library 
for clones that displayed an increased virulence in the worm model of infection. 
Initially, a plate-based mortality assay was established on NGM media using the bacterial 
pathogen P. aeruginosa PA14 as a model of bacterial infection (Tan, Rahme et al. 
1999)(Chapter. 3. ). The results from the use of this assay closely resembled those 
published by other authors using similar assays (Tan, Rahme et al. 1999; Rahme, Ausubel 
et al. 2000; Yorgey, Rahme et al. 2001; Aballay and Ausubel 2002; Ewbank 2002). 
Similar plate-based mortality assays have been used for the study of other human 
pathogens including S. marcescens, (Pujol, Link et al. 2001) S. enterica serovar 
Typhimurium (Labrousse, Chauvet et al. 2000), E. faecalis, S. pneumoniae and S. aureus 
(Garsin, Sifri et al. 2001). This has lead to the identification of a variety of genes not 
previously known to be involved in the virulence of these organisms. Data from previous 
reports combined with the results presented here indicated that the plate-based mortality 
assay described in chapter: 3 could also be used as a tool for the investigation of bacterial 
virulence. 
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A novel method for the measurement of bacterial virulence was developed using a feeding 
inhibition assay. This assay was based on previous observations by Jones and Candido 
(Jones and Candido 1999) of a behavioural response in C. elegans that resulted in an 
inhibition of feeding in a bacterial suspension, when worms were stressed by heat or 
chemicals. Feeding inhibition could be monitored by measuring the OD5sc,,,,, of the 
bacterial suspension in which the nematodes feed, over time. The feeding inhibition assay 
was used to assess the virulence of P. aeruginosa towards C. elegans and this assay was 
found to be more rapid than the plate-based mortality assay. 
A C. elegans-Burkholderia infection model was used to investigate a range of strains from 
the Burkholderia genus. This indicated that C. elegans was susceptible to infection by 
strains from the B. cepacia complex, B. thailandensis and B. pseudomallei. Those B. 
pseudomallei strains reported to have a reduced virulence in mammals also had a reduced 
virulence in nematodes. Importantly the investigation of these B. pseudomallei strains also 
showed that the feeding inhibition assay might not be as useful for the investigation of 
bacterial virulence using C. elegans as the plate-based mortality assay. 
Using the plate-based mortality assay, the killing rates of each B. cepacia complex strain 
was shown to be different. No one genomovar had more nematode-virulent strains than 
another. Strains previously described as causing severe disease in humans were not more 
virulent than other strains in C. elegans. Some strains caused nematodes to move 
aberrantly. One strain, B. cenocepacia sp. nov. J415, also induced the transient formation 
of nose-globs. The pathogen Y. pseudotuberculosis has also been shown to form these 
adherent structures on the anterior and posterior cuticular surfaces of C. elegans. However 
nose-glob formation by B. cenocepacia sp. nov. J415 occurred through a mechanism 
distinct from that employed by Y, pseudotuberculosis. B. cenocepacia sp. nov. J415 is the 
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index strain for the degenerative condition cepacia syndrome in CF patients (Dr. J. Govan, 
Pers. Comm. ). This strain may have adaptations for colonisation of the CF lung which also 
allow it to induce the formation of nose-globs in C. elegans. Overall, the link between 
aberrant movement and nose-glob phenotypes in nematodes, and pathogenicity of B. 
cenocepacia sp. nov J415 in the mammalian host, remains unclear. 
When B. cepacia complex strains were tested in the feeding inhibition assay there was no 
relationship between reduction in nematode feeding rate and genomovar. Strains that 
caused death in the plate-based mortality assay also caused a reduction in consumption rate 
in the feeding inhibition assay. Large differences in virulence were seen between strains 
from the same genomovar and strains known to cause severe disease in humans were not 
consistently the most virulent in either the plate based mortality assay of the feeding 
inhibition assay. Thus the nematode model may not model mammalian infection caused by 
the B. cepacia complex strains tested. 
Strains of B. pseudomallei and B. thailandensis were also investigated in the plate-based 
mortality and feeding inhibition assays. The differences in nematode killing by different 
strains in the plate-based mortality assay reflected differences in virulence as seen in 
vertebrates. However the results from the feeding inhibition assay did not show the same 
relationship. Thus the results from the feeding inhibition assay and the plate-based 
mortality assay do not correlate suggesting feeding inhibition and killing occurs through 
different mechanisms. 
The novel nature of the feeding inhibition assay means that at present no published work 
on its use with bacterial pathogens exists apart from that reported here (Smith 2002). Jones 
and Candido (Jones and Candido 1999) utilised a similar assay for the investigation of 
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feeding inhibition and killing of C. elegans in response to chemicals. Through the use of C. 
elegans mutants they showed that conditions that induced a stress response inhibited 
feeding. The degree of feeding inhibition depended on the amount of stress experienced. 
The level of stress detected was linked to the concentration of particular chemicals but this 
varied depending on the compound used. They could not demonstrate any sensory 
transduction events underlying feeding inhibition and thus could discover no mechanism 
by which this process occurs. However, Jones and Candido did suggest that feeding 
inhibition was a survival response in C. elegans used to limit damage by the ingestion of 
toxic compounds encountered in the environment (Jones and Candido 1999). The work 
reported in this thesis agrees with these results as feeding was also shown to be 
reproducibly inhibited by sodium salicylate. In addition to chemicals, the data here has 
shown that the feeding inhibition response may be a defence against bacterial pathogens, as 
feeding inhibition occurred when C. elegans was fed on suspensions of these organisms. 
Different pathogens were shown to inhibit feeding to a greater or lesser extent. This is 
presumably in part due to differences in virulence, the initial starting ODssam of the 
bacterial suspension and different numbers of nematodes between each experiment. The 
counting of worms in small aliquots can give an indication of the numbers of worms in 
larger samples. However the numbers of nematodes in each well of the feeding inhibition 
assay can only be standardised through the use of specialist worm counting and dispensing 
machinery (http: //www. unionbio. com), which was not available for use in this study. The 
feeding inhibition assay can only show if one bacterial strain is more virulent than another. 
It cannot provide information concerning the events that occur to cause feeding inhibition, 
as it is simply a measure of the change in ODS5Onm of a bacterial suspension over time. The 
feeding inhibition assay, unlike the plate-based mortality assay, does not allow the 
examination of nematodes and thus precludes the observation of particular phenotypic 
changes in worms, such as aberrant movement and nose-glob phenotypes. Also the 
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responses in these assays do not always correlate and strains may appear less virulent in 
the feeding inhibition assay but highly virulent in the plate-based mortality assay and 
mammalian infection models. Hence, the feeding inhibition assay was inherently difficult 
to standardise and was not a robust assay of bacterial virulence. The plate-based mortality 
assay allowed the observation of the events that lead to death in C. elegans. It gave results 
that were consistently reproducible, which mimicked levels of virulence of B. 
pseudomallei in mammals. Therefore, it must be considered the better model of B. 
pseudomallei pathogenicity using C. elegans and overall the better tool for the 
investigation of bacterial virulence. 
8.2. Investigation of B. pseudomallei pathogenesis using the nematode C. elegans. 
The interaction of B. pseudomallei with the cells of the C. elegans intestinal tract was 
investigated through TEM (Chapter: 5. ). After 24 hours post exposure no close association 
of B. pseudomallei with the cells lining the intestine or invasion of these cells was 
observed. This suggests that intracellular invasion does not occur and that killing of C. 
elegans does not involve the invasion of nematode tissues, intracellular spread and 
replication of the organism as seen in the mammalian host (Kespichayawattana, 
Rattanachetkul et al. 2000). Thus the interaction of B. pseudomallei with the cells of the C. 
elegans gut was not similar to that seen in mammalian tissues. However a number of 
bacteria appeared to be in the process of cellular division at the point of fixation indicating 
that these may have been viable (Figure: 5.4). As no invasion of the tissues surrounding the 
gut was observed but killing still occurs during B. pseudomallei infection of C. elegans, 
this suggests that killing may be initially mediated by secreted products. As a saprophytic 
organism B. pseudomallei could be expected to produce a variety of extracellular products 
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(Haase, Janzen et al. 1997; Ellis 1999; Brett and Woods 2000; Dance 2000). This may 
include the paralysing toxin implicated in the nematode killing process (0' Quinn, 
Wiegand et al. 2001; Gan 2002), other toxins including a putative cell elongating factor 
and a cytoleathal peptide (Haase, Jensen et al. 1997) or proteases (Ellis 1999). These 
products could damage C. elegans cells and eventually degrade the nematode to a level 
where invasion and digestion of underlying tissues is possible resulting in death of the 
worm. 
TEM allowed the observation of B. pseudomallei in the nematode gut early in the infection 
process. This approach although useful could not provide information concerning the 
molecular interactions that lead to B. pseudomallei virulence in C. elegans. To address 
this, molecular approaches to the investigation of B. pseudomallei virulence were explored 
in chapters: 6 and 7. Firstly B. pseudomallei mutants were assessed for their virulence in 
nematodes (Chapter: 6. ). This showed that the C. elegans-Burkholderia infection model 
was capable of identifying mutations that result in a decrease in virulence in both 
nematodes and mammalian models of infection. 
Other workers have also shown that C. elegans is a model of disease for a variety of 
bacterial pathogens including B. pseudomallei (Table: 1.1. ). 0' Quinn eta! (0' Quinn, 
Wiegand et al. 2001) first described the use of a C. elegans-Burkholderia infection model. 
They showed that C. elegans was susceptible to a range of Burkholderia strains including 
B. cepacia, B. thailandensis and B. pseudomallei. Gan et al (Gan 2002) then used a similar 
assay to further investigate B. pseudomallei virulence and showed that the differences in 
virulence of strains seen in nematodes mirrored that seen in mammals as was found in this 
study. Gan et al also used this model to screen a large number of B. pseudomallei mutants. 
From 3,400 transposon mutants, five were isolated that showed reduced virulence in C. 
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elegans. The interrupted genes were not previously known to play a role the in virulence of 
B. pseudomallei and included a putative amino acid transporter and a putative ABC 
transporter protein (Gan 2002). To confirm the functional relevance of the interrupted 
genes to mammalian pathogenesis, each mutant was then screened in BALB/c mice. Mice 
infected with the mutants displayed an increased time to death. In this study I also 
identified B. pseudomallei mutants attenuated in C. elegans; B. pseudomallei 6H2 was less 
virulent in nematodes and mice infected with B. pseudomallei 6H2 showed an increased 
time to death. When the interrupted gene was identified it was found to be a gene not 
previously known to be involved in the virulence of B. pseudomallei in vivo. These data, 
together with the findings of Gan et al (Gan 2002), show that the nematode C. elegans can 
be used to investigate B. pseudomallei virulence in the mammalian host. 
The success of the C. elegans-Burkholderia model in the identification of a transposon 
mutant with decreased virulence, prompted me to investigate other molecular approaches 
to the investigation of bacterial virulence factors. The usefulness of C. elegans for the 
screening of a B. pseudomallei genomic cosmid library carried in E. coli, for clones with 
increased virulence was explored (Chapter: 7. ). However, no single cosmid clone 
displaying an increased virulence was identified using the feeding inhibition assay. When 
the levels of B. pseudomallei protein expression from cosmids was assessed, no expression 
was detected using Western blotting, Coomassie Blue staining or silver staining of SDS- 
PAGE gels. This suggests that the quantities of protein produced were below the detection 
level of these methods. This then would explain the lack of any effect seen in the C. 
elegans model, as levels may be too low to be biologically efficacious in nematodes. As 
the feeding inhibition assay relies on the use of a liquid medium, already very small 
quantities of virulence factors might be further diluted. The plate-based mortality assay 
exposes worms to high concentrations of the challenge bacterium and its products. Thus, 
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the use of the plate-based mortality assay, to screen cosmid clones may in retrospect have 
been more appropriate. 
This is the first reported use of an assay based on nematode worms being used for the 
screening of cosmid libraries for clones with increased virulence. Hence these results 
cannot be compared to work carried out by other authors using these techniques. However 
cosmid clones with increased virulence have been identified using other in vivo and in vitro 
assay methodologies (Regue 2001; Robey 2002). A further study, using a plate-based 
assay, may allow the identification of cosmid clones with increased pathogenicity and 
allow isolation of genes important in nematode killing. As the results presented in thesis 
have shown, these genes could also be important in the pathogenesis of B. pseudomallel in 
mammalian models of infection. 
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8.3. Conclusions 
The aims of this thesis, stated in section: 1.6. have been met. The investigation of 
techniques for the study of bacterial pathogenicity using C. elegans has lead to the 
establishment of a nematode model of B. pseudomallei infection. When this model was 
investigated further, assays carried out on solid media were also found to be a better model 
of B. pseudomallei virulence in mammals. B. pseudomallei mutants that had a reduced 
virulence towards nematodes in a plate-based mortality assay also showed a decrease in 
virulence in mammalian models of infection. Hence C. elegans has been found to be a 
useful model for the study of B. pseudomallei pathogenesis. This allows the nematode 
model described in this thesis to be used as tool for the isolation of attenuated mutants, for 
further study in mammalian infection models. As the methods used to screen mutants are 
rapid and cost effective, the study of B. pseudomallei-host interactions would be greatly 
facilitated through the use of nematode models. They may help to reduce animal usage in 
the initial stages of any study involving the screening of B. pseudomallei mutant libraries, 
while providing valuable information concerning the molecular events that lead to 
virulence in mammals. Infection models using the C. elegans nematode continue to 
provide valuable information regarding the pathogenicity of a number of other bacterial 
pathogens (Tan 2002). Thus, the use of the C. elegans-Burkholderia model will also 
continue to provide important information regarding the pathogenesis of B. pseudomallci, 
which may eventually lead to a greater understanding of this relatively poorly characterised 
pathogen. 
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EcoR I 
Not I 
' T3 j 
SuperCas f BamH 1 cosmid vector 
7.9 kb T7 t 
Not I 
X, a 
EcoR I 
Appendix: 1. Physical map of the supercos-1 cosmid vector. The red box shows the 
restriction endonucleases that can be used for cloning. Courtesy of Stratagene, UK. 
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Appendix: 2. A physical map of the cloning vector pUC18/19 which was used for cloning 
and characterisation of genes containing transposon insertions. The diagram within the 
black box shows the multiple cloning site of pUC19 which was used in the characterisation 
of the interrupted gene in the mutant B. pseudomallei 6H2 (Chapter: 6). The red box shows 
the sequence and position of the sac 1 restriction endonuclease sites used for cloning of B. 
pseudomallei genomic DNA. 
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Mr 
ýý 220000 
97000 
66000 
45000 
30000 
20100 
14300 
Appendix: 3. High range rainbow marker molecular weight standard (Amersham, UK) 
used in this study to show the weight of proteins separated using in SDS-PAGE. 
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Primers Sequencing primer Sequence (5'-3') 
M13 forward TTT CCC AGT CAC GAC GTT G 
M13 reverse GGA TAA CAA TTT CAC ACA GG 
Appendix. 4. Primers and primer sequences used in the DNA sequencing of cloned DNA 
within the multiple cloning site of the plasmid vector pUC19. 
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